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ABSTRACT 
  
The effects of development and virulence on gene expression in the 
protozoan parasite Neospora caninum 
 
Kittichai Unjit 
 
Neospora caninum is an obligate intracellular protozoan parasite which causes 
abortion in cattle and neuromuscular disease in dogs. Neosporosis causes substantial 
economic losses in both dairy and beef cattle industries worldwide. This thesis 
explores changes in genes and proteins expression associated with development and 
virulence of N. caninum in order to gain more biological information in this parasite. 
To achieve the global quantification of genes and proteins expression under different 
phenotypic conditions, transcriptomics and proteomics approaches are used to 
investigate these phenomenons. 
 
Chapter 2 examines the differential protein expression during tachyzoites-
bradyzoites stage conversion using a label-free proteomics approach and finds that 
the differential protein expression of most apical secretory proteins decrease in 
abundance in bradyzoites stage. In addition, most of proteins associated with parasite 
motility were also reduced in abundance in bradyzoites. This indicates that proteins 
associated with host cell adhesion, invasion and gliding motility are down-regulated 
in the quiescent cyst-forming stage. 
 
Chapter 3 compares the transcriptomic profiles of low- and high-virulence N. 
caninum using RNA-Seq and finds that protein phosphatase 2C (PP2C) was 
preferentially expressed in the high-virulence strain, while a group of SRS family 
proteins was preferentially expressed in low-virulence conditions. This finding 
suggests that PP2C might play a role in virulence, while a group of SRS proteins 
might be associated with to limiting N. caninum virulence. 
 
Chapter 4 compares protein expression in low- and high-virulence N. caninum strains 
at three different time points using a label-free quantitative proteomic approach and 
v 
 
finds that Rop24 was preferentially expressed in high-virulence N. caninum at all 
time points. Proteins associated with host cell attachment such as SAG3, TgSRS35A 
and cathepsin C2 also showed preferentially expression throughout the time course. 
This finding indicates that Rop24 might be associated with the N. caninum virulence, 
while the discovery of proteins associated with host cell attachment in low-virulence 
conditions might suggest that such strains are more efficient in invading host cells 
than high-virulence strains. 
 
Overall, this thesis identifies genes and proteins such as the rhoptry associated 
proteins PP2C and Rop24, which might be associated with virulence in neosporosis. 
It also shows that many proteins involved in host cell adhesion, invasion and parasite 
movement decrease in abundance in the cyst-forming bradyzoite stage. These 
discoveries enhance our understanding of parasite biology, providing a basis for 
future research into novel ways to prevent and control the disease by inhibiting 
parasite survival and transmission. 
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Chapter 1: Introduction 
 
2 
 
1.1 Neosporosis 
 
Neosporosis is a parasitic disease caused by Neospora  caninum, an obligate 
intracellular protozoan belonging to phylum Apicomplexa (Dubey et al., 1988a). N. 
caninum is a member in the same phylum as three well known parasites: Toxoplasma 
gondii (causing toxoplasmosis in humans and animals) (Dardé et al., 1998), 
Plasmodium falciparum (causing malaria in humans) (Nabet et al., 2016), and 
Eimeria tenella (causing intestinal diseases in diverse animals) (Jordan et al., 2011). 
Apicomplexan parasites have been characterized by an apical complex situated at 
one end of their structure. The apical complex is important as a unique evolutionary 
adaptive for host cell invasion (Goodswen et al., 2013).   
 
N. caninum causes neosporosis in cattle (Bos taurus) and domestic dogs (Canis 
familiaris). Neosporosis is a major cause of abortion in both dairy and beef cattle 
worldwide and neuromuscular disease in infected dog. It has been found in cattle in 
every country where the disease has been sought (Al-Qassab et al., 2010). The loss to 
cattle typically happens after primary infection during pregnancy period and the 
recrudescence of the persistent infection is common during gestation (Dubey et al., 
2006). N. caninum is closely related to T.gondii and they share many common 
biological and morphological characteristics, until 1988, N. caninum was 
misdiagnosed as T. gondii (Bjerkas and Dubey, 1991; Dubey et al., 1988a; Dubey 
and Lindsay, 1996).  Transplacental (vertical) transmission is the major route of 
transmission for neosporosis. This route of transmission play a significant role in 
maintaining the infection within the herd (Rojo-Montejo et al., 2009a). Once 
infected, cattle and dogs can remain infected for their entire lives (Barber and Trees, 
1998).  
 
Abortion is the main clinical sign in cattle infected with Neospora. Pregnant cows 
may abort from three months of gestation up to term but mostly between 5-7 months 
of pregnancy. Infected foetuses are mostly born clinically normal but persistently 
infected, however some may die, be reabsorbed, mummified, autolyzed, or stillborn. 
Aborted foetuses typically present lesions as multifocal necrosis surrounded by 
inflammatory cells affecting organs such as brain, spinal cord, heart, lung, and 
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placenta (Barr et al., 1991). Approximately 80-90% of infected calves might be 
Neospora carriers; most of these are clinically normal.  
 
In dogs, N. caninum can cause severe disease to dogs of all ages but it is mostly 
found in puppies (Nishimura et al., 2015). Pathology in dogs typically comprises 
pelvic limb paralysis and rigid hyperextension (Dubey and Schares, 2011; Reichel et 
al., 2007). Dogs may show encephalomyelitis and myositis which results in paralysis 
and early death in puppies (Bjerkas et al., 1984). However, the neurological signs 
which are seen in adult dogs are variable depending on the site of parasite 
multiplication in central nervous system (Dubey, 2003).  
 
N. caninum is a heteroxenous parasite requiring more than one host to complete its 
life cycle; sexual replication occurs in definitive, canid hosts and asexual replication 
occurring in intermediate, bovine hosts (Donahoe et al., 2015; Dubey et al., 2006). 
Dogs (Canis familiaris) are typically the definitive host of N. caninum (McAllister et 
al., 1998) although other canids such as coyotes (Canis latrans) (Gondim et al., 
2004), gray wolves (Canis lupus) (Dubey et al., 2011) and  Australian dingoes 
(Canis lupus dingo) (King et al., 2010) have been observed to excrete oocysts after 
feeding on infected tissue cyst. N. caninum is a haploid organism which displays 
sexual reproduction in its canine host. Although, dogs infected with N. caninum are 
not always sero-positive (Lindsay et al., 1999a; McAllister et al., 1998), all dogs 
should be considered as an important source of N. caninum transmission whether 
they have seroconverted or not (Reichel et al., 2014).  
 
Several animal species can be infected with N. caninum: parasites isolated from dogs 
have been classified as  Nc-1 (Dubey et al., 1988b), Nc-Bahia (Sawada et al., 2000), 
and Nc Liverpool (Barber et al., 1993). Nc BPA1, BPA2 (Conrad et al., 1993), Nc 
KBA1, KBA2 (Kim et al., 2000), Nc-Spain 1H (Rojo-Montejo et al., 2009b), Nc-
Spain 2H, 3H, 4H, and 5H as well as Nc-Spain 6, 7, 8, 9, and 10 (Regidor-Cerrillo et 
al., 2008) were isolated from cattle; Nc-Sheep from sheep (Koyama et al., 2001), and 
NcBrBuf 1, 2, 3, 4, and 5 from water buffalo (Rodrigues et al., 2004). In addition 
there are reports antibodies against N. caninum being detected in white-tailed deer 
(Odocoileus virginianus) (Lindsay et al., 2002), crows (Corvus corax) (Molina-
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López et al., 2012), hares (Lepus europaeus), zebra (Equus burchelli), Thorold’s deer 
(Cervus albirostris), sika deer (Cerus Nippon pseudodaxis), fallow deer (Dama 
dama), moose (Alces alces), mouflon (Ovis ammon), European bison (Bison 
Bonasus), sea otter (Enhydra lutris) and dolphin (Tursiops truncatus) (Dubey et al., 
2007). These observations suggest that wild animals also play an important role in 
the epidemiology of neosporosis. 
 
1.2 Life cycle of N. caninum 
 
The life cycle of N. caninum comprises three distinct asexual infectious stages 
known as sporozoites, tachyzoites and bradyzoites (Dubey, 1999b) (Figure 1.1). 
Unsporulated oocysts are excreted by definitive host into the environment within 5 to 
17 days after ingesting tissue cysts (Lindsay et al., 1999a). Sporulated oocysts are 
active after 3 days in the environment. Each sporulated oocyst contains two 
sporocysts and each sporocyst cantains four sporozoites (Dubey et al., 2002). The 
oocyst is resistant to environmental degradation, with a wall that is tolerant to 
freezing and drying, allowing infective sporozoites to survive in the external 
environment for several weeks. The intermediate host as well as the definitive host 
can be infected with N. caninum by ingesting sporozoite containing oocysts. 
Sporozoites are released from ingested oocyst into the gut of the host, these then 
invade the gut wall and differentiate to tachyzoites. Cell invasion by tachyzoites 
results in the creation of a parasitophorous vacuolar membrane (PVM) that is 
followed by rapid asexual replication by endodyogeny. The tachyzoites can be 
transmitted to the developing foetus via the placenta. In response to host immune 
reponses, the rapidly dividing tachyzoites can convert into slowly replicating 
bradyzoites which can survive for the life of the intermediate host (Dubey and 
Lindsay, 1996). The bradyzoites residing within the quiescent tissue cysts can lead to 
recrudescent infection if the host immune is suppressed, for example during 
pregnancy or concomitant disease (Haddad et al., 2005). When the same tissue cysts 
are ingested by dogs, often via contaminated meat, the bradyzoites are released from 
the cyst and infect epithelial cells of the small intestine, ultimately leading to the 
differentiation of gametocytes. The fusion of gametocytes to produce unsporulated 
oocysts in the lumen of canine gut completes the life cycle.  
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Figure 1.1 Life cycle of Neospora  caninum ( reprinted from Dubey ( 1999a) ) .  The 
dog, a definitive host, ingests tissue cysts and passes unsporulated oocysts into the 
environment in its faeces. Intermediate hosts, such as cattle, ingest sporulated oocyst, 
then sporozoites release and form tachyzoites in cell lining of the gut. The definitive 
host can be infected by ingesting tissue cyst or the tachyzoites will transmit through 
the placenta and infect the foetuses.  The definitive host is infected by ingesting 
infected meat containing tissue cysts. 
 
1.3 Mode of transmission in cattle 
 
Both horizontal and vertical transmission play an important role in the transmission 
of N. caninum among cattle. Horizontal transmission occurs by cattle ingesting 
sporolated oocysts distributed in the environment. To date, there is no report of cow-
to-cow transmission nor evidence that cows can shed oocysts to the environment. 
There are two main routes of vertical transmission that transmit parasites from the 
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dam to their offspring. Exogenous transmission occurs after the dam is infected by 
ingesting sporulated oocysts, while endogenous transmission occurs when the 
infection is recrudescent following a previously infected pregnancy  (Trees and 
Williams, 2005).  Vertical transmission is very efficient in cattle and it is the major 
route of transmission (Barr et al., 1993; Hietala and Thurmond, 1999; Schares et al., 
2005). The infected cow might remain infection for a whole life (Trees et al., 1999) 
and they may transfer the parasites to their fetuses in several next gestation or 
intermittently (Boulton et al., 1995; Piergili Fioretti et al., 2003; Wouda et al., 1998).  
Moreover, transplacental transmission can be re-occurred in the same animal (Barr et 
al., 1993; Bjerkas et al., 1984; Dubey et al., 1988b). Thus, lifelong infections of 
animals contribute to persistent infection of the herd through this mechanism  (Beck 
et al., 2009). However, French et al. (1999) examined the transmission and control of 
N. caninum using deterministic and stochastic models. They found that vertical 
transmission alone was not sustained the infection of N. caninum in the cattle herds 
even though the high probability of vertical transmission was shown. Molecular 
analysis of N. caninum populations suggested that a clonal population is typical 
where vertical transmission is efficient  (Perez-Zaballos et al., 2005). 
  
Neosporosis remains a challenging disease to control.  N. caninum can be killed by 
drugs but these are not adequate for disease control. The most effective way to 
control neosporosis is vaccination. However, at the present there are no effective 
vaccines against neosporosis available (Reichel and Ellis, 2009). While the analysis 
from Reichel & Ellis (2009) showed that vaccination is the most cost effective 
approach to control neosporosis. In the absence of effective drugs and vaccines, the 
most appropriate ways to control bovine neosporosis are employing good and 
effective management systems, for example by avoiding contact between dogs and 
grazing cattle. 
 
1.4 N. caninum cellular structure and function 
 
There are three infectious stages of N. caninum known as tachyzoites, bradyzoites, 
and sporozoites. Tachyzoites and bradyzoites are found in the tissues of intermediate 
and definitive hosts, while sporozoites are found in sporocysts inside the oocysts, 
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which are formed in the intestine of definitive host and excreted via their faeces 
(Dubey et al., 2006). 
 
1.4.1 The tachyzoite stage  
 
Tachyzoite is a fast replicating form of N. caninum associated with acute infection. 
The size of N. caninum tachyzoite is 3-7 x 1-5 µm (Dubey et al., 2002) which is 
slightly larger than T. gondii and depending on the stage of replication (Dubey 
&Lindsay, 1996). The N. caninum tachyzoite has a crescent shape, pointed at the 
anterior end and rounded at the posterior end (Figure 1.2). It contains two apical 
rings, 22 subpellicular microtubules, conoid, cytoskeleton, micropore, subpellicular 
microtubule, secretory organelles (such as rhoptries, micronemes and dense 
granules), mitochondria, apicoplast, endoplasmic reticulum, nucleus, Golgi complex 
and ribosome (Lindsay et al., 1993; Speer and Dubey, 1989). The outer membrane is 
covered with a pellicle which consists of three layers of plasma membrane.  
 
Tachyzoites divide into two zoites by endodyogeny and they can be found in neural 
cells, macrophages, fibroblasts, vascular endothelial cells, hepatocytes, myocytes, 
and renal tubular epithelial cells (Bjerkas and Presthus, 1989; Dubey et al., 1988a; 
Speer and Dubey, 1989). Tachyzoites invade host cells by active invasion, localise 
within a parasitophorous vacuole (PV), and become intracellular within 5 minutes 
after attach with host cells (Hemphill et al., 1996). They may be located in more than 
one PV per host cell.  
 
1.4.2 The bradyzoite stage  
 
Bradyzoite is a slowly replicating form of N. caninum that represents the chronic 
stage of the disease. Bradyzoite form cysts with surrounding walls up to 4 µm thick; 
cysts vary in size depending on the number of bradyzoites contained within (Dubey 
et al., 2006). The shape of tissue cysts are often round to oval and up to 107 µm long. 
They are mostly found in neural tissues such as brain spinal cord, nerves and retina 
(Dubey et al., 1988a; Dubey et al., 1990) and they can be found in skeletal muscles 
(Dubey et al., 1989).  Bradyzoite is slender and 6-8 x 1-1.8 µm in size. They contain 
8 
 
the same organelles as found in tachyzoites except there are fewer of rhoptries and 
more amylopectin granules  than tachyzoites (Dubey and Lindsay, 1996).  
 
1.4.3 The sporozoite stage  
 
The sporozoite stage of N. caninum is found within the oocyst. Each oocyst contains 
two sporocysts and each sporocyst contains four sporozoites (Lindsay et al., 1999b). 
The size of oocysts is roughly 10 x 12 µm with smooth colourless wall of 0.6 - 0.8 
µm thickness. The oocysts are spherical to sub-spherical and excreted with the faeces 
of the canid host in unsporulated form. Sporocysts are ellipsoidal with size of 8 x 6 
µm and their wall thickness are 0.5 -0.6 µm. Sporozoites are characterized by the 
position of the nucleus, which is located centrally or slightly posteriorly (Lindsay et 
al., 1999b).  
 
Although little is known about the biology of the N. caninum oocyst, it is a key factor 
in neosporosis epidemiology in cattle (Dubey et al., 2007). The large number of 
contaminated oocysts in the environment leads to the high chance of infection 
(Goodswen et al., 2013).   The prepatent period before the shedding of oocysts by 
definitive host varies from 5- 10 days after N. caninum infection (Al-Qassab et al., 
2010) and they might be continually excreted for 10 days (McAllister et al., 1998; 
McCann et al., 2007). The age of the host, type of feeding tissues, and immunity 
status of host affect the rate of oocyst shedding (Dubey et al., 2007). For example, 
the number of oocysts shedded was higher in dogs that ingest infected calf tissue 
than in those that ingested mouse tissue cysts. It has also been shown that infected 
puppies shed oocysts at a higher rate than adult dogs (Gondim et al., 2002). 
 
1.5 Stage conversion from tachyzoites to bradyzoites stage of N. 
caninum 
 
The Neospora tachyzoites can convert into bradyzoites in response to host immunity 
for survival in the host. Tachyzoites differentiate to bradyzoites after triggering by 
the host immune response leading to cyst forming in host tissues. Recrudescence can 
occur in pregnant cattle caused by the suppression of host immunity and incur 
transplacental transmission. The vertical transmission is an important route for the 
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persistent infection from generation to generation. The tachyzoite-bradyzoite 
conversion process is central to pathogenesis, establishing a chronic infection, and 
disease reactivation (Lyons et al., 2002). The knowledge of protein expression 
involved in N. caninum stage conversion will provide a better understanding of 
pathogenesis for neosporosis. 
 
In vitro tachyzoite-bradyzoite conversion can be induced in T. gondii using inhibitors 
of mitochondrial function and inducers of oxidative stress (Bohne et al., 1994; Soete 
et al., 1994). Nitric oxide (NO) has been shown to induce the stage conversion  as it 
is an inhibitor of mitochondrial function and an indirect stressor of the parasites 
(Lyons et al., 2002). The bradyzoites-tachyzoites stage conversion could also be 
induced using alkaline medium (Soete et al., 1993). In N. caninum, Vonlaufen et al. 
(2002) successfully developed the stage conversion assay from tachyzoites to 
bradyzoites using 70 µM sodium nitroprusside (SNP) and the parasites can survive 
for up to 8 days. The murine epidermal keratinocytes was used as host model which 
was infected with tachyzoites of N. caninum Liverpool strain. Their result revealed 
significant reduction in parasites multiplication. The immunofluorescence assay was 
used to detect BAG1 antibodies which could be firstly detected at day 4 (35% BAG1 
expression), then at day 8 (60% BAG1 expression) in parasitophorous vacuole (PV) 
and those PV expressing BAG1 exhibited strongly reduced in expression of 
tachyzoites marker antigens Nc SAG1. The other N. caninum stage conversion 
development was also performed by Vonlaufen et al. (2004) using another host cell 
type as Vero cells for the development. They found that the optimal concentration of 
SNP was 17 µM. This concentration did not visibly destroy the structural integrity of 
the Vero cells monolayer. This developed procedure has been applied in this study. 
 
1.6 Host cell invasion and N. caninum apical complex 
 
Invasion process of host cells and subsequent intracellular development is vital for N. 
caninum to survive and proliferate (Hemphill et al., 1999; Hemphill et al., 2004). The 
invasion process is similar to T. gondii. A low-affinity contact between tachyzoites 
and the host cell surface membrane is established, followed by the attachment 
process which requires N. caninum metabolic energy for invading the host cell 
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(Hemphill et al., 1996). The tachyzoite invades the host cell by reorientating itself 
perpendicularly to the surface of the host cells and advancing at the anterior end. 
Once in the host cell cytoplasm it is enclosed by the PVM acquired from host cell 
membrane (Hemphill and Gottstein, 2006). The tachyzoite immediately starts to 
divide by endodyogeny which can be visualised at approximately 6 hours after 
invasion. Host cell lysis occurs after 72-80 hours leading to parasite to egress and 
infect the neighbouring cells (Hemphill, 1999). The unique secretory organelles that 
comprise the apical complex (micronemes, rhoptries and dense granules) are shown 
in Figure 1.2 and play a key role in this process. 
 
1.6.1 Micronemes 
 
Micronemes are rod-like shaped organelles located at the anterior region of 
apicomplexan parasites (Dubey et al., 1998). Microneme proteins (MICs) play an 
important role in host cell invasion and are the first proteins to be released upon 
attachment to the host cell (Carruthers and Sibley, 1997b; Sonda et al., 2000).  The 
micronemes seccrete adhesins which interact with actin-myosin motors to contribute 
driving movement essential for host cell invasion (Dobrowolski and Sibley, 1996; 
Keeley and Soldati, 2004; Morisaki et al., 1995), while several microneme proteins 
are associated with the gliding movement of apicomplexa (Tomley and Soldati, 
2001).  N. caninum and T. gondii  contain 38 and 33 genes respectively that encode 
microneme proteins (Reid et al., 2012).  MIC1 has adhesive domains helping the 
parasite to attach to host cells (Garnett et al., 2009).  MIC1 forms a complex with 
MIC4 and MIC6 which is important for the invasion process of the parasite (Reiss et 
al., 2001a; Saouros et al., 2005a).  TgMIC2 contains transmembrane adhesion which 
play a vital role in gliding motility and host cell invasion (Huynh and Carruthers, 
2006). NcMIC2 contains integrin- and TSP-like domains which are a member of the 
TSP family of adhesive proteins (Naitza et al., 1998). A complex of MIC2 and 
MIC2-associated protein (M2AP) is essential for host cell entry and attachment 
(Jewett and Sibley, 2004).  NcMIC3 has also been shown to interact with the host 
cell surface proteoglycan during host cell binding (Naguleswaran et al., 2002). 
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1.6.2 Rhoptries 
 
Rhoptries are club shaped organelles with a narrow anterior neck extending into the 
conoid, which act as ducts to release their contents (Bannister et al., 2003; Bradley et 
al., 2005). Rhoptries secrete rhoptry neck proteins (RONs) such as RON2, RON4, 
RON5 and RON8, shortly after microneme proteins. These form a complex with 
microneme protein apical membrane antigen 1 (AMA1) to effect a moving junction 
with the host cell membrane during invasion (Alexander et al., 2005; Besteiro et al., 
2009; Tyler and Boothroyd, 2011). The moving junction is the mechanism by which 
N. caninum enters host cells and establishes a PV (Alexander et al., 2005). Rhoptry 
proteins (ROP) are released slightly after RONs and the invasion process.  ROP play 
a significant role in early and later stage of invasion as well as localisation and 
formation of the PV (Bradley et al., 2005).  Soluble ROP1 is released into the PV 
after its formation (Saffer et al., 1992) while ROP2 is secreted into the PVM where it 
attaches to the host mitochondria and may enable the parasite to obtain host nutrients 
(Beckers et al., 1994; Sinai and Joiner, 2001).  
 
Some ROP proteins have been shown to be associated with virulence in T. gondii 
such as ROP5, ROP16 and ROP18. TgROP5 can reduce interferon- γ (IFN-γ)-
induced and immunity–related GTPases (IRGs), which promote parasite killing by 
disrupting the PVM (Niedelman et al., 2012). TgROP16 is secreted into the host 
cytosol during host cell invasion where it phosphorylates STAT3/6 and so modulates 
the expression of inflammatory mediators such as IL-10 and IL-23 (Jensen et al., 
2011). TgROP18 abundance correlates with parasite multiplication rate with kinase 
activity in T. gondii (El Hajj et al., 2007). However, Reid et al. (2012) found that 
ROP18 in N. caninum is pseudogenised and so does not play the same role. 
Consequently, N. caninum is unable to phosphorylate host immunity-related 
GTPases via this mechanism.  
 
1.6.3 Dense granules 
 
Dense granules are located at the posterior end of N. caninum and are similar to 
micronemes in their appearance (Bannister et al., 2003; Speer et al., 1999). Dense 
granule (GRA) proteins are secretory proteins that contain transmembrane domains. 
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In general, GRA proteins are secreted into the PV; GRA1 is released into the PV 
(Sibley et al., 1995) and GRA2, GRA4 and GRA6 are involved in intravacuolar 
network membrane (Labruyere et al., 1999). They are involved in PV maturation and 
are essential for parasite growth (Carruthers and Sibley, 1997b; Dubremetz et al., 
1993). Most GRA proteins are secreted  within one hour of PV formation 
(Dubremetz et al., 1993). GRA proteins are associated with many important 
processes in host invasion, for example providing nutrient acquisition, parasite 
egression and modulating the initial immune response (Braun et al., 2013; Cesbron-
Delauw, 1994; Coppens et al., 2006; Okada et al., 2013; Travier et al., 2008).  
 
 
 
Figure 1.2 Diagram of N. caninum tachyzoite which organelles are labelled. 
(Reprinted from (Reid et al., 2012) ) 
 
1.7 The virulence of Toxoplasma gondii 
 
The closest parasite related to N. caninum is T. gondii which show huge amount of 
studies. The crucial of invasion process of T. gondii is rhoptry organelle. The clinical 
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symptoms of toxoplasmosis in human vary from asymptomatic to debilitating or 
even life threatening. While, T. gondii strains differ in their virulence in animals1. 
Sibley & Boothroyd, 1992 analysed 28 strains of T. gondii from many of hosts from 
five continents and found that the ten virulent strains have potential same genotype, 
whereas the nonvirulent strains were moderately polymorphic. These data highly 
suggest that virulent strains of T. gondii originated from a single lineage. Previous 
studies identified three clonal lineages of T. gondii that exhibit different virulence 
phenotypes in mice, with type I strains are lethal in mice, whereas type II show 
intermediate virulence that varies with mouse strain and type III have been 
considered avirulent 26 (Melo et al., 2011; Robert-Gangneux and Darde, 2012; Saeij 
et al., 2005; Xiao and Yolken, 2015), there are many factors influenced the severity 
of toxoplasmosis such as the age and immune status of the infected host (Petersen 
and Dubey, 2001), and stage of the life cycle causing infection (Munoz-Zanzi et al., 
2010), parasite migratory capacity, the growth rate in vitro and the parasite loads in 
mice (Saeij et al., 2005), as well as polymorphism and differential expression of the 
dense granule and rhoptry proteins (Melo et al., 2011). The other different 
phenotypes among the three major lineages include growth rate (Radke et al., 2001), 
frequency of differentiation, motility and ability to cross biological barriers 
(Barragan and Sibley, 2002), disturbance of host cell signalling, intestinal pathology 
induction during acute stage (Liesenfeld, 2002) and CNS pathology development 
during chronic stage in the mouse (Suzuki and Joh, 1994). ROP proteins play an 
important role in modulating of host cell signaling and parasite virulence (Bradley 
and Sibley, 2007). The study of genetic basis for virulence in type I lineage was 
performed by analysis of progeny from genetic cross with type III. It showed that 
ROP18 was designated as the major determinant of virulence in type I lineage while 
this gene was shown type III strain with extremely low level (Taylor et al., 2006). 
ROP18, an active serine/threonine (S/T) protein kinase, is a major factor that 
contributes to strain-specific differences in virulence (Saeij et al., 2006; Taylor et al., 
2006). It is discharged into the host cell and decorates the surface of the 
parasitophorous vacuole membrane (PVM). The expression levels of ROP18 vary 
from high abundance in type I and II strains to a low level in type III strains. 
Transgenic modification of ROP18 from type I or type II strains in the type III strain 
of T. gondii increase virulence approving that this rhoptry protein play role in 
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virulence between strains (Saeij et al., 2006; Taylor et al., 2006). The increased 
virulence of parasites with type I allele of ROP18 is related to increase replication of 
T. gondii (Saeij et al., 2006). A comparison of ROP18 region in T. gondii with the 
related parasite N. caninum suggests that it went through a rearrangement in the 
ancestral progenitor to type I and II strains (Khan et al., 2009), leading to high 
abundance of ROP18 expression in both type I and II lineages and enhance 
virulence. Both virulence of types I and II and avirulence of type III alleles are 
constant in the parasite population revealing evidence of long term stability (Khan et 
al., 2009). The other rhoptry kinase is ROP16 which is key virulence determinant. 
ROP 16 acts to sustain the phosphorylation of STAT3 which is a negative regulator 
of Th1 immune response.  It is a regulator of host cell transcription of type I and III 
during host cell invasion by direct tyrosine phosphorylation of STAT pathways and 
target to the host nucleus (Saeij et al., 2007a). The ROP16 allele shared by type I and 
III which is effective in mediating sustained phosphorylation of STAT3. Type I and 
III strains may be able to avoid detection by immune system by modulating host 
gene expression. This protein not only induced the phosphorylation but also induced 
nuclear translocation of STAT5 to generate protective immunity (Jensen et al., 2013; 
Rosowski and Saeij, 2012). Chang et al. (2015) found that ROP16 can induce SH-
SY5Y apoptosis via mitochondria-dependent p53 pathway by increasing Bax 
expression and decreasing the Bcl-2 expression. T. gondii rhoptry protein5 (ROP5) 
has been determined as a key virulence factor that diminishes the accumulation of 
immunity-related GTPases (IRG) in PVM. IRG has role in PVM integrity and evades 
IFNγ-mediated killing by intracellular parasites (Etheridge et al., 2014). ROP5 locus 
is the quantitative trait locus (QTL) found in a genetic cross between type I and II 
strains (Jensen et al., 2013). The genetic disturbance of the ROP5 in a type I strain 
revealed an attenuated of T. gondii (Jensen et al., 2013; Rosowski and Saeij, 2012). 
The comparison of the three pair-wise cross among three different type of T. gondii 
suggested that ROP5 and ROP18 interact together showing about 90% of the 
differences in acute virulence between these three lineages. 
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Table 1.1 Summary of T. gondii virulence 
T. gondii (strain) Virulence High abundance of ROP protein 
Type I  high ROP18 ROP16 ROP5 
Type II intermediate ROP5 
Type III low ROP16 
 
1.8 The virulence of Neospora caninum 
 
Virulence in N.caninum is the ability of the parasite to induce pathology in mice and 
of the parasite to transmit via the placenta (Al-Qassab et al., 2010).  Virulence can 
vary among N. caninum strains and ranges between asymptomatic infections to 
abortion. For example, the Nc Spain 1H strain, which was isolated from the brain of 
infected healthy calf, is considered a low-virulence strain. While Nc Liverpool, 
which was collected from the cerebrum of a congenitally infected puppy, has 
displayed high virulence (Barber et al., 1993).  
.  
There are several experimental studies concerning virulence in animal models such 
as pregnant mice and pregnant cattle. They reveal marked phenotypic differences 
between low- and high-virulence strains, for example in invasion rate and tachyzoite 
yield in cell culture (Pereira Garcia-Melo et al., 2010). The in vitro invasion 
efficiency and intracellular proliferation rate associated with virulence in N. caninum 
study was performed by (Regidor-Cerrillo et al. (2011)). Nc-Liverpool and ten 
Spanish N. caninum isolates (Nc-Spain 1H –Nc-Spain 10) were used for the 
investigation. They found that the Nc Spain 4H and Nc- Liverpool revealed the 
significant highest of invasion rate than Nc-Spain 3H and Nc-Spain 1H at 4 hr pi by 
Dunn’s test. Nc Spain 7 has shown high virulence in a mouse model, similar to Nc-1  
(Pereira Garcia-Melo et al., 2010). Infection with Nc Spain 7 is associated with 
greater severe lesions in the brain compared to controls, as well as higher parasite 
burdens in late phase infection and increased parasite dissemination (Pereira Garcia-
Melo et al., 2010). 
 
Conversely, low-virulence strains such as Nc Spain 1H (Rojo-Montejo et al., 2009a) 
and Nc Nowra (Miller et al., 2002) often do not cause any clinical signs in cattle. 
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Rojo-Montejo et al. (2009b) examined pregnant and non-pregnant BALB/c mice 
infected with Nc Spain 1H. The result showed that no clinical signs and foetal death 
occurred, and no parasites could be detected in mouse brain tissue during the chronic 
infection stage. However, pregnant mice infected with Nc-1 did show high placental 
transmission leading to high neonatal mortality rate. The other virulent study to 
visualise the immunome among three biologically different isolates as Nc Spain 7 
and Nc-Liv (high virulence) and Nc Spain 1H (low virulence) was performed by 
Regidor-Cerrillo et al. (2015). The sera from experimentally infected mice from three 
isolates were determined by  2-DE immunoblot. They found that all isolates 
exhibited a highly similar antigenic pattern which most of the spots located in acidic 
region (pH 3-7) and located in 3 antigenic areas as 250-70, 45-37 and 35-15KDa. 
The sera from Nc-Spain 7 and Nc-Liv infected mice showed the highest number of 
antigens. Chryssafidis et al. (2014) studied the pathogenicity of Nc-Bahia (low 
virulence) and Nc-1 (high virulence) by intravenous inoculation of 5x108 N. caninum 
tachyzoites on the 70th day of gestation in pregnant cows and buffaloes. The result 
revealed that abortion was occurred in only 1 from 5 cows on 42 days post infection 
(dpi) with Nc-Bahia and no abortion was found in buffaloes (n=3) while all animals 
(n=5), two cows and three buffaloes infected with Nc-1 aborted on day 35 dpi. N. 
caninum can be detected by semi-nested PCR in maternal, foetal and placental 
tissues which revealed the evident of vertical transmission in both strains. They 
suggested that Nc-Bahia had shown lower pathogenicity than Nc-1 as showing fewer 
abortions and milder histological lesions.  
 
Schock et al. (2001) analyzed biological and genetic variation of six N. caninum 
isolates obtaining from bovine and canine origin by measuring growth rate in vitro, 
Western blotting and random amplification of polymorphic DNA (RAPD). The intra-
species diversity of N. caninum analysis showed that heterogeneity exists within 
species. The growth rate in vitro revealed significant variation among isolates by 
determining [H] uracil uptake. The multiplication of Nc-Liverpool showed the fastest 
rate than others and at more than two time of Nc-1 multiplication rate. On the other 
hand, Nc-SweB1 multiplied significantly slower rate which were 10 times less than 
Nc-Liverpool. The isolates of Nc-LivB1, BPA-1, JPA-2, and Nc-1 are intermediate 
in multiplication rate. The result of western blotting revealed no antigenic differences 
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detected between any of 6 isolates. Lastly, the result of RAPD illustrated that it was 
able to differentiate DNA polymorphisms between N. caninum isolates for example 
the pattern of band for Nc BPA-1, JPA-2, NC-1, NC LivB1 and Nc-SeB1 showed 
identical band but NC-Liverpool revealed clear polymorphic band at around 360, 480 
and 630 bp. These could be indicated intra-species diversity in N. caninum and 
exhibits heterogeneity exists within species. The pathogenicity study of NC-
Liverpool and NC-SweB1 was performed by Atkinson et al. (1999). They inoculated 
the tachyzoites to mice and found more necrosis in brain lesion of mice infected with 
NC-Liverpool than NC-SweB1. The pathogenicity in cattle depended on timing of 
infection, immune status of the host. Due to the vertical transmission is predominant 
in N. caninum infection, these might limit the opportunity of sexual recombination of 
the parasite leading to have a similar clonal population structure (French et al., 
1999). Knowledge from above experiment revealed clinical signs related to virulence 
among N. caninum strains. Thus, the genetic diversity of neosporosis will be useful 
for understanding the pathogenicity and epidemiology of the parasite. 
 
Table 1.2   Summary of N. caninum virulence 
Isolates 
Animal 
Origin 
Virulence Country Reference 
Nc-
Liverpool 
Dog High United 
Kingdom 
(Barber et al., 1993) 
Nc Spain 7 Bovine High Spain (Regidor-Cerrillo et al., 2008) 
Nc-1 Dog High USA (Dubey et al., 1988b) 
BPA1 Bovine High USA (Conrad et al., 1993) 
Nc Spain 1H Bovine Low Spain (Rojo-Montejo et al., 2009b) 
Nc Nowra Bovine Low Australia (Miller et al., 2002) 
Nc Bahia Dog Low Brazil (Gondim et al., 2001) 
Nc JAP1 Bovine Low Japan (Yamane et al., 1996) 
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1.9 Economic impact of bovine neosporosis 
 
Neosporosis causes economic losses to both dairy and beef cattle production (Larson 
et al., 2004). This is due to reproductive failures including  stillbirths, infertility, 
foetal death in early stage and resorption but also reduction in productivity, for 
example in milk production (Hobson et al., 2002) weight gain (Barling et al., 2001) 
growth rate and feeding efficiency (Trees et al., 1999). Moreover, neosporosis results 
in prolonged calving interval, increased culling rate (Hall et al., 2005), increased 
diagnosis cost and lactation time as well as decreased breeding stock value (Haddad 
et al., 2005), all of which impact on the cost of farm management. One study of N. 
caninum sero-prevalence in adult cattle in south west England revealed that 94% of 
herds were infected (i.e. at least one animal in the herd was sero-positive) (Woodbine 
et al., 2008). In England and Wales, neosporosis is the main cause of abortion in 
cattle estimated to cause 12.5% or 6000 abortions per year (Davison et al., 1999). 
Overall, neosporosis may represent an economic loss of 2-5% per year to each farm 
however, some farms can incur losses up to 20% due to this disease. Globally, losses 
to livestock systems caused by neosporosis are approximately one million dollars per 
year (Reichel et al., 2013). The estimated median losses caused by abortion were 
annually accounted for US$ 1,298.3 million which could be divided by continent as 
US$ 852.4 million (65.7%) in North America, US$ 239.7 million (18.5%) in South 
America, US$ 137.5 million (10.6%) in Australia and US$ 67.8 million (5.3%) in 
Europe. There were 46.5 million cows of dairy industry at annual risk of abortion 
(pregnant cows) in the 10 countries which can be estimated to be US$ 18.16 per 
individual cow on average. In addition, there were 102.2 million beef cattle at risk 
(pregnant) in eight countries which was estimated to be US$ 4.46 individually. At 
farm level, the median loss per farm was approximately accounted for US$ 1,600.0 
in dairy industry and only US$ 150.0 in beef industry (Reichel et al., 2013).  
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1.10 Omics Approaches to investigate gene and protein expression 
 
1.10.1 Transcriptomics  
 
Nowadays, transcriptomics has been rapidly developed because of the advance in 
next-generation sequencing technology. Transcriptomics is a technique used to 
investigate mRNA molecules or transcriptomes in cells or organisms of interest. 
Transcriptome is a collection of all RNA existing in cells at any given time point. 
The level of RNA transcripts is varying in different developmental stage and 
conditions. The study of transcriptomes provides the information of change 
happening in the cell at the transcriptional level. In addition, it helps understanding 
the function of gene, revealing the molecular composition of cells and detecting 
development of disease (Wang et al., 2009). There are three methods which are 
commonly performed to investigate the transcriptome expression profile; real-time 
quantitative PCR (qPCR), microarrays and RNA-Sequencing (RNA-Seq). 
 
1.10.1.1 Real-time quantitative PCR (qPCR) 
 
qPCR provides highly quantitative and sensitive data. It is generally appropriate for a 
relatively small number of transcripts in a large set of samples. In this method, 
reverse transcriptase transcribes RNA into complementary DNA (cDNA) which act 
as template for qPCR reaction.  
The quantification is performed by measuring the change of expression levels of 
mRNA interpreted by cDNA. The relative quantification is easy to perform as the 
amount of genes are directly compared to the amount of the control reference genes.  
 
1.10.1.2 Microarrays 
 
Microarray can explore tens of thousands of transcripts which has led to determine a 
wide range of biological problems. (Zhao et al., 2014). This technique can identify 
genes that are preferentially expressed between two conditions, for example, 
diseased and non-diseased, developmental processes and/or drug responses as well as 
the evolution of gene regulation in different species (Kerr et al., 2008; Passador-
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Gurgel et al., 2007). This technique quantifies a set of predetermined sequences and 
are still a widely used for transcriptomic profiling. However, there are some 
limitations of this technique, for instance the accuracy of expression measurements is 
limited by background hybridization, especially transcripts present in low abundance. 
Furthermore, probes differ considerably in their hybridization properties, and arrays 
are restricted to interrogate only those genes for which probes are designed (Zhao et 
al., 2014). RNA-Seq have been developed to overcome these limitations. 
 
1.10.1.3 RNA-Sequencing (RNA-Seq) 
 
RNA-Seq involves direct sequencing of transcripts or complementary DNAs 
(cDNAs) using high-throughput sequencing technologies with computational method 
to quantify transcripts in RNA extraction sample. There are several advantages of 
RNA-Seq over the other methods. RNA-Seq data can be mapped to an existing 
genome sequence to reveal sequence variation and strand-specific expression. Unlike 
microarrays, RNA-Seq does not have an upper limit for quantification, it has larger 
dynamic range (> 9000-fold range) of expression levels over which transcripts can be 
detected than microarrays. In addition, RNA-Seq has shown high accuracy for 
quantifying level of transcript and also show high levels of reproducibility (Wang et 
al., 2009). Hence, RNA-Seq generally performs with greater reliability, 
reproducibility and precision than microarrays and are now the preferred method for 
whole transcriptome profiling (Beyer et al., 2012; Montgomery et al., 2010; 
Mortazavi et al., 2008; Nagalakshmi et al., 2010; Wang et al., 2009). The process of 
RNA-Seq starts when the mRNA is converted to cDNA fragments with adaptors at 
one end or both ends. Individual cDNAs are sequenced in a high-throughput manner 
to acquire short sequences from one end (single-end sequencing) or both ends 
(paired-end sequencing).  The reads range is size between 30 and 400 bp. Many 
high-throughput sequencing technologies can be used with RNA-Seq such as the 
Illiumina IG (Mortazavi et al., 2008; Nagalakshmi et al., 2008; Wilhelm et al., 2008), 
Applied Biosystems SOLiD (Cloonan et al., 2008) and Roche 454 Life Science 
system (Barbazuk et al., 2007; Emrich et al., 2007; Vera et al., 2008) 
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1.10.2 Proteomics method 
 
Proteins are an important part in the organisms with many functional roles. 
Proteomics is a study of proteins (Anderson and Anderson, 1998) which is a 
subsequent step in the biological study after genomics and transcriptomics. 
Proteomics is the systematic quantification of all peptides within a cell or organism. 
Mass spectrometry plays a vital role in proteomic analysis (Cravatt et al., 2007). 
 
1.10.2.1 Gel-based proteomics 
 
Gel-based proteomics is a very popular technique to separate and quantify protein. 
This approach can investigate the protein expression in large scale which is cheaper 
than gel-free proteomics.  
Two-dimensional electrophoresis (2DE) is a widely used gel-based method which based 
on two different biochemical characteristics of proteins. First, proteins are separated 
according to their isoelectric point. Then SDS-PAGE separates proteins according to 
their molecular mass. The spots are then visualized, evaluated and finally identified 
proteins by mass spectrometry. 2D Fluorescence Difference Gel Electrophoresis 
(2D-DIGE) has been developed which provides more accurate and reliability in 
protein quantification. Therefore, samples in comparison are run together in the same 
gel as a consequence of reducing the potential gel-to-gel variation (Kondo, 2008). 
However, this technique requires some skills, time consuming, laborious, low 
sensitivity and has some technical restrictions associated with protein resolving mass 
(Old et al., 2005; Zhu et al., 2010). In addition, this technique is limited in dynamic 
range, and often struggles to identify hydrophobic proteins and those with high 
molecular weight and pI values (Zhu et al., 2010).  
 
1.10.2.2 Non-Gel-based proteomics 
 
The non-gel-based methods such as label-based quantitative technique and label-free 
quantitative technique were developed to reduce the gel-based method limitations. 
These methods provide potential tools to investigate large-scale protein expression 
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and characterisation in biological samples (Domon and Aebersold, 2006; Motoyama 
and Yates, 2008).   
 
1.10.2.2.1 Label-based quantitative proteomics 
 
The label - based quantitative technique as isotope labelling method has been 
incorporated into mass spectrometry as internal standards or relative references (Zhu 
et al., 2010). This technique differentiates the proteins in the sample by using 
chemical and physical properties of isotope labelled compounds that match with their 
natural compounds of the samples except their masses. This method offers valuable 
flexibility to study protein expression change using quantitative proteomics tools. 
Though, most labelling quantification methods also have the limitation such as 
increased time and complex sample preparation, require higher concentration of 
samples, expensive, incomplete labelling and require specific software for 
quantification. These restriction of label –based quantitative method lead to increase 
the interest of label-free proteomics techniques which provide quicker, cleaner and 
simpler quantification outcome (America and Cordewener, 2008; Chen and Yates Iii, 
2007; Old et al., 2005; Patel et al., 2009) .   
 
1.10.2.2.2 Label-free quantitative proteomics  
 
The method of label-free quantitative proteomic was used to analyse the proteins 
expression throughout this thesis. The samples preparation for these techniques were 
individually performed then each injected to LC-MS/MS (Figure 1.3). There are 2 
categories of measurement used for protein quantification as measurement of ion 
intensity changes for example peptides peak area or peak heights in chromatography 
and measurement of the spectral counting of identified proteins. The peptide peak 
intensity (or spectral count) is measured for each LC-MS/MS run and the change in 
protein expression are calculated by comparing between different conditions (Zhu et 
al., 2010).  
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Figure 1.3 Diagram of label-free quantitative proteome analysis. (Reprinted from 
Megger et al. (2013)) The workflow start from samples cells are lysed using lysis 
detergents followed by protein extraction and digestion. Then the samples are put 
through LC-MS/MS followed by protein identification and quantification by 
determining ion intensity generated by spectral counting. Data analysis is performed 
using bioinformatics tool. 
 
1.10.3 Reverse-phase high performance liquid chromatography (LC) 
 
This technique is used to separate a complex mixture of peptides in order to achieve 
the better resolution of the peptides containing in the samples.  High performance 
liquid chromatography (HPLC) is an analytical process in which the sample mixtures 
as peptides contained in liquid mobile phase. The protein samples are forced under 
the pressure to pass through a stationary phase within a tightly-packed column. Then 
compounds bind to the column based on their chemical properties in the stationary 
phase. In reverse-phase (RP) HPLC, non-polar molecules are recollected whereas 
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polar molecules are prior to elute. The mobile phase solvent buffer is adjusted along 
the gradient, by slowly increasing the acetonitrile content, in order to elute more 
polar molecules by increasing hydrophobicity (Simpson 2003).  
 
1.10.4 Tandem mass spectrometry (MS/MS) 
 
Mass spectrometry estimates the molecular mass of the samples by measuring the 
mass to charge ratio (m/z) of ions in gas phase. Peptides in each sample are changed 
to the gas phase by an ionisation source for example electrospray ionisation source 
(ESI). The measurement of peptides mass (m/z) is performed by the detector 
followed by fragmentation of peptides via collision with an inert gas. The three most 
abundance peptides are chosen for fragmentation using collision induced dissociation 
(CID). The m/z of the fragmented ion is measured. The data of each sample from 
mass spectra are matched to known peptides as peptide spectrum match (PSM).  The 
data are then analysed using bioinformatics tools.  
 
1.10.5 Protein identification and bioinformatics analysis 
 
Mass spectral data are searched against an in silico database to identify proteins. This 
process is performed to obtain all possible peptides that are cleaved by the enzyme. 
For T. gondii, N. caninum and related parasite species, ToxoDB is the resource that 
contains the most effective in silico database used for searching. A false discovery 
rate (FDR) scoring system is used as a cut off to determine identified peptides. The 
higher the number of significant peptides, leads to the higher the confidence of 
protein identifications. Many algorithms have been developed for protein 
identification using mass spectral data as an input, for example MASCOT (Perkins et 
al., 1999), SEQUEST (Eng et al., 1994),  X!tandem (Craig and Beavis, 2004) and 
PEAKs (Zhang et al., 2012). These search engines identify peptides by using 
algorithms which is identical to the precursor and MS/MS spectral data against the 
translated genome database. Then, the score unique to the spectra searched against 
theoretical spectra of the organism of interest is obtained. In order to confirm that 
peptides identified do not include any false positives, so the false discovery rate 
(FDR) is required. It is done by re-searching the data with a false database by using 
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the reverse amino acid sequences of the actual database used for the protein search. 
The acceptable value should be around 1% or less.The identified proteins obtaining 
from LC-MS/MS analysis with less than 2 peptides are excluded for further analysis. 
 
1.10.6 Omics and apicomplexan parasites 
 
Nowadays many researchers have been working with -omics technologies to 
understand the biology of organisms as well as the interactions between host and 
parasites (Goodswen et al., 2013). These techniques composed of genomics, 
transcriptomics, proteomics and metabolomics. The recent genomics research 
comparing N. caninum and T. gondii provides vast knowledge about the pathogen 
which delivers the information of the evolution of both species (Reid et al., 2012).  
These -omics research does not only provide the understanding of the organisms 
itself, but can also be identify the drug targets and vaccine against the disease 
(Goodswen et al., 2013). The variations occurring at molecular level of nucleotides, 
genes and proteins can be detected by comparing the -omics data between species or 
strains of organisms.  
  
The purpose of system biology study is to incorporate several biological data through 
different levels of structure and scale which represent an initial paradigm in the 
scientific process (Reid et al., 2012). The system is important for recognising the 
biological process and events occurring at any given time or in response to infection 
(Jovanovic et al., 2015). The -omics approach has driven the movement of the 
studies to boarder a biological knowledge and overview all information in system.  
 
There are several studies of apicomplexan parasite virulence related to -omics study. 
Xia et al. (2008) used 2D-electrophoresis, gel liquid chromatography coupled with 
tandem mass spectrometry and MudPIT to analyse the proteome of T. gondii. The 
draft genome of T. gondii predicted approximately 8,000 genes with varying degrees 
of confidence. Their data revealed how proteomics can perform the predictions 
which can discover new genes. Approximately one-third (2,252) of predicted 
proteins together with 2,477 intron-spanning peptides contributed supporting evident 
for correct splice site annotation. Another proteomics study was done by Regidor-
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Cerrillo et al. (2012a). They studied the proteomics profile between virulent and 
attenuated N. caninum isolates using DIGE and MALDI-TOF MS method. The 
results revealed that changed in 60 protein spots; 39 spots were preferentially 
expressed in Nc Spain7 and 21 spots were abundant in Nc Spain 1H. The highest 
number of differentially expressed spots were shown in Nc Spain7. They found 
NcMIC1 decreased in abundance in Nc Spain 1H than Nc Spain 7 which might due 
to reduce invasiveness of this isolate. The ROP40 was found in Nc Spain7 which 
might play different role in both strains. The additional study of a large scale 
proteogenomics in T. gondii and N. caninum were performed by Krishna et al. 
(2015). They queried proteomics data against RNASeq derived gene models; a panel 
of official and alternate models. Additionally, several newly generated and many 
previously published MS datasets were used for proteomics analysis. Their result 
revealed the identification of loci that were not existing in current genome 
annotations. It could be indicated that RNA-seq can be used as a tool for validation 
of genome annotation models. Yang et al. (2013) identified T. gondii genes candidate 
which might represent for phenotypic variation among type I strains using 
comparative genomics and transcriptomics approaches. There were 1,394 single 
nucleotide polymorphisms (SNPs) and insertions/deletions (dels) between RH and 
GT1from whole genome sequencing. The achievement of gene candidates could 
represent for type I phenotypic differences by analysing SNPs/indels combined with 
differentially expressed of genes between RH and GT1 strains. The result revealed a 
polymorphism of GRA2 differences in the invasion of the interferon gamma 
response between RH and GT1 strains. Moreover, only RH strain recruited 
phosphorylated IkBa to PVM which was partially dependent on GRA2. However, the 
other strains in type I cannot recruit.  The comparative genomics and transcriptomics 
study between T. gondii and N. caninum was performed by Reid et al. (2012). They 
sequenced the tachyzoites stage of N. caninum genome and transcriptome. The result 
showed an expansion of surface antigen gene families in N. caninum and the rhoptry 
kinase ROP18 is pseudogenised in N. caninum which leads N. caninum unable to 
phosphorylate host immunity-related GTPases like how T. gondii does. 
 
Some of -omics studies related to N. caninum stage conversions were also 
performed. Marugan-Hernandez et al. (2010) investigated the differentially 
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expression proteins of tachyzoites and bradyzoites stage using DIGE couple with MS 
analysis. They found 72 spots were differentially expressed in which 53 spots were 
more abundant in bradyzoites and 19 spots were high abundant in tachyzoites. The 
26 proteins were obtained and identified from MS in which 20 proteins were from 
bradyzoites and 6 proteins were from tachyzoites. The key proteins found in 
bradyzoites stage included glycolysis related proteins such as enolase and 
glyceraldehyde-3-phosphatedehydrogenase, stress response related such as HSP70 
and HSP90 and GRA9. The more abundant protein related to krebs cycle as isocitrate 
dehydrogenase 2 was found in tachyzoites stage. The other transcriptomic study of 
stage conversion was performed by Vermont (2012). The RNA-Seq technology was 
employed to investigate the mRNA expression during tachzoites-bradyzoites 
conversion process. The key finding had shown that rhoptry proteins reduced 
abundance of transcripts expression in bradyzoites stage which might due to a less 
importance of invasive proteins in bradyzoites stage.   
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1.11 Aims and objectives 
 
The overall aim of this thesis is to advance the understanding of N. caninum biology 
by investigating the systematic view of specific genes and proteins related to the 
parasites virulence as well as the key proteins during stage conversion from 
tachyzoites to bradyzoites. The biological information of N. caninum virulence will 
provide the divergent evolutionary biology between two different isolates. Moreover, 
the investigation of proteome involved in N. caninum stage conversion will provide 
more biological knowledge in the parasite life cycle.  
 
 In chapter two, the proteomics profile of N. caninum stage conversion from 
tachyzoites to bradyzoites were analysed using label-free quantitative techniques. 
The differential protein expression between the two phenotypically stages were 
compared to identify the key genes involved in each stage.  
 
In chapter three, the transcriptomics analysis was used to compare differential 
transcript expression between low- and high- virulent of N. caninum using RNA-Seq 
approach. Two different isolates causing differential pathogenicity were investigated 
to visualise the similarity and different in term of transcripts expression. 
 
In chapter four, label-free proteomics technique was used to compare the differential 
protein expression between low and high virulence isolates of N. caninum. The 
proteomics profile of both isolates were then analysed using bioinformatics tools 
such as progenesis.   
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Chapter 2:  Analysis of protein expression during N. 
caninum tachyzoites to bradyzoites stage conversion 
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2.1 Introduction  
 
There are three invasive stages in the life cycle of N. caninum: tachyzoites, 
bradyzoite-containing tissue cysts and sporozoite-containing oocysts. Tachyzoites 
are responsible for acute infection while the slowly replicating bradyzoites are 
responsible for establishing chronic infection (Buxton et al., 2002). N. caninum has 
to survive in a fluctuating environment, withstanding physiological and 
immunological changes from the host, and it has evolved a diverse set of regulatory 
mechanisms. (Eastick and Elsheikha, 2010). The mechanisms stimulating tachyzoite 
to bradyzoite stage conversion can be viewed as one such adaptive response 
(Marugan-Hernandez et al., 2010). Moreover, the reactivation of tissue cysts in an 
immunocompromised animal, especially during pregnancy, may cause bradyzoite to 
tachyzoite retransformation followed by placental infection and congenital fetal 
infection (Quinn et al., 2002). Knowledge of tachyzoite-bradyzoite stage conversion 
will help to clarify mechanisms of persistent N. caninum infection by determining 
key proteins that show high abundance in the bradyzoite stage.   
 
2.1.1 Stage conversion in Apicomplexan parasites 
 
The stage conversion phenomenon is common in organisms with complex life cycles 
in order to survive in the host, such as apicomplexan parasites. (Ferreira da Silva 
Mda et al., 2008; Schwan and Hinnebusch, 1998). Not only does the characteristic 
shape of tachyzoites differ from bradyzoites but the function of each stage is 
different also (Vonlaufen et al., 2004). Tachyzoites replicate rapidly while 
bradyzoites replicate slowly. Once the rapid replicating tachyzoites become stressed 
by the host immune response they change into the dormant cysts which are tolerant 
to host immunity. Stage conversion can be characterized with several techniques. 
Morphological changes affecting cellular ultrastructure can be compared using 
transmission electron microscopy (TEM) (Jardine, 1996; Kang et al., 2008; Speer et 
al., 1999). For example, bradyzoites are slimmer than tachyzoites and the nucleus of 
bradyzoite is located at the posterior end while it is located at the middle of 
tachyzoites. Moreover, the bradyzoite contains more rhoptries, amylopectins, and 
micronemes, while dense granules are numerous in tachyzoites stage (Kang et al., 
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2008). Immunohistochemistry and immunofluorescent assays are able to differentiate 
between stages by labelling the parasites with N. caninum stage-specific antibodies, 
for example, N. caninum tachyzoite surface antigens NcSAG1 and NcSRS2 (Fuchs et 
al., 1998; Vonlaufen et al., 2004) and T. gondii bradyzoite antigen1(TgBAG1). 
TgBAG1 have shown cross reactivity to N. caninum bradyzoite antigen 1 
(McAllister et al., 1996). There are three more proteins determined as bradyzoite 
specific antigens including NcSAG4, NcBSR4 (Fernandez-Garcia et al., 2006; 
Risco-Castillo et al., 2007) and SRS13 (Reid et al., 2012). Additionally, there are 
some proteins identified as tachyzoite specific proteins such as surface antigens 
SAG1 and SRS2 (Hemphill et al., 1997b; Howe et al., 1998), MIC1 (Keller et al., 
2002) and GRA1, GRA2, GRA3, GRA4, GRA5 and GRA6 (Fuchs et al., 1998; 
Tilley et al., 1997). 
 
To study stage conversion process, there have been many techniques developed to 
induce stage conversion and encystation in vitro. For example, changing the pH of 
growing medium and increasing growing temperature (Weiss et al., 1999). It can also 
achieve by stressing the culture with chemical agents such as nitric oxide (NO) and 
NO donor sodium nitroprusside (SNP) (Vonlaufen et al., 2004; Vonlaufen et al., 
2002) as well as inducing bradyzoites specific marker (BAG1) expression 
(McAllister et al., 1996; Risco-Castillo et al., 2004; Vonlaufen et al., 2002).   
 
2.1.2 The proteomics studies of stage conversion in N. caninum 
 
Proteomics is one of valuable tool to study protein expression in tachyzoites and 
bradyzoites of N. caninum (Fuchs et al., 1998; Kang et al., 2008). Vonlaufen et al., 
(2004) developed the technique for initiating Neospora stage conversion from 
tachyzoites to bradyzoites stage by using SNP. They found that 17 µM SNP could 
induce the stage conversion while not harming the culture. Sodium dodecyl sulfate-
polyacrilamide gel electrophoresis (SDS-PAGE) and immunoblotting were used to 
investigate the protein differential expression in each parasite stage. Their results 
showed that bradyzoite specific protein BAG1 preferentially increased in expression 
while the expression of tachyzoites surface antigens NcSAG1 and NcSRS2 were 
reduced during stage conversion. Neospora dense granule proteins such as GRA1, 
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GRA2 and GRA7 were shown incoporated in cyst wall of bradyzoites. Another study 
was done by Kang et al. (2008), who investigated the differential protein expression 
of Neospora tachyzoites and bradyzoites stage in different time point including day 
3, 5, 7 and 9 post induction with 70 µM SNP. Proteomics analysis was carried out 
using SDS-PAGE and western blot. They found that the tachyzoite specific antigens 
were identified at ~ 40 kDa MW in the tachyzoite stage and were not seen at the 
bradyzoite stage. While rabbit polyclonal antibodies against bradyzoites detected the 
significant increase in expression of bradyzoites stage at MW ~25 kDa by western 
blotting. BAG1 was  used as a marker to determine stage conversion by IFA.  
Marugan-Hernandez et al. (2010) identified differentially expressed proteins during 
stage conversion using difference gel electrophoresis (DIGE) technology followed by 
MS analysis. They found 72 spots were differentially expressed (p < 0.05 and fold 
change >1.5). Among these protein spots, 53 spots showed high abundant in 
bradyzoites and 19 spots were more abundant in tachyzoites. There were 26 proteins 
identified by MS analysis in which 20 proteins were of higher abundance in 
bradyzoites and 6 proteins showed preferentially expression in tachyzoites. Proteins 
with high abundance in bradyzoites include enolase, glyceraldehyde-3-phosphate 
dehydrogenase, heat shock protein HSP70 and 90, and dense granule GRA9. Proteins 
with higher abundance in tachyzoites was isocitrate dehydrogenase2. Another study 
investigating stage conversion of N. caninum was done by (Sarah, 2012) using 
transcriptomics apporach. They investigated mRNA level during tachyzoites-
bradyzoites interconversion using Illumina Hi-Seq2000 next generation sequencing 
technology. Stage conversion was induced using 50 µM SNP and the samples were 
collected at day 0, 1, 3 and 6 post induction. The result focused on on three groups of 
apical proteins which showed that the rhoptry gene expression decreased over the 
experimental time course; microneme genes expression displayed both increases and 
decreases, while the dense granule genes were not significantly differentially 
expressed. 
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2.1.3 Aims and Objectives 
 
The aim of this study is to investigate changes in protein expression during the stage 
conversion from N. caninum tachyzoites to bradyzoites, over a six-day experimental 
course.  
 
Objective of this study: 
1. To undertake in vitro stage conversion of N. caninum using SNP with 
confirmation by IFA 
2. To identify and quantify differentially-expressed proteins during stage 
conversion using a label-free quantitative proteomics approach 
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2.2 Materials and Methods 
 
2.2.1 Cell culture 
 
Cultivation of Vero cells (African green monkey kidney fibroblasts) were maintained 
in DMEM (Dulbecco’s Modified Eagle’s medium, Sigma-Aldrich®) containing 10% 
foetal bovine serum (Sigma-Aldrich®), 100 U/ml penicillin and 100 µg/ml 
streptomycin sulphate (Sigma-Aldrich®). The medium was passed through a filter 
prior to use. The amount of 1x105 Vero cells in 5 mL medium was added into 25 cm2 
flasks (T25). The flasks were placed in a 37 oC incubator with 5% CO2 and observed 
daily.  
 
2.2.2 Neospora tachyzoites infection 
 
The purified N. caninum Liverpool strain tachyzoites 1x105/cm2 were added to the 
Vero cells culture flask which had shown 10-20% confluent (about 24 hours after 
passaging).  The infected Vero cells with N. caninum were placed at 37oC in a 5% 
CO2 incubator.  
 
2.2.3 Isolation of N. caninum tachyzoites 
 
Briefly, the parasite infected Vero cells were scraped and transferred to 50 ml 
centrifuge tube. The culture medium containing N. caninum and Vero cells were 
suspended through a 20-gauge needle and put through a 47mm diameter 3 µm 
nucleoporeTM polycarbonate membranes (Whatman) in order to purify the parasite. 
The parasite was washed with cold phosphate buffered saline (PBS) and centrifuged 
twice at 1500 x g for 10 minutes at 4 oC. Then parasite pellets were re-suspended in 2 
mL of cold PBS. The purified parasites were centrifuged at 13,000 x g for 10 minutes 
at 4 oC. The supernatant was discarded. The parasite pellets were kept at -80 oC prior 
to use. 
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2.2.4 Neospora stage conversion induction using sodium 
nitroprusside  
 
The Neospora stage conversion was done by adding sodium nitroprusside (SNP) 
(Sigma-Aldrich®) at a final concentration of 17 µM (stock SNP solution 10 mg/ml in 
distilled water) at the time of infection. The infected Vero cells culture with N. 
caninum were incubated in 37 oC with 5% CO2. The fresh medium containing 17 µM 
SNP were replaced every day up to 6 days. The tachyzoites sample of N. caninum 
were collected at three different times as day 0 of induction (day 3 post infection 
without SNP treatment), day 3 (day 6 post infection) and day 6 (day 9 post infection) 
respectively. The parasite were harvested using the same protocol as in section 2.2.2.  
Three biological replicates were collected for each time point (Table 2.1). 
 
In addition, the parallel experiment was established using a SNP concentration of 70 
µM to induce the stage conversion. However, the Vero cells started to detach after 3 
days of SNP treatment and Vero cells were unhealthy. Moreover, the additional stage 
conversion of day 8 post SNP treatment (day 11 post infection) were also attempted 
in order to visualise more bradyzoite forming but the Vero cells were mostly 
detached at day 6 post SNP treatment. 
 
Table 2.1 Description of samples of tachyzoites/bradyzoites stage conversion 
collected at Day 0, 3 and 6 post SNP treatment 
 
Samples 
Days duration after SNP 
treatment 
Days duration after N. caninum   
infection 
1 0 3 
2 3 6 
3 6 9 
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2.2.5 Immunofluorescence assay (IFA) to determine stage conversion 
  
The IFA was used to confirm the stage conversion by observing the presence of 
bradyzoite-specific marker BAG1. The IFA slide was coated with poly-L lysine 
(molecular weight 70,000-150,000, Sigma Aldrich®) for 20 mins at room 
temperature. Vero cells was cultured on the slides (in parallel with the culture in the 
flasks) at the concentration 1 × 104 cells per well and kept in the incubator at 37 oC 
with 5% CO2. The Vero cell culture was observed daily until 80-90% confluent. 
Between 5x103-1x104 tachzoites of the N. caninum Liverpool strain were added to 
each well containing Vero cells. The induction buffer with 17µM SNP, 10% FBS 
and 1% PS in DMEM was made and added to the culture on day 3 post induction. 
Same medium without SNP was added to Vero cells as a control. The medium was 
changed daily. 
  
The process of IFA were carried out as follows. Parasite-infected cells were washed 
three times with PBS, then fixed and permeablised with 4% (v/v) formaldehyde and 
0.5% (v/v) TritonX-100 in PBS. The slides were incubated at room temperature for 
15 minutes, followed by three washes with PBS. The slides were blocked with 5% 
(v/v) normal goat serum twice for ten minutes. After that, all slides were washed 
with 1% (v/v) FBS/PBS.  The BAG1 primary antibody polyclonal rabbit antiserum 
(kindly provided by Prof. Andrew Hemphil, University of Bern, Switzerland) was 
diluted into 1:200 with 1% (v/v) FBS/PBS and put on the slides, then incubated at 
room temperature for one hour. The slides were quickly washed six times with PBS 
and a secondary antibody Alexafuor 488 was added (kindly provided by Dr. Olivier 
Touzelet, University of Liverpool) which was diluted into 1:1000 with 1% (v/v) 
FBS/PBS and incubated at room temperature for one hour. The slides were briefly 
washed for six times with 1% (v/v) FBS/PBS and then with PBS followed by six 
times washeswith ddH2O. The slides were mounted with Vectashield containing 
DAPI and covered with foil, left to dry and kept in the fridge until observing under 
fluorescence microscopy.  
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2.2.6 Sample digestion for proteomics analysis 
 
This step was performed by Dr. Dong Xia, Department of Infection Biology, 
University of Liverpool. A sample was diluted in 25 mM ammonium bicarbonate to 
a volume of 160 µl, then added 10 µl of 1% Rapigest (Waters) (final concentration 
0.05% (w/v). Samples were incubated at 80 oC for 10 mins. A total of 10 µl of 9.2 
mg/kg ditiothreitol reagent (DTT) was applied to each sample (at a final 
concentration of 3 mM) and incubated at 60 oC for 10 minutes. Then a total of 10 µl 
of 33 mg/ml iodoacetamide was added (at a final concentration of 9 mM) to each 
sample and incubated at room temperature in the dark. After that a total 10 µl of 
trypsin (200 µg/ml of 25 mM ammonium bicarbonate) was added to sample at the 
ratio of 50:1 protein: trypsin and incubated at 37 oC overnight. Trifluoroacetic acid 
(TFA) was added to all samples at a final concentration of 0.5% (v/v)) and incubated 
at 37 oC for 45 minutes. The samples were centrifuged at 13,000 x g at 4 oC for 20 
minutes. The supernatant of each sample was collected and kept in fridge (4 oC) prior 
to mass spectrometry analysis. Digest was loaded onto a 12% SDS-PAGE to 
determine the complete digestion of proteins as a quality control 
 
2.2.7 Liquid chromatography mass spectrometry LC-MS/MS 
 
This procedure was performed by Dr. Dong Xia, University of Liverpool. Separated 
peptides in samples were analysed by on-line nanoflow LC using the Thermo 
Ultimate 3000 nano system (Thermo Fisher Scientific) attached with Q-Exactive 
mass spectrometer (Thermo Fisher Scientific). Examined samples were put on a 50 
cm Easy-Spray column with 75 µm internal diameter contained 2µm C18 particles 
attached to a silica nano-electrospray emitter (Thermo Fisher Scientific). The column 
was performed under 35oC. Chromatography was done with a buffer containing 0.1% 
formic acid (buffer A) and 80% ACN in 0.1% formic acid (buffer B). The separation 
of peptides was performed by a linear gradient of 5-50% buffer B of 120 min at flow 
rate 300 nl/min. The operation of Q-Exactive were achieved in data-dependent mode 
with survey scans required at a resolution of 70,000. The first top ten abundant 
isotope pattern with charge conditions +2, +3 and/or +4 from survey scan were 
chosen with an isolation window of 2.0. They were fragmented by higher energy 
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collisional dissociation and normalized collision energies of 30. The highest ion 
injection times for the survey scan was 250 ms and the MS/MS was 100 ms. The ion 
target value was set for survey scans and MS/MS at 1e6 and 1e4, respectively. 
Repetitive sequencing of peptides was reduced to 20 s through dynamic exclusion of 
peptides sequence.   
 
2.2.8 MS data processing by Progenesis  
 
The raw data obtained from LC-MS/MS were imported to ProgenesisTM QI software 
(Version 3.0, Nonlinear Dynamics). Data were divided into three groups following 
the induction time points as day 0, 3 and 6 respectively. The data of MS scans were 
transformed to peak lists. Then sample reference was chosen among tested samples 
by the software after assessing the 2-D mapping (m/z against retention time) for LC 
variability.  The rest of samples were aligned to the reference by retention time. After 
the peak picking, spectra were exported for peptide identification using Mascot 
(version 2.3.02, Matrix Science) against the sequence database. The identified 
peptides were imported back to Progenesis and the data were normalised against all 
identified peptides. Protein abundance (iBAQ) was calculated as the sum of all the 
peak intensities (from Progenesis output) divided by the number of theoretically 
observable tryptic peptides (Schwanhausser et al 2011). Protein abundance was 
normalised by dividing the protein iBAQ value by the summed iBAQ values for that 
sample. The reported abundance is the mean of the biological replicates.  
Q values are the adjusted p-value which are using an optimised FDR )False 
Discovery Rate( approach. FDR is the proportion of false positive expected to get 
from a test. P- value present the probability of false positive from one test while q –
value is a measure of significance in term of FDR associated with each tested feature. 
Q value is needed when thousands of variables )e.g. gene expression levels( have to 
measure. So an adjustment of p-value is necessary when the multiple tests are 
making on the same (Storey, 2003). 
 
39 
 
2.2.9 Protein identification by Mascot 
 
Mascot (Version 2.3.02, Matrix Science) is a search engine to identify protein from 
MS spectra. The spectra were also compared to a decoy database containing reversed 
peptide sequences to obtain a false discovery rate (FDR). Protein sequences were 
downloaded from ToxoDB database of N. caninum Liverpool strain (ToxoDB, 
Version 11). The search parameters of Mascot were set with precursor mass 
tolerance of 10 ppm and fragment mass tolerance of 0.01 Da. Carbamidomethylation 
of cysteine (C) was set as a fixed modification and oxidation of methionine (M) was 
established as a variable modification. One missed tryptic cleavage site was allowed 
with charge states +1, +2 and +3. The protein identifications were made at FDR < 
0.01 with a minimum of two unique peptides per protein.   
 
2.2.10 Cluster analysis 
   
This method was done in order to visualise the trend of protein expressions over the 
stage induction time course. The GProX software package version 1.1.12  (Rigbolt et 
al., 2011) was employed to generate the cluster analysis. The clustering is based on 
fuzzy c-means algorithm as a fuzzification value of 2 for 100 iterations (Futschik and 
Carlisle, 2005). The similar protein expression trends were grouped together into 6 
clusters.  
 
2.2.11 Gene Ontology enrichment analysis 
GO enrichment analysis was performed to interpret the biological relevance of the 
protein clusters. topGO package  (Alexa and Rahnenfuhrer, 2016) was used for 
obtaining GO terms enriched for each cluster. The R scripts for topGO was kindly 
provided by Dr. Vicky Hunt, University of Liverpool.  
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2.3 Results 
 
IFA was used to verify the stage conversion of N. caninum. The BAG1 bradyzoite-
specific antibody was detected in N. caninum infected Vero cells at day 5 post 
induction while this antibody was not detected in the control samples (Figure 2.1). 
 
2.3.1 Differential protein expression and cluster analyses 
 
A total number of 1,475 proteins were identified and quantified by Progenesis TM. 
There were 299 proteins showing preferential expression at different point during the 
stage conversion time course with statistical significance (unique peptides  2, 
adjusted p value < 0.05 and fold change  2). All 229 proteins were clustered into 6 
groups following their expression trend using GProX (Figure 2.2).  A majority of 
proteins showed a downward trend in expression over the time course (Cluster1 and 
6, n = 143). Proteins in cluster 5 (n=23) showed an upward trend from day 0 to day 3 
and then dropped from day 3 to day 6. On the other hand, cluster 3 (n=42) and cluster 
4 (n=47) exhibited an upward trend throughout the time course while cluster 2 
(n=44) showed a downward trend from day 0 to day 3 and a slightly upward from 
day 3 to day 6. 
 
As expected, most of microneme and dense granule proteins showed a downward 
trend in abundance throughout the time course for example one unidentified 
microneme protein (cluster 6), MIC7 (cluster1), MIC2, MIC3, MIC6, MIC10 and 
MIC11 (cluster5) as well as GRA1, GRA3 (cluster1), GRA6 and GRA7 (cluster 6). 
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Figure 2.1 Immunofluorescence image of N. caninum infected Vero cells inducing stage conversion with 17µM SNP at day 5 post induction  A 
and D) Vero cells staining with DAPI; B and E) N. caninum staining with BAG1 bradyzoite-specific antibody (Alexafuor 488-green)  C and F) 
Combining image of Vero cells infected with N. caninum  Images A,B,C are  a stage induction with SNP and Images D,E,F are control without 
SNP 
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Figure 2.2 Cluster analyses of N. caninum stage conversion from tachyzoites to 
bradyzoites stage using SNP treatment. The X-axis shows the experimental time 
point as 1 = Day 0, 2 = Day 3 and 3 = Day 6. The Y-axis reveals the protein 
expression changes of N. caninum. 
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Proteins in cluster 1 (Table 2.2, Appendix Table I and Figure 2.2) revealed no change 
in expression from day 0 to day 3 followed by decreasing expression to day 6. The 
proteins with the highest fold changes include a putative calmodulin CAM2, 
ubiquitin family protein and a GAP40 protein, which is associated with parasite 
movement and host cell invasion. A putative cyclophilin that has roles in parasite 
biochemistry and host parasite interaction also shows downward trend.  Apical 
proteins found in this cluster include secretory proteins such as microneme protein 
MIC7, dense granule protein GRA3 and GRA1 as well as rhoptry protein ROP17. 
This finding indicates that stage conversion of tachyzoite to bradyzoites was 
successful, as the apical secretory proteins are expected to be less abundant by day 6.  
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Table 2.2 Top twenty most differentially expressed proteins of cluster 1 showing downward expression trend throughout three time points 
ID N. caninum description T. gondii  orthologues D0 D3 D6 
Fold 
change 
q Value 
NCLIV_025600 putative calmodulin calmodulin CAM2 (CAM2) 265739.36 263341.31 25032.09 10.61595 0.00139 
NCLIV_043870 conserved hypothetical protein hypothetical protein 632804.95 491318.85 83413.24 7.58639 0.00066 
NCLIV_036200 putative cyclophilin peptidyl-prolyl cis-trans isomerase family 1 440164.70 311944.18 61153.88 7.19766 0.00194 
NCLIV_053590 WD-40 repeat protein, related transducin beta-like protein TBL1 (TBL1) 1078432.05 1120640.79 167584.27 6.68703 0.00339 
NCLIV_043320 
rna recognition motif (RRM)-containing 
protein,related 
U2 snRNP auxilliary factor, large subunit, 
splicing factor subfamily protein 
999741.20 910921.59 149615.12 6.68209 0.00293 
NCLIV_017040 Phosphofructokinase, related phosphofructokinase PFKII (PFKII) 846932.48 613245.67 156661.14 5.40614 0.00459 
NCLIV_047600 hypothetical protein hypothetical protein 245166.59 265982.91 50582.39 5.25841 0.00485 
NCLIV_064340 putative prefoldin subunit prefoldin subunit 6, putative 252216.14 225237.83 49038.51 5.14323 0.00198 
NCLIV_042770 hypothetical protein hydrolase, NUDIX family protein 191186.70 246180.35 48626.41 5.06269 0.02926 
NCLIV_048800 hypothetical protein ubiquitin family protein 1616946.72 1243199.11 319526.01 5.06045 0.00152 
NCLIV_019600 hypothetical protein 
clathrin adaptor complex small chain 
subfamily protein 
584126.80 516189.27 119401.46 4.89212 0.00175 
NCLIV_053360 conserved hypothetical protein 
transcription elongation factor SPT6 
(SPT6) 
133160.44 107140.26 30173.92 4.41310 0.00156 
NCLIV_001770 
putative DNAK family domain 
containing protein 
tetratricopeptide repeat-containing protein 1353555.83 938777.78 321447.71 4.21081 0.00267 
NCLIV_056590 
putative phosphatidylinositol-4-
phosphate 5-kinase 
MORN repeat-containing protein 1058324.45 896339.46 251841.30 4.20235 0.00751 
NCLIV_024440 hypothetical protein 
vacuolar protein sorting-associated protein 
26, putative 
265255.35 220355.64 66567.25 3.98477 0.00371 
NCLIV_056360 Eukaryotic initiation factor, related 
DEAD (Asp-Glu-Ala-Asp) box 
polypeptide DDX6 (DDX6) 
512884.26 586998.49 151636.41 3.87109 0.02395 
NCLIV_054550 Cytochrome c oxidase subunit 2, related cytochrome C oxidase subunit IIb, putative 3972133.77 2765119.30 1059769.01 3.74811 0.00058 
NCLIV_019450 hypothetical protein signal peptidase 551941.50 669909.50 192573.35 3.47872 0.00073 
NCLIV_025710 unspecified product microneme protein MIC7 (MIC7) 4010693.96 3108615.04 1165075.86 3.44243 0.00528 
NCLIV_005190 
putative transcription elongation factor 
FACT 140 kDa 
transcriptional elongation factor FACT140 
(FACT140) 
1102959.20 893566.69 329756.63 3.34477 0.00230 
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Cluster 2 (Table 2.3, Appendix Table II and Figure 2.2) revealed decrease in 
expression from day 0 to day 3 followed by minimal change until day 6.  Most of the 
proteins in the top twenty differentially-expressed proteins were hypothetical 
proteins.  Some notable proteins in this cluster are a putative U4/U6 small nuclear 
ribonucleoprotein, which is required to assemble an active spliceosome, and catalase, 
which is responsible for degradation of hydrogen peroxide to water and oxygen. 
Moreover, some key proteins involved in host cell invasion are found in this cluster, 
for example, two rhoptry proteins as ROP6 and ROP9, rhoptry neck protein RON10 
and dense granule protein DG32, two myosin A proteins, rhomboid protease ROM4, 
glideosome-associated protein with multiple-membrane spans GAPM3 
(NCLIV_035190) and glideosome-associated protein with multiple-membrane 
(NCLIV_044350).  This finding suggests that lower expression of these invasion 
protein is required after the differentiation of the parasite to quiescent stage. 
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Table 2.3 Top twenty most differentially expressed proteins of cluster 2 showing downward expression trend and then not change in expression 
ID N. caninum description T. gondii  orthologues D0 D3 D6 Fold change q Value 
NCLIV_021510 conserved hypothetical protein DUF3228 domain-containing protein 396479.64 66940.64 20525.99 19.31598 0.01330 
NCLIV_021410 conserved hypothetical protein hypothetical protein 1934838.90 217867.71 638107.78 8.88080 0.00297 
NCLIV_056730 conserved hypothetical protein hypothetical protein 588892.91 92014.19 80675.27 7.29955 0.01047 
NCLIV_020430 hypothetical protein 
cleft lip and palate transmembrane protein 1 
(clptm1) protein 
714046.52 151961.38 122149.83 5.84566 0.04728 
NCLIV_018260 
putative U4/U6 small nuclear 
ribonucleoprotein 
WD domain, G-beta repeat-containing 
protein 
155932.92 44142.10 27703.00 5.62874 0.03875 
NCLIV_040600 hypothetical protein 
signal recognition particle receptor beta 
subunit protein 
5691004.50 1028281.60 1039360.97 5.53448 0.03800 
NCLIV_008860 hypothetical protein UDP-galactose transporter family protein 671184.72 203690.15 142488.38 4.71045 0.00485 
NCLIV_065570 putative translation initiation factor SUI1 translation initiation factor SUI1, putative 1995635.11 558339.68 505226.56 3.94998 0.00066 
NCLIV_046970 conserved hypothetical protein hypothetical protein 1103666.88 301124.81 411043.97 3.66515 0.00993 
NCLIV_048040 conserved hypothetical protein hypothetical protein 1109215.06 316639.53 401233.78 3.50308 0.01931 
NCLIV_051590 putative GTP binding protein GTP-binding protein, putative 8497994.99 3170482.10 2547632.15 3.33564 0.00293 
NCLIV_036630 putative 14-3-3 protein 14-3-3 superfamily protein 153305.83 46317.57 114537.63 3.30989 0.02400 
NCLIV_004510 
putative kelch motif domain-containing 
protein 
kelch repeat-containing protein 136045.70 41180.82 88555.08 3.30362 0.04414 
NCLIV_005050 putative coatomer delta subunit 
adaptor complexes medium subunit family 
protein 
3716585.02 1425511.92 1139790.55 3.26076 0.00156 
NCLIV_005040 conserved hypothetical protein hypothetical protein 2968418.05 943944.08 1068584.01 3.14470 0.00273 
NCLIV_032240 Catalase (EC 1.11.1.6), related catalase 66004502.11 21314140.59 
23758910.7
2 
3.09675 0.00282 
NCLIV_058300 hypothetical protein hypothetical protein 2576396.59 840942.93 1649767.24 3.06370 0.03922 
NCLIV_035190 conserved hypothetical protein 
glideosome-associated protein with multiple-
membrane spans GAPM3 
3676957.38 1267464.45 2785751.42 2.90103 0.00854 
NCLIV_045490 conserved hypothetical protein hypothetical protein 1081874.99 394781.00 617225.23 2.74044 0.00548 
NCLIV_058000 putative alanine dehydrogenase 
NAD(P) transhydrogenase subunit beta, 
putative 
12759821.55 4755062.00 5570964.71 2.68342 0.02397 
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Proteins in cluster 3 (Table 2.4, Appendix Table III and Figure 2.2) showed an 
upward expression trend throughout the time course. The proteins found in this 
cluster include a ubiquitin family domain containing protein, HEAT repeat-
containing protein, and stress indicator proteins such as heat shock proteins HSP60 
and HSP90. Proteins involved with parasite movement such as microtubule 
associated protein SPM2 (SPM2) and putative kinesin heavy chain, the enzyme 
create energy storage such as ATPase synthase subunit alpha and ATP synthase beta 
subunit ATP-B (ATPB) were also in this cluster. However, some proteins potentially 
involved in host cell invasion were also found in this cluster such as ROP35, myosin 
I and camoludin. This may reflect the fact that some tachyzoites remain in the culture 
at day 6, as not all parasites have converted into bradyzoites. 
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Table 2.4 Top twenty most differentially expressed proteins of cluster 3 showing upward expression trend throughout three time points 
ID N. caninum description T. gondii  orthologues D0 D3 D6 
Fold 
change 
q Value 
NCLIV_012950 
putative ubiquitin family domain-
containing protein 
ubiquitin family protein 32183.17 352394.63 1089634.23 33.85726 0.00250 
NCLIV_001290 conserved hypothetical protein HEAT repeat-containing protein 385271.78 820139.66 4696425.55 12.18990 0.00139 
NCLIV_035590 conserved hypothetical protein hypothetical protein 1513363.22 9352111.17 12779680.14 8.44456 0.01333 
NCLIV_033910 hypothetical protein 
WD domain, G-beta repeat-containing 
protein 
665310.80 1515968.93 5159820.96 7.75550 0.00714 
NCLIV_012600 hypothetical protein UBX domain-containing protein 1216519.76 3110979.71 9384912.85 7.71456 0.01076 
NCLIV_031460 conserved hypothetical protein hypothetical protein 4253666.60 7494357.69 28251210.99 6.64161 0.00156 
NCLIV_066970 
putative enoyl-acyl carrier 
reductase 
enoyl-acyl carrier reductase ENR 
(ENR) 
7574215.54 22602986.54 41683983.44 5.50341 0.04438 
NCLIV_015620 
60S ribosomal protein L36, 
related 
ribosomal protein RPL36 (RPL36) 3902566.58 7980362.45 18483879.84 4.73634 0.00329 
NCLIV_044410 unspecified product 
rhoptry kinase family protein ROP35 
(ROP35) 
20917373.66 28776282.42 95433729.32 4.56241 0.00762 
NCLIV_038590 conserved hypothetical protein hypothetical protein 150718.32 429752.79 655892.18 4.35177 0.00589 
NCLIV_065440 hypothetical protein calmodulin, putative 8454788.39 15033666.83 34716268.40 4.10611 0.00415 
NCLIV_065210 KLLA0F09449p, related heat shock protein HSP60 (HSP60) 36358177.28 54507306.08 140030918.30 3.85143 0.00569 
NCLIV_014050 conserved hypothetical protein 
microtubule associated protein SPM2 
(SPM2) 
522829.03 827953.23 1913522.53 3.65994 0.01407 
NCLIV_030650 
putative 26S protease regulatory 
subunit 6b 
26S proteasome regulatory subunit 6b, 
putative 
1195117.95 1771237.37 4252425.39 3.55816 0.00085 
NCLIV_024860 
Proteasome/cyclosome repeat 
family protein,related 
Proteasome/cyclosome repeat-
containing protein 
2564313.44 3917997.98 9027531.44 3.52045 0.00419 
NCLIV_006060 conserved hypothetical protein hypothetical protein 728248.46 1356145.96 2366549.83 3.24965 0.00655 
NCLIV_034090 putative kinesin heavy chain kinesin heavy chain, putative 2048222.47 4914383.62 6617486.51 3.23084 0.01873 
NCLIV_022370 Ribophorin I, related hypothetical protein 125163.22 218550.97 383389.85 3.06312 0.02062 
NCLIV_002190 conserved hypothetical protein hypothetical protein 1368076.06 2540517.20 4097414.88 2.99502 0.01794 
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Cluster 4 (Table 2.5, Appendix Table IV and Figure 2.2) exhibited unchanged 
protein expression from day 0 to day 3, followed by increasing expression from day 
3 to day 6.  Proteins involved in parasite growth are seen in this cluster, such as 
serine/threonine-protein phosphatase 2A and serine/threonine-protein phosphatase 
PP1. This might due to the bradyzoite formation. Enzymes related to energy 
metabolism such as isocitrate dehydrogenase as well as the proteasome (Prosome, 
macropain) subunit, beta type, 1, which is related to degrade the unnecessary proteins 
by proteolysis, were also seen in this cluster. An activator of HSP90 ATPase 1 
family protein was identified, which is related to the stress condition as from the 
parasite pressure from the treatment. Moreover, surface antigen such as SAG-related 
sequence SRS35A, rhoptry kinase family protein, rhoptry protein and actin, which 
are associated with host cell invasion, were found in this cluster. This could be 
caused by some tachyzoites still being in the culture at day 6. 
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Table 2.5 Top twenty most differentially expressed proteins of cluster 4 showing not change or slightly down expression trend at the beginning 
and then upward expression trend 
ID N. caninum description T. gondii  orthologues D0 D3 D6 
Fold 
change 
q Value 
NCLIV_020970 conserved hypothetical protein GYF domain-containing protein 451657.79 625660.82 9665977.74 21.40111 0.00032 
NCLIV_019580 SRS domain-containing protein SAG-related sequence SRS35A (SRS35A) 303766.07 373644.29 3658692.90 12.04444 0.00114 
NCLIV_004250 
putative nuclear RNA binding 
protein 
hypothetical protein 2796716.17 4026163.48 23359224.10 8.35238 0.00066 
NCLIV_060500 conserved hypothetical protein hypothetical protein 37674990.75 53448716.98 297628121.50 7.89989 0.00417 
NCLIV_016250 putative cytidine deaminase 
cytidine and deoxycytidylate deaminase 
zinc-binding region domain-containing 
protein 
1710510.18 2416250.81 12384871.19 7.24045 0.00066 
NCLIV_007800 unspecified product hypothetical protein 57927434.60 69343600.66 343683829.60 5.93301 0.00133 
NCLIV_031700 DEHA2G03652p, related LsmAD domain-containing protein 528306.96 101558.13 579518.71 5.70628 0.04211 
NCLIV_048330 hypothetical protein 
serine/threonine-protein phosphatase 2A 
catalytic subunit beta isoform, putative 
354085.24 232071.42 1157635.38 4.98827 0.00392 
NCLIV_007510 conserved hypothetical protein hypothetical protein 2835411.64 2798676.06 13455993.20 4.80799 0.00473 
NCLIV_039280 
isocitrate dehydrogenase-like 
protein, related 
isocitrate dehydrogenase 3402418.68 4394418.36 16146865.25 4.74570 0.00196 
NCLIV_017840 conserved hypothetical protein membrane protein 3742394.05 3674093.12 15954504.80 4.34243 0.00170 
NCLIV_016330 putative phosphomannomutase 2 phosphomannomutase 78653.89 66253.03 273498.16 4.12809 0.02291 
NCLIV_031970 hypothetical protein 
pre-mRNA processing splicing factor PRP8 
(PRP8) 
4616679.00 5443197.93 18867085.16 4.08672 0.00499 
NCLIV_041270 hypothetical protein RuvB family 2 protein 957256.25 658961.86 2433646.21 3.69315 0.00118 
NCLIV_055690 hypothetical protein small GTPase Rab2, putative 2685377.41 2725196.60 9531330.85 3.54934 0.00298 
NCLIV_063230 hypothetical protein CRAL/TRIO domain-containing protein 989286.38 817158.05 2592223.66 3.17224 0.02502 
NCLIV_051820 hypothetical protein small GTP binding protein rab1a, putative 7441716.63 7966699.96 23471753.59 3.15408 0.00367 
NCLIV_054750 hypothetical protein serine/threonine phosophatase PP1 6688114.92 5946345.40 18412003.87 3.09636 0.00332 
NCLIV_009170 
proteasome (Prosome, macropain) 
subunit, beta type, 1, related 
proteasome subunit beta type 2, putative 1264325.79 808412.90 2493083.11 3.08392 0.01410 
NCLIV_052510 hypothetical protein hypothetical protein 5436994.54 5025834.72 14992101.37 2.98301 0.00937 
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Cluster 5 (Table 2.6, Appendix Table V and Figure 2.2) revealed upward expression 
trend from day 0 to day 3 and downward trend from day 3 to day 6. The majority of 
proteins found in this chapter was microneme proteins such as MIC2, MIC 3, MIC 6, 
MIC 10 and MIC 11 and two surface antigen found as SAG-related sequence 
SRS16E(SRS6) and surface antigen repeat-containing protein. 
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Table 2.6 Top twenty most differentially expressed proteins of cluster 5 showing upward expression and then downward expression trend 
ID N. caninum description T. gondii  orthologues D0 D3 D6 
Fold 
change 
q Value 
NCLIV_042540 
putative PBS lyase HEAT-like repeat 
domain-containing protein 
HEAT repeat-containing protein 120685.78 233588.55 25276.21 9.24144 0.00337 
NCLIV_001550 
putative ribonucleoside-diphosphate 
reductase, large subunit 
ribonucleoside-diphosphate reductase 
large chain 
87340.33 583783.56 418757.21 6.68401 0.00638 
NCLIV_051450 
putative centromere/microtubule 
binding protein 
rRNA pseudouridine synthase 223142.17 1220448.03 675565.49 5.46937 0.00778 
NCLIV_033680 
Solute carrier family 25 
(Mitochondrial carrier,dicarboxylate 
transporter), member 10, related 
2-oxoglutarate/malate translocase 
OMT (OMT) 
329636.97 1525846.96 793626.42 4.62887 0.00066 
NCLIV_013700 
putative CHCH domain-containing 
protein 
CHCH domain-containing protein 856631.00 3695217.99 2024348.95 4.31366 0.01140 
NCLIV_032940 putative adenosine transporter nucleoside transporter protein 891615.53 2919848.11 767821.02 3.80277 0.00226 
NCLIV_037590 conserved hypothetical protein hypothetical protein 1270323.18 2177673.77 611453.73 3.56147 0.04333 
NCLIV_032950 
putative deoxyuridine 5'-triphosphate 
nucleotidohydrolase 
deoxyuridine 5'-triphosphate 
nucleotidohydrolase, putative 
564550.47 1609532.21 768416.03 2.85100 0.00751 
NCLIV_010050 srs domain-containing protein SAG-related sequence SRS16E (SRS6) 1285383.80 2211278.86 835739.05 2.64590 0.00175 
NCLIV_032910 hypothetical protein SPFH domain / Band 7 family protein 1312561.54 3427174.12 2072315.96 2.61106 0.00802 
NCLIV_061760 putative microneme protein MIC6 microneme protein MIC6 (MIC6) 99847150.72 145373153.80 57170746.58 2.54279 0.00214 
NCLIV_051890 unspecified product 
AP2 domain transcription factor 
AP2X-7 (AP2X7) 
512977.59 796420.85 316090.41 2.51960 0.01159 
NCLIV_022970 unspecified product microneme protein MIC2 (MIC2) 19596185.13 34068901.48 13797268.62 2.46925 0.00674 
NCLIV_001620 conserved hypothetical protein hypothetical protein 197451.04 472436.90 366920.74 2.39268 0.00720 
NCLIV_010600 putative microneme protein MIC3 microneme protein MIC3 (MIC3) 460862170.3 597623331.90 263553637.7 2.26756 0.00066 
NCLIV_012130 
eukaryotic translation initiation factor 
3 subunit 7-like protein, related 
eukaryotic translation initiation factor 3 
subunit 7, putative 
3058435.49 4282803.69 1901774.7 2.25200 0.00720 
NCLIV_060470 hypothetical protein cysteine-tRNA synthetase (CysRS) 1168807.61 2187167.46 993506.64 2.20146 0.04842 
NCLIV_046540 putative oligoendopeptidase F peptidase family M3 protein 559748.68 1227000.02 598720.08 2.19206 0.00556 
NCLIV_013360 putative plectin 
surface antigen repeat-containing 
protein 
161159.37 212122.31 97005.97 2.18669 0.00740 
NCLIV_016150 Serine--pyruvate transaminase,related alanine-glyoxylate aminotransferase 604348.13 1232329.87 570792.00 2.15898 0.01293 
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Proteins in cluster 6 (Table 2.7, Appendix Table VI and Figure 2.2) displayed 
decreasing expression throughout the time course. Proteins in this cluster included 
those associated with energy metabolism such as formate/nitrite transporter protein 
and UDP-glucose 4-epimerase. Also proteins associated with apical secretory 
organelles such as dense granule protein GRA7 and GRA 6, rhoptry protein ROP15 
and ROP24 and a microneme protein. Some enzymes such as acid phosphatase that 
localise in the rhoptries and NTPase I that localises in dense granules, as well as 
protease inhibitors such as protease inhibitor PI1 and protease inhibitor PI2, which 
are mostly expressed in tachyzoites, were also in this cluster.  
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Table 2.7 Top twenty most highly expressed proteins of cluster 6 showing downward expression trend throughout three time points 
ID N. caninum description T. gondii  orthologues D0 D3 D6 
Fold 
change 
q Value 
NCLIV_004050 
formate/nitrite transporter family 
protein,related 
formate/nitrite transporter protein 526974.15 182506.23 8223.52 64.08132 0.00499 
NCLIV_0275 
peptidyl-prolyl cis-trans isomerase 
NIMA-interacting 1 
peptidylprolyl isomerase 1247517.81 221748.16 49890.12 25.00531 0.00332 
NCLIV_045400 hypothetical protein splicing factor 3A subunit 2, putative 369688.77 177245.27 33584.01 11.00788 0.01333 
NCLIV_056130 conserved hypothetical protein hypothetical protein 1531949.74 740896.97 178443.55 8.58507 0.00078 
NCLIV_057250 conserved hypothetical protein hypothetical protein 3146278.19 1580093.20 376648.63 8.35335 0.00236 
NCLIV_046950 UDP-glucose 4-epimerase, related UDP-glucose 4-epimerase 206692.55 85457.45 26501.99 7.79913 0.00739 
NCLIV_039080 
adaptin N terminal region family 
protein,related 
beta-COP 2967373.03 1361368.99 393575.40 7.53953 0.00259 
NCLIV_050780 conserved hypothetical protein hypothetical protein 1641546.33 736822.23 226831.19 7.23686 0.00282 
NCLIV_048930 hypothetical protein 
importin-beta N-terminal domain-
containing protein 
1152760.57 366793.78 161921.32 7.11926 0.00409 
NCLIV_060900 conserved hypothetical protein hypothetical protein 343669.12 126206.43 49841.19 6.89528 0.00655 
NCLIV_007120 hypothetical protein microneme protein, putative 1298651.02 635904.54 206501.33 6.28883 0.00467 
NCLIV_055980 conserved hypothetical protein hypothetical protein 5287578.25 2117710.36 880652.61 6.00416 0.00066 
NCLIV_063240 DnaJ homologue, related DnaJ domain-containing protein 379609.76 206332.62 66489.75 5.70930 0.00876 
NCLIV_044100 conserved hypothetical protein hypothetical protein 1075443.92 373675.67 193536.67 5.55680 0.01201 
NCLIV_057280 
Peptidylprolyl isomerase D 
(Cyclophilin D),related 
tetratricopeptide repeat-containing protein 389988.54 192061.67 70593.74 5.52441 0.01568 
NCLIV_011690 unspecified product rhoptry protein ROP15 (ROP15) 3193011.07 1200586.02 608179.47 5.25011 0.04398 
NCLIV_058260 hypothetical protein N/A 6073953.30 3533331.29 1282677.41 4.73537 0.00145 
NCLIV_010110 hypothetical protein 
ubiquinol-cytochrome c reductase hinge 
protein, putative 
1529043.10 938260.82 333063.12 4.59085 0.00372 
NCLIV_006620 
trehalose-6-phosphate synthase of 
likely plant origin, related 
trehalose-phosphatase 157243.48 69697.86 34737.52 4.52662 0.04629 
NCLIV_019240 conserved hypothetical protein hypothetical protein 2088544.07 1098747.25 465879.65 4.48301 0.00241 
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2.3.2 GO enrichment analysis 
 
GO term enrichment analysis was carried out using topGO for each cluster. 
However, not all clusters provided the statistically enriched GO categories.  
 
Proteins in cluster 1 have shown decreased expression during stage conversion. 
Enriched GO biological processes terms are shown in Table 2.8. These include  
peptide, cellular amide and organonitrogen compound metabolic process, peptide and 
amide biosynthetic process, translation and gene expression. These GO terms suggest 
that during stage conversion less energy is required to form a complex molecule in 
living cells. All proteins involved in GO term are related to protein synthesis such as 
putative isoleucine-tRNAsynthetase, putative 40S ribosomal protein S29, Eukaryotic 
translation initiation factor 5, related; Ribosomal protein S21-maize (ISS), related 
and Glutaminyl-tRNA synthetase, related (Table 2.8).  
 
The GO molecular function terms enriched in cluster 3, which showed an upward 
expression trend, mainly associated with the binding activities that involved in the 
regulation of nucleic acid synthesis. Proteins involved in this molecular function 
were hsp90, related; putative TCP-1/cpn60 chaperonin family protein; ATP synthase 
subunit beta, related; putative 26S protease regulatory subunit 6b; putative kinesin 
heavy chain; KLLA0F09449p, related and Myosin, related (Table 2.8).  
 
The GO terms enriched in cluster 4 revealed biological regulation processes 
comprising of regulation of cellular process, biological regulation and response to 
stimulus and signalling transduction processes comprising of cell communication, 
signal transduction, signalling, intracellular signal transduction, single organism 
signalling and cellular response to stimulus. However, most of the categories share 
the same set of proteins such as adp-ribosylation factor 4, Adenylate/guanylate 
cyclase with GAF sensor and FHA domain and two hypothetical proteins. 
Glutathione reductase, related was only associated to biological regulation. 
 
Molecular function terms enriched in cluster 4 comprised hydrolase activity, GTP 
binding, guanyl nucleotide binding, and guanyl ribonucleotide binding. There are 13 
56 
 
proteins involved in hydrolase activity as proteasome (Prosome, macropain) subunit, 
beta type, 1, mgc81714 protein, putative cytidine deaminase, tubulin alpha chain, 
Family T1, proteasome beta subunit, threonine peptidase, related, hypothetical 
protein and  5 proteins related to GTP binding, guanyl nucleotide binding and guanyl 
ribonucleotide binding as adp-ribosylation factor 4, related, tubulin alpha chain and 
hypothetical protein.  
 
Biological process enriched in cluster 5, which are preferentially expressed from day 
0 to day 3 and then drop in abundance from day3 to day 6, included metabolic 
processes involved in nucleobase-containing compounds, cellular aromatic 
compounds, heterocycle metabolic process, organic cyclic compounds and cellular 
nitrogen compounds. The cellular metabolic process is related to nucleobases, 
nucleosides, nucleotides and nucleic acids.  Significantly enriched GO terms related 
to cluster 5 are associated with the same set of proteins such as putative 
ribonucleoside-diphosphate reductase, large subunit, putative deoxyuridine 5'-
triphosphate nucleotidohydrolase, putative ATP synthase, putative 
centromere/microtubule binding protein and hypothetical protein.
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 Table 2.8 Gene Ontology: enriched biological process and molecular function terms obtained from cluster 1, 3, 4 and 5 of N. caninum stage 
conversion from tachyzoite to bradyzoite using topGO 
Cluster 
GO 
categories 
GO.ID Term Identify Proteins Annotated Significant Expected 
Fisher 
exact 
test 
1 
Biological 
process 
GO:0006518 peptide metabolic process putative isoleucine-
tRNAsynthetase, hypothetical 
protein, putative 40S 
ribosomal protein S29, 
Eukaryotic translation 
initiation factor 5,related, 
Ribosomal protein S21-maize 
(ISS), related, Glutaminyl-
tRNA synthetase,related, 
17 7 3.34 0.023 
GO:0043603 cellular amide metabolic process 17 7 3.34 0.023 
GO:1901564 
organonitrogen compound 
metabolic process 
26 9 5.1 0.031 
GO:0006412 Translation 15 6 2.94 0.043 
GO:0043043 peptide biosynthetic process 15 6 2.94 0.043 
GO:0043604 amide biosynthetic process 15 6 2.94 0.043 
GO:0010467 gene expression 19 7 3.73 0.044 
3 
Molecular 
function 
GO:0005524 ATP binding 
hsp90, unspecified product,  
putative TCP-1/cpn60 
chaperonin family protein 
hypothetical protein , ATP 
synthase subunit beta, related,  
putative 26S protease 
regulatory subunit 6b, putative 
kinesin heavy chain, 
hypothetical protein, 
KLLA0F09449p, related, 
Myosin, related 
30 11 5.03 0.0027 
GO:0030554 adenyl nucleotide binding 30 11 5.03 0.0027 
GO:0032559 adenyl ribonucleotide binding 30 11 5.03 0.0027 
GO:0001882 nucleoside binding 41 12 6.88 0.0152 
GO:0001883 purine nucleoside binding 41 12 6.88 0.0152 
GO:0017076 purine nucleotide binding 41 12 6.88 0.0152 
GO:0032549 ribonucleoside binding 41 12 6.88 0.0152 
GO:0032550 purine ribonucleoside binding 41 12 6.88 0.0152 
GO:0032553 ribonucleotide binding 41 12 6.88 0.0152 
GO:0032555 purine ribonucleotide binding 41 12 6.88 0.0152 
GO:0035639 
purine ribonucleoside 
triphosphate binding 41 12 6.88 0.0152 
GO:0097367 carbohydrate derivative binding 41 12 6.88 0.0152 
GO:0000166 nucleotide binding 42 12 7.04 0.0189 
GO:0036094 small molecule binding 42 12 7.04 0.0189 
GO:0043168 anion binding 42 12 7.04 0.0189 
GO:1901265 nucleoside phosphate binding 42 12 7.04 0.0189 
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4 
Biological 
process 
GO:0050794 regulation of cellular process 
adp-ribosylation factor 4, 
Adenylate/guanylate cyclase 
with GAF sensor and FHA 
domain, and two hypothetical 
protein 
8 5 1.79 0.013 
GO:0050789 regulation of biological process 9 5 2.02 0.026 
GO:0065007 biological regulation 9 5 2.02 0.026 
GO:0050896 response to stimulus 10 5 2.24 0.043 
GO:0007154 cell communication 7 4 1.57 0.043 
GO:0007165 signal transduction 7 4 1.57 0.043 
GO:0023052 signalling 7 4 1.57 0.043 
GO:0035556 intracellular signal transduction 7 4 1.57 0.043 
GO:0044700 single organism signaling 7 4 1.57 0.043 
GO:0051716 cellular response to stimulus 7 4 1.57 0.043 
Molecular 
function 
GO:0016787 hydrolase activity 
adp-ribosylation factor 4, 
related, tubulin alpha c, three 
hypothetical protein 
41 13 7.64 0.014 
GO:0005525 GTP binding 11 5 2.05 0.033 
GO:0019001 guanyl nucleotide binding 11 5 2.05 0.033 
GO:0032561 guanyl ribonucleotide binding 11 5 2.05 0.033 
5 
Biological 
process 
GO:0006139 
nucleobase-containing 
compound metabolic process 
putative ribonucleoside-
diphosphate reductase, large 
subunit 
putative deoxyuridine 5'-
triphosphate 
nucleotidohydrolase,  
putative ATP synthase, 
putative 
centromere/microtubule 
binding protein, 
hypothetical protein 
19 5 1.6 0.0084 
GO:0006725 
cellular aromatic compound 
metabolic process 
19 5 1.6 0.0084 
GO:0046483 heterocycle metabolic process 19 5 1.6 0.0084 
GO:1901360 
organic cyclic compound 
metabolic proces 
19 5 1.6 0.0084 
GO:0006807 
nitrogen compound metabolic 
process 
32 5 2.69 0.0199 
GO:0034641 
cellular nitrogen compound 
metabolic process 
32 5 2.69 0.0199 
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2.4 Discussion 
 
The aim of this chapter was to investigate the protein expression changes during the 
N. caninum differentiation from tachzoites to bradyzoites stage. Due to the close 
similarity of the two species and the more advanced status of T. gondii annotation, 
many of the N. caninum protein names referred to in this study for unspecified 
product and hypothetical proteins were based on their orthologue proteins in T. 
gondii.  
 
The BAG1 antigen was detected in N. caninum at day 5 post induction with SNP 
using IFA technique indicated the successfully inducing stage conversion. The 
analysis of GO term enrichment was performed for all cluster sets using topGO in 
order to interpret functional involvement of these proteins. However, the results 
mainly returned high-level, inclusive GO categories that are not particularly 
associated with stage conversion. This has lead to the focus of data interpretation on 
individual proteins, which was discussed below. 
 
2.4.1 Proteins involved in stage conversion 
 
From the current study, many proteins involved in host cell invasion showed a 
downward trend in expression, such as several microneme, dense granule and rhoptry 
proteins. This suggested that the expression of these secretory proteins is required 
less in quiescent bradyzoite-containing cysts than actively replicating tachyzoites. 
 
2.4.1.1 Microneme proteins  
 
Several microneme proteins had shown downward trend in abundance throughout all 
three time points such as MIC7 (Reid et al., 2012), whereas , MIC2, MIC3, MIC6, 
MIC10 and MIC11 had higher abundance at day 3 comparing to day 0 before 
decreased in abundant from day 3 to day 6 (cluster 5). MICs are released from 
microneme organelle after attaching to host cell. They play an important role in host 
cell recognition and invasion process in T. gondii.  (Carruthers and Sibley, 1999).  
The observation that many MICs were found more abundant at day 3 post induction 
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comparing to day 0 would have coincided with the second round of infections where 
parasites were egressing from the host cells and start to infect the new cells. The 
results also suggested that microneme proteins were not required in chronic 
bradyzoites forming stage as they all showed lowest in abundance on day 6 post 
induction. The results agrees with previous study which indicated that microneme 
proteins can be expressed in both tachyzoites and bradyzoites but mostly found in 
tachyzoites (Sonda et al., 2000).  
 
2.4.1.2 Rhoptries proteins 
 
In this study, most of rhoptry proteins decreased in expression throughout the time 
course such as ROP6, ROP 9, ROP15, ROP17, ROP24 and RON10. Rhoptry 
proteins play a critical role in host cell invasion and are also associated with 
virulence in T. gondii (Peixoto et al., 2010; Reese and Boothroyd, 2011; Saeij et al., 
2007b).The finding more abundant of  ROP 9 in tachyzoites stage in this study 
agrees with the study from  Reichmann et al. (2002), which found that ROP 9 is a 
tachyzoites- specific rhoptry proteins in T. gondii. However, this finding contradicts 
with the study of Marugan-Hernandez et al. (2010), where they found ROP9 was 
overexpressed in bradyzoites stage. In this study, ROP6 was in high abundance in 
tachyzoites, which is determined as an intrinsically disordered protein. ROP6 have 
no kinase activities in T. gondii and its biochemical and physical properties are still 
unknown as 60% of ROP6 is predicted to be intrinsically disorderdered (Lee et al., 
2014).  ROP15 is thought to have a role in parasite virulence as the expression of  
ROP15 protein decreased in a mutant temperature-sensitive N. caninum (Pollo-
Oliveira et al., 2013). The decreasing abundance of ROP15 and the other ROP 
proteins in the bradyzoite stage in this study correlates with the diminished activity 
of bradyzoites invasion of the host cells.  It seems like the low abundance of rhoptry 
proteins in bradyzoites is because this life stage is slower invade host cells than 
tachyzoite stage. However, ROP35 did show increased abundance throughout the 
time course (cluster3) which suggests an important role in the bradyzoite stage. This 
finding is consistent with the study of Fox et al. (2016).  They found that some of 
ROP proteins including ROP35 were associated with chronic infection. Moreover, 
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they showed that the deletion of ROP35 resulted in substantially reduced cyst 
burden. 
2.4.1.3 Dense Granule Proteins 
 
Most of the dense granule proteins (GRA) exhibited downward expression trend 
during the time course. GRA proteins are released at the sub-apical area of the 
parasite within 1 hour of N. caninum penetration and formation of PV (Carruthers 
and Sibley, 1997a; Dubremetz et al., 1993). In this study, GRA1, GRA3, GRA6, 
GRA7 and dense granule protein DG32 were observed in high abundance in 
tachyzoites at day 0 and they were not seen at day 6. GRA1, although did not 
observe in this study at day 6, might be cross-reactive with bradyzoites (Cesbron-
Delauw et al., 1989), which can be found in both tachyzoites and bradyzoites stage 
(Nam, 2009). GRA3 is exocytosed after invasion into PV of host cells and associated 
with the PVM (Achbarou et al., 1991). GRA6 is localised in dense granules of 
tachyzoites as well as in the PV. The function of GRA6 is thought to have a role in 
the antigenicity and pathogenicity of T. gondii. This protein stabilises the tubular 
network with the support of GRA2 after invasion host cells (Mercier et al., 2002). 
Vonlaufen et al. (2004) found that dense granule NcGRA1, NcGRA2 and NcGRA7 
suspected to be involved in tissue cyst wall formation because these dense granule 
protein were secreted and accumulated in the cyst wall during the stage conversion. 
Their finding suggested that NcGRA1 and NcGRA2 might be used as N. caninum 
markers to identify chronic infection by serological methods (Atkinson et al., 2001; 
Ellis et al., 2000). Their finding was contradicted with the current study. This might 
be GRA7 can also be found in tachyzoite stage. In this study, all GRA proteins 
showed decreased abundant over the experimental time course.  This study found 
that several invasion proteins were reduced in expression during the induction of 
bradyzoite formation, which is in agreement with previous studies (Bohne et al., 
1999; Kang et al., 2008; Lekutis et al., 2001; Manger et al., 1998). 
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2.4.1.4 Rhomboid proteins 
 
Rhomboid 4 proteins (ROM4) showed decreased expression during conversion stage 
(cluster 2). A rhomboid protease is sheded by intramembrane proteolysis to support 
host cell invasion and motility of the parasite. TgROM4 associates in surface 
adhesins with MIC2, AMA1 and MIC3. Buguliskis et al. (2010) suppressed the 
TgROM4 causing the disruption of gliding motility, decreased MIC2 secretion and 
failure to invade host cells. The down-regulation of ROM 4 interrupts the normal 
apical-posterior gradient of adhesins leading to less efficient of host cell invasion and 
motility in T. gondii. Brossier et al. (2005) stated that ROM1, ROM4 and ROM5 are 
expressed in T. gondii tachyzoites. In this study, ROM4 decreased in expression 
during the stage differentiation, which might indicate that ROM4 and its associated 
invasion mechanism is required less into a bradyzoite stage. 
 
2.4.1.5 Calmodulin proteins 
 
Two calmodulin proteins including calmodulin CAM2 and calmodulin, putative 
showed decreased expression (cluster 1) throughout time course. Moreover, CAM2 
revealed the highest fold change at 10.61. In T. gondii, intracellular calcium ions 
interact with calmodulin to induce cell motility, cell division, secretion, cytoskeletal 
activity and protein synthesis (Song et al., 2004). The formation of a Ca2+-
calmodulin complex is associated with signal transduction pathways (Cheung, 1980). 
Their role is associated with host cell attachment and invasion (Kieschnick et al., 
2001). Once N. caninum converts to the bradyzoite stage, calmodulin may be less 
important in protein expression concerning to host cell invasion. 
 
2.4.2 Protein associated with parasite motility 
 
The proteins associated with parasite motility and host cell invasion such as gliding 
associated proteins GAP40, glideosome-associated protein with multiple-membrane 
spans GAPM3, glideosome-associated protein with multiple-membrane, and two 
proteins of myosin A have shown reduced expression throughout the induction time 
course (cluster 1 and 2). The gliding associated proteins GAP40 have critical roles in 
63 
 
intracellular replication and they are also important for parasite stability (Harding et 
al., 2016). Harding et al. (2016) found that lacking of GAP40 or GAP 50 in T. 
gondii, is capable to replicate but could not be completed. In this study, these 
proteins associated with gliding activity and intracellular replication have revealed 
deceased abundance during stage conversion. This reflects the slow multiplication 
rate of bradyzoites within tissue cysts. 
 
2.4.3 Metabolic enzyme  
 
Fructose-1,6-biphosphate is a glycolytic enzyme that was differentially expressed in 
bradyzoites (day 6) in this study. This finding is comparable to the study of Tomavo 
(2001). They found that Toxoplasma bradyzoites stage might depend on anaerobic 
glycolysis. Moreover this finding is consistent with the study of Marugan-Hernandez 
et al. (2010) who found that fructose-1,6 biphosphate was more abundant in N. 
caninum bradyzoites.  
 
2.4.4 Heat shock proteins 
 
The development of bradyzoites using chemical treatment such as SNP can induce a 
stress condition that is associated with heat shock proteins (hsp) (Weiss et al., 
1998a).  Weiss et al. (1998b) found that hsp70 family is induced during bradyzoite 
differentiation. Marugan-Hernandez et al. (2010) also found hsp 90 to be 
differentially abundant in bradyzoites after inducing stage conversion using SNP. 
These studies are consistent with the present data where hsp90 and hsp60 were most 
abundant in bradyzoiotes (cluster 3). However, hsp40 showed the opposite trend 
(cluster 1).  Echeverria et al. (2005) studied the role of hsp90 in T. gondii during 
stage differentiation under stress. They suggested that hsp90 plays an important role 
in stage conversion and this protein is suitable for using as a potential drug target 
against T. gondii. One consequence of stressing bradyzoites may be to introduce 
DNA damage in leading to inhibition of cell replication (Tomavo, 2001).  
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2.4.5 Bradyzoites associated proteins   
 
Two bradyzoites associated proteins such as SAG-related sequence SRS35A 
(NCLIV_019580) and putative high molecular mass nuclear antigen 
(NCLIV_030890) have both revealed increase in expression during the time course. 
This finding is associated that bradyzoites specific marker (BAG1) antibody revealed 
positive at day 5 post induction by IFA and is consistent with the study of Vonlaufen 
et al. (2004). However, dense granule protein GRA6 (NCLIV_052880) has exhibited 
decrease in expression over the time course. This might due to GRA6 can be found 
in both tachyzoites and bradyzoites stage.  
 
2.4.6 In vitro stage conversion 
 
The study of Vonlaufen et al. (2004) has shown that SNP could trigger the stage 
conversion from tachyzoites to bradyzoites stage which determined by increasing in 
expression of N. caninum bradyzoites marker such as NcBAG1 and cyst wall antigen 
as MAbCC2 and decreasing in expression of tachyzoites surface antigens such as 
NcSAG1 and NcSRS2.The SDS-PAGE and immunoblotting were used for detection. 
However, this technique is not appropriate to obtain higher amount of bradyzoites for 
further studies which require high amount of the samples such as biochemical, 
molecular and functional investigation. The current study has shown successful 
induction of stage conversion from tachyzoites to bradyzoites stage with the same 
SNP concentration at 17 µM. However, the SNP concentration of 70 µM has 
destroyed the Vero cells after a few days of application. One possible reasons might 
be the length of cell culture, i.e. 6 days post induction equals to 9 days post infection 
which might be too long for infected Vero cells to survive.  The other method that 
can use to measure the bradyzoite formation such as transmissible electron 
microscope, immunohistochemistry, conventional PCR, quantitative realtime PCR, 
mass spectrometry. In this study, real time PCR is suggested to visualised the 
bradyzoite formation as this method can quantify the expression level of BAG1. 
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2.4.7 Differences between Toxoplasma and Neospora in their 
propensity to differentiate to bradyzoites 
 
Similarly, to T. gondii, N. caninum can be differentiated from tachyzoites to 
bradyzoites stage. It seems likely that similar mechanisms such as stress induced 
stage conversion underlie developmental transition in both organisms.  However, not 
all of methods used to induce stage conversion for T. gondii, can be used for 
inducing the differentiation process for N. caninum (Weiss et al., 1999). It might be 
due to the difference in its biology such as natural host range (Dubey et al., 2002), 
antigenicity (Bjorkman and Hemphill, 1998; Hemphill et al., 1997a; Howe and 
Sibley, 1999), some ultra-structural features (Hemphill et al., 2004; Speer et al., 
1999) and its host cell recognition (Naguleswaran et al., 2002; Naguleswaran et al., 
2003). Weiss et al. (1999) used protocol that successfully developed the stage 
conversion for T. gondii by increasing the pH of the medium for culturing T. gondii 
infected human fibroblasts with tylosine to develop stage conversion for N. caninum. 
The result showed that the yield of obtaining parasites was low during the stage 
conversion, indicating that the method offered lower efficiency to differentiate the 
conversion process in vitro than T. gondii. In addition, (Dubey and Lindsay, 1996) 
found that most of cyst formation of T. gondii forms in several organs but N. 
caninum form cyst mostly in neural tissue. However, the spontaneous rate of cyst 
formation for low virulent ME49 strains of T. gondii in culture is higher than virulent 
RH strains (Dubey et al., 1998; Soete et al., 1994). It is consistent with the cyst 
formation of N. caninum, a development of thick refractile cyst wall was occurred 
more common with high virulent Nc-Liv isolate than with lower virulent NC-2 
isolate (Vonlaufen et al., 2004). This study showed the visualise of BAG1 by IFA but 
the vero cells was not look good at day 6 post induction. The comparison study 
between T. gondii and N. caninum suggested to perform to see the difference. 
 
2.4.8 Limitations of the study and suggestions for future 
prospectives 
 
In this study, cells infected with tachyzoites at day 0 after treated with SNP was used 
as control. The evidence of not seeing the BAG1 reaction by IFA at day 0 has been 
proved for the stage of parasite that was not yet convert to bradyzoites stage. 
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However, cells were not treated with SNP should be included for experimental 
control, so the stage conversion process will provide more reliable result. The 
validation of experiment need to be considered such as proper parasite: host ratio. In 
this study, the parasite to host ratio was used as 1:1 and it showed that most of Vero 
cells were destroyed at day 6 post induction.  The proper ratio might be less parasite 
to host such as 1: 2-4 (parasite: host) ratio. This would allow an extension of the 
stage conversion experiment upto 8-9 days post induction (Vonlaufen et al., 2004). 
Extension of the duration of stage conversion experiment might yield purer 
bradyzoites productions.  However, it might contain a lot of dead cells which would 
interfere with the experimental results. The IFA method which was used to confirm 
the conversion stage in this experiment was performed at day 5 post induction, which 
was not consistent with the experimental design. This is due to less amount of BAG1 
antibody. It would be better to set the IFA method following the time point in the 
experiment time course, which would provide more reliable result on the stage 
conversion progression and . Moreover, tachyzoite specific antigen can also be added 
to IFA method to give more view of stage conversion synchronisation.  
 
Furthermore, most of the proteins were annotated as hypothetical proteins and 
unspecified products with no known functions. It limits the depth of data 
interpretation. With more activities in the field of Neospora research, it is expected 
that increasing number of proteins will be annotated in the nearly future. It is also to 
be considered that the synchronization of N. caninum stage conversion should be 
regulated, where all parasites should be brought to same phase. This is important for 
studying cell cycle of the parasite for example extending the duration of SNP 
induction to obtain more bradyzoites. One more limitation is this study is not 
reflecting the real situation like in animal body as in cell culture have no immunity in 
cell culture 
 
The proteomics study of tachyzoites-bradyzoites stage of N. caninum is important to 
know the biological information of this conversion stage as it is important in 
pathogenesis. More approach such as metabolomics method may be applied for 
further investigation in order to deeply know about the melobolism related to the 
stage conversion.  
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2.4.9 Comparative study of proteomics and transcriptomics of N. 
caninum tachyzoites to bradyzoites stage conversion  
 
Vermont (2012) studied the N. caninum stage conversion using RNA-Seq method to 
investigate the transcripts expression trend during the experimental time course at 
day 0, 1, 3 and 6 post SNP induction with the concentration of 50 µM. Their study 
was focused on the apical genes as micronemes, rhoptry and dense granules genes 
which involved in host cells invasion process. So the comparative analysis between 
both methods are performed only in these three protein families. The transcriptomics 
result found that rhoptry genes such as ROP40, ROP14 and Toxofilin have shown 
decreased expression during the stage conversion time course which is consistent 
with proteomics study. Their results indicated that the decrease in abundant of 
rhoptry proteins because these proteins are less important in invasion process of 
bradyzoites  However, ROP35 has shown increase in abundant in current study but 
this ROP proteins was associated to the chronic infection and cyst formation (Fox et 
al., 2016). 
 
The transcriptomics finding of microneme genes has shown both increase and 
decrease in abundance during the time course. This finding is inconsistent with the 
proteomics study as most micronemes proteins as MIC2, MIC3, MIC6, MIC10 and 
MIC11 have revealed increase in abundant from day0 to day 3 post induction and 
then decrease in protein expression at day6 post induction. In addition, MIC7 has 
shown decrease in expression during the stage conversion time course and no MICs 
have shown high abundant at day 6 post induction.  
 
No dense granule genes were expressed in the transcriptomics study. This might 
indicate the transcriptional process of these genes was remarkably robust or there 
might have been some other elements controlling the translation (Vermont, 2012).  
Their finding is not consistent with the proteomics results presented in this study as 
several dense granule proteins quantified in the study exhibited decrease in 
expression throughout the time course. The dense granule are known to function after 
micronemes and rhoptry proteins in the invasion process, which establishment in PV 
(Carruthers and Sibley, 1997a) which is supported by the proteomics finding. 
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The correlation between transcriptomics and proteomics data has been proved to be 
low. The mRNA transcripts abundances might be only partially correlated with the 
protein abundances depending on the type of organism. For example the study of  
human DAOY medulliblastoma cell line showing that approximately 30-40% of 
protein abundance variance correlated to mRNA abundance (Vogel and Marcotte, 
2012). There are many factors involved in this process such as post transcriptional 
regulation of mRNA and posttranslational modification of protein (Perco et al., 2010; 
Yang et al., 2015). As a consequence, gene expression abundance might not correlate 
with protein expression abundance. 
 
Many previous studies revealed the comparable between transcriptomic and 
proteomic data are indicated weak correlation in protozoan parasites such as 
Plasmodium, Toxoplasma and other Apicomplexan parasites. The differences 
between mRNA and protein expression can be explained by biological mechanisms 
including, firstly, regulation of expression such as selective protein degradation, and 
variations in protein turnover rates. Secondly, post-translation regulation such as 
mRNA decay, and translational repression. Moreover, the previous studies in 
apicomplexan parasites, it has evidences that might be occured from stage-specific 
adaptation that induce transcriptional changes and will reflect protein changes. In 
addition, technical factor such as lacks of collected sample concurrently 
transcriptomic and proteomic analysis, and lacks of statistical models to prove the 
errors in each transcriptomic and proteomic data (Wastling et al., 2009) 
  
The experiments used to study the relation between transcriptomic and proteomic 
data are Expressed Sequence Tags (EST) or Microarray expression for attain 
transcriptomic data and 1 gel-based analysis of parasite protein (one- or two-
dimensional gel electrophoresis) followed by mass spectrometry of trypsin digested 
bands or spots or whole shotgun proteome analysis (Wastling and Xia, 2016). These 
will be resolved 30-40% of proteome of protozoan parasite (Wastling et al., 2009). 
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2.5 Conclusions 
 
In summary, most of the apical secretary proteins such as micronemes, rhoptries and 
dense granules have shown reduced expression in the bradyzoites-like stage during 
the stage conversion and most bradyzoites associated proteins have shown increase 
in expression. This indicates that when the parasites are preparing to convert stage, 
the apical secretory proteins might be less important in bradyzoites stage. 
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Chapter 3: Comparative transcriptomics of  
low- and high-virulence strains of N. caninum 
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3.1 Introduction 
 
3.1.1 Neospora virulence 
 
Parasite virulence can be in simple terms as destruction or the ability to form disease, 
or as a complex feature including parasitic infection, invasion, rate of reproduction, 
and pathogenicity  (Garnick, 1992). The virulence of T. gondii, which is closely 
related to N. caninum, is defined by the multiplication rate of the parasite and the 
stimulation of various kinds of immune response in mice (Dubremetz and Lebrun, 
2012). The factors involved in multiplication rate seem to be involved in virulence 
factors of T. gondii.  Al-Qassab et al. (2010) defined virulence in N. caninum as the 
ability of the organism to induce clinical signs of neosporosis in mice, transplacental 
transmission and survival of offspring in infected animal. There are some N. caninum 
isolates defined as low virulence such as Nc JAP1 (Yamane et al., 1996; Yamane et 
al., 1997), Nc-Sheep (Koyama et al., 2001), Nc-Nowra (Miller et al., 2002), Nc-
Spain 1H (Rojo-Montejo et al., 2009a) and Nc-Goias (García-Melo et al., 2009). All 
low virulence strains were isolated from asymtomatic calves or sheep. Conversely, 
some of N. caninum strains determined are as high-virulence, for example Nc-1 
(Dubey et al., 1988b), Nc-Liverpool (Barber et al., 1993; Barber et al., 1995) and Nc 
Spain 7 (Regidor-Cerrillo et al., 2008).  
 
The low and high-virulence strains of N. caninum used in this study were Nc Spain 
1H and Nc Spain 7, respectively. Nc Spain 1 was originally isolated from a 
congenitally infected calf brain and was shown to be less virulent than Nc1 both in 
pregnant and non-pregnant mouse models, with a low tachyzoite yield. Moreover, 
the viability rate in in vitro cell culture of Nc Spain 1H was decreased (Rojo-Montejo 
et al., 2009a). The high-virulence Nc Spain 7 strain was isolated from naturally 
asymptomatic infected calf’s brain (Regidor-Cerrillo et al., 2008). It causes foetal 
death and abortion in pregnant heifers while immunological responses could be 
detected after day 14 post infection (Caspe et al., 2012).  
 
Intraspecific variation of N. caninum is important as the high-virulence of the 
parasites can cause reproductive failure in cattle and neuromuscular disorders in 
dogs. On the other hand, low virulence strains cause very mild clinical signs.  These 
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variations also depend on the infected host response; for example Nc-1 has been 
shown to be more virulent than Nc-Liverpool in sheep, while Nc-Liverpool displayed 
greater virulence than Nc1 in BALB/c mice with the former being more abundant in 
the brain (Collantes-Fernandez et al., 2006). Moreover, host susceptibility plays a 
role in N. caninum infection; for example, inbred BALB/c mice, immunodeficient 
mice, INF-γ KO mice and gerbils are susceptible to neosporosis (Dubey and Lindsay, 
1996; Dubey et al., 1998).   Indeed, disease phenotype among N. caninum is not 
strictly conserved within the species due to significant variation levels within the 
population. The factors contributing to the diversity of N. caninum may involve 
broad intermediate host range, geographical distribution, and the parasite capability 
to reproduce sexually (Al-Qassab et al., 2010).  
 
3.1.2 The difference in pathogenicity between low- and high-
virulence N. caninum  
 
Pathogenicity is the ability of an organism to cause disease in an infected host. The 
pathogenicity of N. caninum has been investigated in many approaches such as in 
vivo and in vitro experiments, pathological observations, and molecular techniques 
(Caspe et al., 2012; Cavalcante et al., 2012; Regidor-Cerrillo et al., 2014; Rojo-
Montejo et al., 2009a). For example, the low virulence Nc Spain 1H strain does not 
cause foetopathy in infected cattle at day 70 of the gestation period but fetal death 
occurred in three out of five dams infected with the high-virulence Nc-1 strain  
(Rojo-Montejo et al. (2009a).  A comparison of the in vitro tachyzoites yield and 
viability rate between these strains using plaque assays found that Nc Spain 1H 
exhibited lower tachyzoites yield and lower viability rate than Nc-1 (Rojo-Montejo et 
al. (2009a). Moreover, in the pregnant mouse model almost 100% of offspring 
survived in Nc Spain 1H infected group and Neospora DNA was detected from only 
1 pup. In contrast, the high mortality rate was demonstrated in Nc-1 infected group.   
 
The study of pathogenicity in high-virulence Nc Spain 7 was performed by Caspe et 
al. (2012). The result showed that four out of seven pregnant cattle aborted after 
inoculation of dams with high-virulence Nc Spain 7 at day 65 of pregnancy. The 
abortion occured at 3 to 5 weeks post infection. On the other hand, the cattle in the 
control group inoculated with PBS did not show any abortion. Similarly, foetal death 
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occurred after injecting with Nc-Liverpool (Williams et al., 2000) and Nc-1 
(Macaldowie et al., 2004) tachyzoites to early pregnancy of cattle. The previous 
experimental study associated to virulence of N. caninum revealed the significant 
difference of the clinical evidence between low and high-virulence strain of N. 
caninum. However, the genetic factors influencing the variation of virulence in N. 
caninum are still unclear. A transcriptomics approach can be used to explore gene 
expression in strains of N. caninum with different virulence phenotypes to gain a 
better understanding of biological information related to virulence in N. caninum.  
  
3.1.3 Transcriptomics and RNA-Seq 
 
The transcriptome is the complete set of all the messenger RNA (mRNA) in a cell 
(Wang et al., 2009). The transcriptome is important for identifying the functional 
elements of the genome and for quantifying genome-wide gene expression. The 
regulation of gene expression is a basic mechanism in all cells that maintains 
development, homeostasis and adaptation to environments (Gomez et al., 2010). 
Transcriptomic data from a sample of interest can be obtained by several methods 
such as microarrays, expressed sequence tag (EST) collections, serial analysis of 
gene expression (SAGE), massively parallel signature sequencing (MPSS) tags, Cap 
analysis of gene expression (CAGE) and RNA-Seq (Wang et al., 2009; Wastling et 
al., 2009). Microarrays can detect nucleic acids in a sample by hybridization to 
probes on microchips. This method is high throughput and not too expensive. 
However, microarrays depend on present genome sequence knowledge, high 
background toward cross hybridization and restrict the range of detection due to 
interfering from background and saturation of signals. Even though the sequence-
based methods such as Sanger sequencing of cDNA or EST libraries provide the 
cDNA sequence determination, these are relatively low throughput, expensive and 
not quantitative (Wang et al., 2009).  The tag-based sequencing methods for example 
SAGE, CAGE and MPSS were developed to overcome these limitations. They 
provided more precise estimation. However, these techniques are still expensive and 
a specific portion of short tags cannot be perfectly mapped to the reference genome. 
In contrast, RNA-Seq provides a method for mapping and precisely quantifying 
mRNA with high-throughput (Chu and Corey, 2012). 
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3.1.4 RNA-Seq 
 
The RNA-Sequencing (RNA-Seq) method was developed to investigate gene 
expression (Mortazavi et al., 2008; Nagalakshmi et al., 2008; Wang et al., 2009). It is 
normally used for comparative experiments where transcript abundance is 
determined from multiple samples (Li et al., 2012). RNA-Seq has many advantages 
over existing methods such as greater accuracy, sensitivity and specificity, a broader 
dynamic range, and it can be applied to all organisms even when there is no sequence 
reference. Microarrays use hybridization to measure gene expression but the 
measurement is limited by the background; RNA-Seq quantifies discrete, digital 
sequencing read counts providing a broader dynamic range with no upper limit for 
quantification enabling a larger range of detection of transcript expression level.  
 
In RNA-Seq, messenger RNA (mRNA) are randomly fragmented into small pieces 
and the total or fractionated mRNA are converted to cDNA fragment library attached 
with adaptors to one or both ends using random primers. Then cDNA library is 
amplified by PCR and each molecule is then sequenced in a high-throughput method, 
resulting in millions of short sequence reads. The size-range of reads is normally 30-
400 bp depending on the techniques used. The reads are then either aligned to the 
reference (genome or transcripts) or de novo assembled without requiring the 
genomic reference . The number of reads mapped to a specific regions are used as a 
measure of expression (Li et al., 2012). Reads density can be used to measure 
transcript and gene expression (Trapnell et al., 2012). In comparison to previous 
methods, RNA-seq represents notable advances. First, the detection of transcripts by 
RNA-Seq is not limited by the current reference genome sequence. Second, RNA-
Seq has a low signal background compared to DNA microarrays, meaning a higher 
accuracy rate for quantifying gene expression as well as a lower requirement for 
starting material (Wang et al., 2009). This method can explore the whole 
transcriptome in a high throughput and quantitative ways as well as providing lower 
cost compared to arrays and large scale Sanger EST sequencing.   
 
There are three categories involved in RNA-Seq analysis tools, namely read 
alignment, transcript assembly or genome annotation, and transcript or gene 
quantification (Trapnell et al., 2012). The quality assessment for sequence reads is 
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the first pipeline for differential expression analysis such as assessment a number of 
reads quality, trimming bases or reads below the requiring cut off and trimming 
residual adapter from reads sequence. Then mapping reads to a reference genome 
sequence is allows the determination of exon/gene expression values and the 
identification of differential gene expression between two conditions. Finally, 
functional terms associated with cohorts of differentially expressed transcripts, such 
as gene ontology (GO) terms, can be analyzed to interpret the biological 
consequences of changes in gene expression.  
 
3.1.5 Application of transcriptomics to the study of virulence in 
apicomplexan parasites 
 
RNA-seq has been applied to the transcriptomic profiles of apicomplexan parasites, 
to examine specific developmental stages, specific phenotypes such as the virulence 
of the parasites (Pedroni et al., 2013). Pedroni et al. (2013) compared transcriptomic 
profiles of geographically distinct virulent and attenuated Babesia bovis strains using 
microarray and RNA-sequencing methods. They found that ves gene expression was 
up-regulated in the virulent strain, consistent with the role of VESA1 proteins in 
cytoadherence of infected cells to endothelial cells. While the spherical body protein 
2 gene family was up-regulated in an attenuated strain. The study concluded that 
these two gene families may play an important role in regulating virulence in B. 
bovis.  
 
In Plasmodium spp., Rovira-Graells et al. (2012) found that the transcriptional 
diversity within clonal Plasmodium falciparum populations were involved in gene 
families associated with host parasite interactions and genes relevant to 
environmental pressure adaptation. Almelli et al. (2014) compared transcriptomic 
patterns of Plasmodium falciparum in children with cerebral malaria with those in 
asymptomatic patients using microarray and quantitative rtPCR. They found a high 
abundance of genes involved in pathogenesis, host cells attachment and erythrocyte 
aggregation in parasites taken from patients with cerebral malaria. However, genes 
encoding exported proteins, Mauere’s cleft proteins, transcriptional factor proteins, 
proteins implicated in protein transport and hypothetical proteins were more 
abundant in parasites from asymtomatic children.  Another transcriptome study of 
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avian malaria was performed by  Lauron et al. (2014), in which erythrocytes 
containing P. gallinaceum were inoculated into white leghorn chicken, identified 
transcripts related to intra-erythrocytic survival and erythrocyte invasion, such as 
apical membrane antigen-1 (ama-1) and rhoptry neck protein 2 (RON2) were 
identified.  
 
The variation in clinical presentation of neosporosis is associated with intra-specific 
diversity of the parasite (Regidor-Cerrillo et al., 2013). Most of the virulence studies 
in N. caninum have been investigated from the clinical appearance and pathology 
while the factors related to virulence are still not known. Moreover, there has been 
no previous analysis of genome-wide gene expression in N. caninum strains with 
contrasting virulence phenotypes using an RNA-Seq approach. A comprehensive 
analysis of N. caninum virulence by transcriptomics is needed because this technique 
can identify those transcripts related to virulence and might provide information on 
the possible function of genes associated with virulence. 
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3.1.6 Aims and Objectives 
 
The aim of this chapter is to compare the transcriptomic profile of low-virulence (Nc 
Spain 1H) and high-virulence (Nc Spain 7) strains of N. caninum and identify 
transcripts displaying significant differential expression between the two strains. 
These transcripts may play a role in virulence.  
 
Objective of this study: 
 
1. To estimate and compare transcript abundance between low- and high- 
virulent strains of N. caninum 
2. To identify differentially expressed transcripts associated with low- and 
high- virulence phenotypes 
3. To identify enriched functional terms consistent with a role in virulence 
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3.2 Materials and Methods 
 
3.2.1 N. caninum tachyzoites preparation  
 
Infection of cell culture with N. caninum was carried out by the Ortega-Mora’s 
group, Complutense University of Madrid, Spain. Tachyzoites pellets of low-virulent 
(Nc Spain 1H) and high-virulent (Nc Spain 7) strains were prepared at 1x108 
tachyzoites (three biological replicates each) and sent to University of Liverpool for 
subsequent procedure. Total RNA was extracted by the author and measured for 
RNA quantitation using Qubit (Life technologies) and NanoDrop 1000 
spectrophotometer (Thermo Scientific).   
 
3.2.2 RNA Extraction 
 
The total RNA of both N. caninum strains was extracted by using RNeasy mini kit 
(Qiagen). Briefly, samples were suspended with 600 µl RLT buffer in order to 
disrupt the tachyzoites and then the lysate was transferred to QIAshredder columns 
(Qiagen) to homogenize the tachyzoites and reduce viscosity, affected by high 
molecular weight cellular components and cell debris. Samples were centrifuged at 
full speed for 2 minutes. The flow-through fluids were kept and 600 µl of 70% 
molecular grade ethanol was added to the fluid. The sample mixture was transferred 
to RNeasy spin column and centrifuged at 10,000 rpm for 30 seconds. The flow-
through was discarded and 700 µl of buffer RW1 was added into the column to wash 
the filter. The columns were centrifuged at 10,000 rpm for 30 seconds and the 
flowthrough was discarded. Five hundred µl of RPE was added to the column and 
centrifuged at 10,000 rpm for 30 seconds. The previous step was repeated by adding 
500 µl of RPE and centrifuged at 10,000 rpm for 2 minutes. The columns were then 
inserted to the other collection tube and centrifuged at 10,000 rpm for 1 minute to 
remove the remaining fluid. The columns were placed into new collection tubes and 
the total RNA was eluted using 30 µl RNase-free water. The columns were incubated 
at room temperature for 1 minute and then centrifuged at 10,000 rpm for 1 minute. 
The flow-through was collected and stored at -80 oC. 
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3.2.3 RNA Quantification 
 
The concentration of total RNA was measured using Qubit assay (Life technologies) 
and the purity was measured using NanoDrop 1000 spectrophotometer (Thermo 
Scientific). These procedures were performed according to the manufacturer’s 
protocols. 
 
3.2.4 Poly-A selection and RNA-Seq libraries preparation 
 
The isolation of messenger RNA (mRNA) was done by the Centre for Genomic 
Research (CGR), at the University of Liverpool. mRNA was isolated from total RNA 
by selecting Poly-Adenylated RNA using two rounds of selection with the Poly-A 
selection kit and Dynabeads mRNA Purification kit (Life Technology, Catalogue No. 
61006). Preparation of RNA-Seq libraries were performed from the Poly-A selected 
material using the Epicentre ScriptSeq v2 RNA-Seq Library Preparation kit 
(Catalogue No. SSV21106, Epicentre). 50 ng of the poly-A selected material was 
used as input into the library preparations, followed by 10 cycles of amplification. 
Then libraries were purified using AMPure XP beads. Qubit was employed for 
library quantification and the Agilent 2100 Bioanalyzer was used for size 
determination. Finally, the libraries were pooled in equimolar amount using the 
Qubit and Bioanalyzer data. Each pool was evaluated for their quantity and quality 
using Bioanalyzer and later by qPCR using the Illumina Library Quantification kit 
from Kapa on a Roche Light Cycler LC480II following manufacturer in protocol. 
The sequenced of pool of libraries was performed on one lane of HiSeq 2500 at 
2x100bp by paired- end sequencing with rapid-run mode chemistry. 
 
3.2.5 Processing and Quality assessment of the RNA-sequence data 
 
The initial processing and the quality assessment of RNA-sequence data was done by 
the CGR using an in-house pipeline. Base-calling and de-multiplexing of indexed 
reads of 6 RNA-Seq samples was prepared using CASAVA version 1.8.2 (Illumina) 
in fastq format. The Illumina adapter sequences were removed from raw fastq files 
by trimming the sequence using Cutadapt version 1.2.1 (Dubey et al., 2011). The 
option “-O,3” was used to trim the 3’ end of any reads which matched the adapter 
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sequence more than 3 bp.  Later the low quality reads were trimmed using Sickle 
version 1.200 and the minimum window quality score of 20 was set. Then reads that 
were shorter than 10 bp were removed. Finally, the R1 (forward reads) and R2 
(reverse reads) were identified if both reads from a pair passed existing filter, while 
the R0 (unpaired reads) were recognized if only one of a read pair passed the filter.  
 
3.2.6 Reads mapped to N. caninum reference genome sequence 
 
Read mapping was carried out by the CGR. Each of the 6 samples of RNA-Seq 
library was aligned to N. caninum genome sequence obtained from ToxoDB website 
(Version 11.0) using TopHat2 (Braun et al., 2013). Reads that mapped to the 
reference in more than one position were rejected.  
 
3.2.7 Differential gene expression analysis 
 
Differential gene expression was identified using the Cufflinks package (Trapnell et 
al., 2010) (http://cufflinks.cbcb.umd.edu/). Cufflinks is a free software used to 
assemble the transcripts in an RNA-Seq sample (Trapnell et al., 2012a). The package 
is also used for gene discovery and gene expression analysis of transcriptome 
(mRNA) sequencing data. This program can calculate the abundance of transcripts 
with or without a reference annotation. However, Cufflinks needs a reference 
genome and RNA-Seq reads alignments. It can be used for data normalisation in 
order to remove artifacts and biases which affect the quantification. The mapped 
reads against reference genome (as done by CGR using TopHat 2 aligner 
(http://tophat.cbcb.umd.edu/)) were used as input files which the reads of each 
biological replicate of N. caninum were mapped individually.  The assembly files 
were combined with the reference transcriptome annotation which produced a united 
annotation for further analysis. Then Cuffdiff, a part of Cufflinks, was employed for 
quantifying the merged annotation and provided expression data in a tabular file. 
Cuffdiff examines expression log-fold-change in contrast to the null hypothesis of no 
change for example true log fold-change equal to zero. It can detect significant 
differences in transcript abundance between multiple RNA-seq data sets, allowing 
differential or preferential expression to be identified among multiple conditions 
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(Trapnell et al., 2012a). fold-changefold-changeTranscript abundance in expressed as 
Fragments per kilobase of transcript per million fragments mapped (FPKM). These 
data were then used for further analysis such as gene identification, gene 
differentially expression and gene ontologies. 
 
3.2.8 Gene ontology (GO) enrichment analysis 
 
Transcript sets with significantly greater abundance in in low- and high-virulence 
strains of N. caninum respectively were separately analysed for their ontologies and 
biological function. The GO enrichment analysis was performed using ToxoDB 
website (http://www.toxodb.org/toxo/) in order to explore the gene representatio 
either over-expression or under -xpression of ontological terms in each of gene set by 
comparing to the abundance of these terms across the genomic background. An 
adjusted-P value (q value) of less than 0.05 was used to determine significant 
enrichment of GO terms. The enrichment analysis was divided into three categories: 
biological process, molecular function and cellular component ontologies. Fold 
enrichment was calculated by using the proportion of annotated genes possessing a 
given GO term divided by the proportion of genes with the same term in the 
background (Ashburner et al., 2000). 
 
The other approach for obtaining GO term analysis from each Neospora  strain was 
performed using topGO (Alexa and Rahnenfuhrer, 2016). This method provides tools 
for analysing GO terms using the R package to run the analysis. The R script for 
generating the topGo was kindly provided by Dr. Vicky Hunt, Department of 
Infection Biology, University of Liverpool. 
 
 
 
 
 
 
82 
 
3.3 Results  
 
3.3.1 Transcriptomic profiles of low and high virulence N. caninum 
 
The transcriptomes of the low and high-virulence strains Nc Spain 1H and Nc Spain 
7, respectively, were sequenced at the Centre for Genomic Research, University of 
Liverpool. The sequence data was of high quality, as shown by the total number of 
RNA-Seq read counts obtained and the distribution of read length after trimming  
 
The percentage of reads mapped to the N. caninum reference genome ranged from 
62-77 % (Table 3.1). The percentage of the reads not mapped to reference genome is 
likely to be contamination from the host cells.  
 
Table 3.1 Summary of number and percentage of total reads mapped to the N. 
caninum reference genome using TopHat Version 2.0.10. 
 
Samples 
No. of reads 
to map 
Reads mapped to 
genome 
Percentage of total 
reads mapped 
Nc-1H_1 69,200,330 45,999,810 66.5% 
Nc-1H_2 49,185,566 30,667,545 62.4% 
Nc-1H_3 53,434,568 33,061,233 61.9% 
Nc-7_1 41,148,538 29,866,305 72.6% 
Nc-7_2 50,510,474 39,176,661 77.6% 
Nc-7_3 59,062,862 38,018,906 64.4% 
 
3.3.2 Differentially expressed transcripts between low and high 
virulence strains of N. caninum 
 
A Total of 192 transcripts display differential expression between low and high-
virulence N. caninum with statistically significance (q value < 0.05). Of these, 132 
genes show differential expression with fold-change more than two (log 2 fold-
change < -1 and > 1). Among these genes, 106 genes showed a higher level of 
expression in Nc Spain 1H in comparison to Nc Spain 7 (Table 3.2 and Appendix 
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Table VII).  A further 26 genes showed lower levels of expression in Nc Spain 1H in 
comparison to Nc Spain 7 as shown in Table 3.3. 
 
Table 3.2 Top twenty most preferentially expressed genes in Nc Spain 1H by FPKM 
(Fragments per kilobase of exon per million fragments mapped) 
 
 
Gene ID 
 
Description 
FPKM 
Nc Spain 1H 
FPKM 
Nc Spain 
7 
 
Fold-
change 
 
q value 
NCLIV_005760 putative SRS13 10.8762 1.94971 5.578368 0.005436 
NCLIV_060015 
unspecified 
product 
44.0336 9.91198 4.442463 0.005436 
NCLIV_027990 
putative WD 
domain, G-beta 
repeat-containing 
protein 
4.49324 1.0373 4.331669 0.049833 
NCLIV_046230 
putative cGMP-
inhibited 3',5'-cyclic 
phosphodiesterase 
2.83636 0.664509 4.268355 0.005436 
NCLIV_067430 
conserved 
hypothetical 
protein 
5.3933 1.28166 4.208058 0.005436 
NCLIV_016130 
conserved 
hypothetical 
protein 
10.8443 2.5969 4.175864 0.026189 
NCLIV_042840 
hypothetical 
protein 
23.6494 5.82076 4.062940 0.005436 
NCLIV_069900 
zinc finger 
(CCCH type) 
protein, putative 
2.86731 0.729169 3.932298 0.034852 
NCLIV_042910 
malate 
dehydrogenase, 
related 
118.622 30.3059 3.914155 0.005436 
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Gene ID 
 
Description 
FPKM 
Nc Spain 1H 
FPKM 
Nc Spain 
7 
 
Fold-
change 
 
q value 
NCLIV_003260 putative NcMCP3 95.7119 24.7783 3.862731 0.005436 
NCLIV_038930 
srs domain-
containing protein 
19.956 5.29338 3.769992 0.017441 
NCLIV_000750 
conserved 
hypothetical 
protein 
75.5329 20.0536 3.766551 0.005436 
NCLIV_017300 
putative 3', 5'-
cyclic nucleotide 
phosphodiesterase 
49.9496 13.4756 3.706670 0.005436 
NCLIV_031960 
conserved 
hypothetical 
protein 
13.7958 3.78912 3.640898 0.005436 
NCLIV_015120 
hypothetical 
protein 
16.5114 4.63039 3.565877 0.005436 
NCLIV_013310 
hypothetical 
protein 
6.41478 1.81093 3.542257 0.011354 
NCLIV_068830 
PAN domain-
containing protein 
(EC 3.4.21.27), 
related 
13.9061 4.03794 3.443860 0.014103 
NCLIV_019580 
SRS domain-
containing protein 
1086.73 319.311 3.403359 0.005436 
NCLIV_009520 
conserved 
hypothetical 
protein 
11.335 3.34599 3.387637 0.016162 
NCLIV_021430 
hypothetical 
protein 
8.56093 2.60186 3.290312 0.005436 
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106 transcripts were significant preferentially expressed in Nc Spain 1H,  the greatest 
difference between low and high-virulent strains was   a putative SRS13 
(NCLIV_005760). This is a bradyzoite-specific gene showing 5.58 fold-change 
(adjust p-value < 0.05). There are high abundance transcripts of the other six SRS 
domain-containing transcripts (NCLIV_038930, NCLIV_019580, NCLIV_020100, 
NCLIV_043600, NCLIV_034731 and NCLIV_049510) as well as some metabolic 
enzymes. For example, a putative 3', 5'-cyclic nucleotide phosphodiesterase 
(NCLIV_017300), which has a role in the breakdown of cyclic nucleotides and 
malate dehydrogenase (NCLIV_042910), which has a role in energy metabolism.  
 
By contrast, there are 26 genes in Nc Spain 1H that are significantly less abundant 
than in Nc Spain 7 (Table 3.4 and Appendix Table VIII). Most of these genes of Nc 
Spain 1 H comprise many hypothetical proteins and unspecified products (19 from 
26 genes).The seven genes with verified identifications  are putative retinitis 
pigmentosa GTPase regulator (NCLIV_015810), two putative protein phosphatase 
2C (NCLIV_019010 and NCLIV_022340), putative actin (NCLIV_004950), putative 
adenosine transporter (NCLIV_019000),  putative zinc finger (CCCH type) protein 
(NCLIV_064250)  and putative PPR repeat-containing protein (NCLIV_066300). 
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Table 3.3 Top twenty most preferentially expressed genes in Nc Spain 7 by FPKM 
 
Gene ID Description 
FPKM 
Nc Spain 
1H 
FPKM 
Nc Spain 7 
Fold-
change 
q value 
NCLIV_047150 
conserved 
hypothetical 
protein 
64.2754 513.257 -7.9852 0.0054 
NCLIV_015810 
putative retinitis 
pigmentosa 
GTPase 
regulator 
0.377197 1.69162 -4.4847 0.0092 
NCLIV_038025 
unspecified 
product 
0.716453 2.61539 -3.6504 0.0092 
NCLIV_047420 
conserved 
hypothetical 
protein 
0.528506 1.84384 -3.4887 0.0092 
NCLIV_019010 
putative protein 
phosphatase 2C 
1.47862 4.63615 -3.1354 0.0054 
NCLIV_006200 
hypothetical 
protein 
5.4881 16.8742 -3.0746 0.0054 
NCLIV_069070 
hypothetical 
protein 
110.042 310.791 -2.8242 0.0141 
NCLIV_011060 
conserved 
hypothetical 
protein 
10.8528 29.419 -2.7107 0.0113 
NCLIV_058960 
conserved 
hypothetical 
protein 
2.43305 6.50768 -2.6747 0.0054 
NCLIV_038021 
unspecified 
product 
3.4118 8.72897 -2.5584 0.0054 
NCLIV_050550 
hypothetical 
protein 
6.37614 15.8601 -2.4874 0.0113 
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Gene ID Description 
FPKM 
Nc Spain 
1H 
FPKM 
Nc Spain 7 
Fold-
change 
q value 
NCLIV_006110 
conserved 
hypothetical 
protein 
8.66654 21.1521 -2.4406 0.0054 
NCLIV_004950 putative actin 17.1389 41.1343 -2.4000 0.0054 
NCLIV_046220 
hypothetical 
protein 
2.65258 6.27052 -2.3639 0.0113 
NCLIV_019000 
putative 
adenosine 
transporter 
273.568 626.164 -2.2888 0.0135 
NCLIV_027970 
conserved 
hypothetical 
protein 
243.123 555.452 -2.2846 0.0249 
NCLIV_053760 
unspecified 
product 
19.3859 44.275 -2.2838 0.0054 
NCLIV_012010 
hypothetical 
protein 
64.0725 144.574 -2.2564 0.0054 
NCLIV_064250 
putative zinc 
finger (CCCH 
type) protein 
9.50535 21.2026 -2.2305 0.0054 
NCLIV_066300 
putative PPR 
repeat-
containing 
protein 
5.46844 11.6782 -2.1355 0.0092 
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3.3.3 GO enrichment analysis of differentially expressed transcripts  
 
After identifying the transcripts preferentially expressed in Nc Spain 1H (n = 106) 
and Nc Spain 7 (n = 26), gene ontology enrichment analysis was performed. The 
biological functions of the differentially expressed transcripts were interogated using 
a GO-term enrichment analysis generated by the ToxoDB website and topGO. 
However, topGO did not produce any significant GO enrichment; this may be due to 
the different parameters used by topGO and ToxoDB to generate GO terms. Only the 
transcripts that were preferentially expressed in the low-virulence strain (Nc Spain 
1H) provided a GO-term enrichment while those that showed an increase in 
expression in Nc Spain 7 did not provided any significant GO term. 
 
The GO term enrichment of high abundance Nc Spain 1H transcripts comprised 37 
significant biological process GO terms (Benjamini < 0.05), as shown in Table 3.5 
and Appendix Table III. The GO enrichment of biological process has several 
functions but most of biological process terms contribute a single transcript and some 
terms are associated with the same transcripts leading to widespread redundancy 
among the results.  
 
The significant and non-redundant biological process terms involved parasite 
movement such as microtubule-based movement (GO:0007018), cellular component 
movement (GO:0006928), microtubule-based process (GO:0007017), and carbohydrate 
metabolic process (GO:0005975). In addition, the significant and non-redundant 
cellular component terms also involved parasite movement such as dynein complex 
(GO:0030286), microtubule associated complex (GO:0005875), microtubule 
cytoskeleton (GO:0015630), cytoskeletal part (GO:0044430) and cytoskeleton 
(GO:0005856).  
 
Moreover, the significant molecular function terms comprised of microtubule motor 
activity (GO:0003777), motor activity (GO:0003774), ATPase activity (GO:0016887) 
catalytic activity (GO:0003824), oxidoreductase activity, acting on the CH-OH group 
of donors, NAD or NADP as acceptor (GO:0016616), and cofactor binding 
(GO:0048037). 
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Table 3.4 Gene Ontology enrichment: Biological Process, Cellular Component and Molecular Function of 106 preferentially expressed 
genes in Nc Spain 1H obtained from ToxoDB website 
Term ID Description 
Bgd 
count 
Result 
count 
Pct of 
bgd 
Fold 
enrichment 
Odds ratio P-value Benjamini 
Biological Process: 
GO:0007018 microtubule-based movement 29 5 17.2 10.04 10.89 0.00022 0.00539 
GO:0006928 cellular component movement 31 5 16.1 9.39 10.18 0.00029 0.00539 
GO:0007017 microtubule-based process 41 5 12.2 7.1 7.67 0.00093 0.01149 
GO:0005975 carbohydrate metabolic process 86 5 5.8 3.38 3.61 0.01775 0.04983 
Cellular Component: 
GO:0030286 dynein complex 10 5 50 29.1 31.75 3.05E-06 2.13E-05 
GO:0005875 microtubule associated complex 17 5 29.4 17.12 18.64 2.44E-05 8.54E-05 
GO:0015630 microtubule cytoskeleton 22 5 22.7 13.23 14.38 7.01E-05 0.00016 
GO:0044430 cytoskeletal part 35 5 14.3 8.32 9.01 0.00048 0.00084 
GO:0005856 cytoskeleton 40 5 12.5 7.28 7.87 0.0008 0.00117 
Molecular Function: 
GO:0003777 microtubule motor activity 29 5 17.2 10.04 10.89 0.00022 0.00529 
GO:0003774 motor activity 40 5 12.5 7.28 7.87 0.00084 0.01009 
GO:0016887 ATPase activity 111 7 6.3 3.67 4.04 0.003326 0.019487 
GO:0016616 
oxidoreductase activity, acting on the CH-OH 
group of donors, NAD or NADP as acceptor 
18 3 16.7 9.7 10.18 0.00490 0.01948 
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Table 3.5 Identified genes involved in GO term: biological process, cellular component and molecular function of preferentially 
expressed transcripts of Nc Spain 1 H obtained from ToxoDB database 
 
Gene ID Description T. gondii Ortholog Biological process 
Cellular 
component 
Molecular function 
NCLIV_050200 
 
GF18580, related 
 
Dynein heavy chain  
family protein 
microtubule-based 
movement 
dynein 
complex 
ATP binding, 
ATPase activity, 
microtubule motor 
activity, 
nucleoside-
triphosphatase 
activity, nucleotide 
binding 
NCLIV_054090 
hypothetical protein 
 
Dynein heavy chain  
family protein 
NCLIV_065960 
Dynein heavy chain 1, 
axonemal, related 
dynein heavy chain 
family protein 
NCLIV_026260 
GA26239, related 
 
Dynein heavy chain  
family protein 
NCLIV_034170 
hypothetical protein 
 
Dynein heavy chain  
family protein 
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Gene ID Description T. gondii Ortholog Biological process 
Cellular 
component 
Molecular function 
NCLIV_042910 
malate dehydrogenase, 
related 
malate dehydrogenase 
carbohydrate 
metabolic process, 
cellular 
carbohydrate 
metabolic process, 
malate metabolic 
process, oxidation-
reduction process 
null 
L-malate 
dehydrogenase 
activity, catalytic 
activity, 
oxidoreductase 
activity 
NCLIV_043550 
glycerol-3-phosphate 
dehydrogenase, related 
glycerol-3-phosphate 
dehydrogenase, related 
carbohydrate 
metabolic process, 
glycerol-3-
phosphate catabolic 
process, oxidation-
reduction process 
cytoplasm 
NAD binding, 
glycerol-3-
phosphate 
dehydrogenase 
[NAD+] activity, 
protein 
homodimerization 
activity, 
oxidoreductase 
activity 
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Gene ID Description T. gondii Ortholog Biological process 
Cellular 
component 
Molecular function 
  
NCLIV_062520 
3-ketoacyl-(Acyl-carrier-
protein) reductase, related 
3-ketoacyl-(Acyl-
carrier-protein) 
reductase, related 
null null 
oxidoreductase 
activity 
NCLIV_015830 
hypothetical protein 
 
ABC transporter 
transmembrane region 
domain-containing 
protein 
transmembrane 
transport, transport 
integral to 
membrane 
ATP binding, 
ATPase activity, 
nucleoside-
triphosphatase 
activity, nucleotide 
binding 
NCLIV_022240 ATPase, related ATPase, related 
ATP biosynthetic 
process, ATP 
catabolic process, 
cation transport, 
metabolic process 
integral to 
membrane, 
membrane 
ATP binding, 
ATPase activity, 
catalytic activity, 
metal ion binding, 
nucleotide binding 
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The transcripts preferentially expressed in Nc Spain 1H that were identified as 
contributing to each GO term are shown in Table 3.6. There are five genes which are 
involved in microtubule and parasite movement such as GF18580, related (T. gondii 
Ortholog: Dynein heavy chain  family protein) (NCLIV_050200), hypothetical 
protein (T. gondii Ortholog: Dynein heavy chain  family protein) (NCLIV_054090), 
Dynein heavy chain 1, axonemal, related (NCLIV_065960), GA26239, related 
(Ortholog T. gondii: Dynein heavy chain  family protein) (NCLIV_026260), and 
hypothetical protein (T. gondii Ortholog: Dynein heavy chain  family protein) 
(NCLIV_034170). 
 
Moreover, five metabolic enzymes have been identified; malate dehydrogenase 
related (NCLIV_042910), glycerol-3-phosphate dehydrogenase related 
(NCLIV_043550), 3-ketoacyl-(Acyl-carrier-protein) reductase related 
(NCLIV_062520) involved with oxidoreductase activity, ATPase related 
(NCLIV_022240) and a hypothetical protein (NCLIV_015830) involved ATPase 
activity. 
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3.4 Discussion 
 
3.4.1 The SRS gene family may be associated with limiting N. 
caninum virulence 
 
The aim of this study was to identify differentially expressed transcripts between low 
and high-virulence strains of N. caninum. The results have shown that a putative 
SRS13 gene was the most significantly differentially expressed transcripts with the 
highest fold-change and is more abundant in Nc Spain 1H than Nc Spain 7. The 
SRS13 gene has been described as a bradyzoite-specific gene (Tomita et al., 2013). 
The bradyzoites are the slowly-multiplying, encysted, quiescent form that are 
thought to be less important in the host cell invasion. A further six SRS domain-
containing transcripts were identified as being preferentially expressed in the low-
virulence Nc Spain 1 H strain. All of these genes belong to the SRS surface antigen 
gene family which localises to the cell surface of N. caninum (Reid et al., 2012) . 
SRS genes play an important role in attaching to the host cells, stimulating the host 
immunity and regulating parasite virulence (Kim & Boothroyd, 2005). It was 
suggested that the large number of surface antigen genes (SRSs) is important for 
infecting a wide range of host in T. gondii (Howe et al., 1998; Boothroyd, 2009). 
However, (Reid et al., 2012) found that SRS genes were more significantly expanded 
in N. caninum than T. gondii, although N. caninum has narrower host range than T. 
gondii. A study of SRS genes in T. gondii revealed that some of these genes reduce 
the virulence of the parasite. Wasmuth et al. (2012)  found that overexpression of 
SRS29C attenuated the virulence of the T. gondii WT strain in mice and they 
discovered that SRS29C is an important negative regulator of acute T. gondii in 
murine models. Moreover, Lekutis et al. (2001) stated that the SRS genes could play 
a significant role in invading the host cell, modulating immune response and/or 
virulence attenuation. In this study, the SRS genes were preferentially expressed in 
the low-virulence strain (Nc Spain 1 H); hence, it may be that SRS genes are 
involved in limiting the virulence of N. caninum through a moderation of its host 
interaction not yet understood.  
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3.4.2 Malate dehydrogenase 
 
The malate dehydrogenase related gene was found to be more abundant in Nc Spain 
1H. This enzyme plays a vital role as a part of the energy production cycle of T. 
gondii. Malate dehydrogenase (MDH) is associated with tricarboxylic acid cycle 
(TCA) which provides the energy sources for the activities of parasites such as 
motility, host cell invasion and rapid multiplication (Hassan et al., 2014). This 
energy production enzyme is important in parasites for maintaining their life cycles 
(Nwagwu and Opperdoes, 1982). Liu et al. (2016) suggested that malate 
dehydrogenase in T. gondii (TgMDH) could be a potential vaccine candidate as this 
enzyme has been shown to be an immunogenic compound. The finding of malate 
dehydrogenase in low virulence strains reflect the general biology of the parasite for 
survival. 
 
3.4.3 Microneme adhesive repeat domain-containing proteins 
(MCPs) 
 
Two microneme adhesive repeat domain-containing proteins (MCPs) such as 
putative NcMCP3 and NcMCP4 were more abundant in Nc Spain 1H than Nc Spain 
7. The MCPs are a subset of the micronemes (MICs) which have been found to bind 
a component of glycoproteins called sialic acid, and glycolipids from the host cell 
membrane. It targets host cells and is common in moving junction proteins. The 
studied of T. gondii by (Friedrich et al., 2010)stated that MCPs are unique and 
conserved in coccidian protozoa such as Toxoplasma, Neospora , Sarcocystis and 
Eimeria parasites. MCPs are not present in Plasmodium, Theileria and 
Cryptosporidium. Gong et al. (2014) found that TgMCP4 localised near the rhoptry 
of parasite and can be detected in PV. Three type of heat shock protein can interact 
with TgMCP4 and disruption this proteins was affected theoir growth. The finding of 
these proteins might indicate the better growth rate of Nc Spain 1H. 
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3.4.4 Protein phosphatase 2C may be associated with N. caninum 
virulence 
 
In contrast, there are 26 genes showing preferential expression in Nc Spain 7. Most 
of them encode hypothetical proteins and unspecified products (19 from 26 genes) of 
which the function is not known. However, there are two putative protein 
phosphatase 2C genes found to be more abundant in high-virulence Nc Spain 7 
strain. This is consistent with a study by Regidor-Cerrillo et al. (2015) who examined 
immunome expression in N. caninum tachyzoites of three strains (Nc Liv, Nc Spain 
1H and Nc Spain 7). They found that serine-threonine phosphatase 2C could not be 
detected in the Nc Spain 1H pooled sera, while it was present in sera from animals 
infected with Nc Liv and Nc Spain 7.  
 
The protein phosphatase 2C (PP2C) is one of four main classes of serine/threonine 
specific protein phosphatase. They have many cellular functions such as cell 
signalling, cell splicing, the cell cycle and cell development (Luan, 2003). PP2C is a 
rhoptry-localized protein that is secreted during T. gondii invasion to transport a 
parasite-derived protein phosphatase 2C direct into the nucleus of infected cell 
(Gilbert et al., 2007). Then PP2C will be in the host nucleus, but the protein may 
have targets within the rhoptries. An identified cytoplasmic Toxoplasma PP2C has 
been found interact with actin binding protein Toxophilin in parasite lysate (Delorme 
et al., 2003). It is suspected that PP2C has no function as a phosphatase, alternatively 
it may bind to host substrates resulting in them not being available for orientation by 
host or parasite phosphatase (Gilbert et al., 2007).  The PP2C delivery into the host 
nucleus illustrates that the rhoptry protein can be entered to the host cytoplasm 
during the burst by secreting rhoptry proteins. It is indicated that this mechanism is 
very important to deliver parasite protein into the host cells. PP2C disruption  caused 
mild growth appearance that can be complemented by the wild-type gene indicating 
that it is important in parasite’s lytic cycle. Thus, it may be that PP2C has a role in 
determining N. caninum virulence as these proteins found high abundant in Nc Spain 
7 and they can transport the parasite-derived molecule directly to the nucleus of host 
cells.  
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3.4.5 Validation of identified gene 
 
The transcriptomic study will come out with the interested gene which shows high 
expression level. The method used for validate the gene is Real-time quantitative 
PCR (RT-qPCR)(Zhang et al., 2010). RT-qPCR is a reliable and sensitive method for 
measuring gene expression level. This technique can quantify gene expression and 
characterization of gene regulation. The internal reference genes are used to remove 
sample-to-sample variations which may increase because of test variation.  
 
3.4.6 GO terms enrichment of genes preferentially expressed in the 
low virulence strain are involved in parasite movement  
 
The biological process (BP) GO terms of low-virulence Nc Spain 1H has revealed 
several functions involved in movement such as microtubule-based movement, 
cellular component movement and microtubule-based process. This is consistent 
with the cellular component (CC) GO terms which are also involved in movement 
such as, dynein complex, microtubule associated complex and microtubule 
cytoskeleton. Furthermore, movement associated GO terms are enriched in molecular 
function (MF) term such as microtubule motor activity and motor activity. 
 
The microtubules in eukaryotes are essential for chromosome segregation during 
multiplication, elongate shape of invasive zoites and motility (Morrissette, 2015). 
There are five genes such as Dynein heavy chain 1, GF18580, GA26239, and two 
hypothetical proteins which are orthologous to the Dynein heavy chain family 
protein in T. gondii. All of these genes made the same contribution to the GO term as 
microtubule-based movement, dynein complex and microtubule motor activity. 
 
The biological GO term of microtubule-based movement (GO: 0007018) is 
associated with motor proteins and are involved in the movement of organelles, other 
microtubules or other particles along microtubules. Microtubules are critically 
important in apicomplexan parasites. They are responsible for many kinds of 
movement in eukaryotic organisms and also involved in cell division, cell 
replication, fertility, intracellular structure organization, intracellular transport and 
the movement of cilia and flagella (Morrissette, 2015). It suggests that the low 
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virulence Nc Spain 1H might have a better capability in movement, cell division and 
host cell invasion than the high-virulence Nc Spain 7 strain.  Microtubules are 
necessary components of structures in Toxoplasma gondii. The microtubule 
cytoskeleton is mainly conserved in four “zoite” stages which  role in host cell 
invasion and asexual replication (Morrissette, 2015). The tachyzoites of Toxoplasma 
and other apicomplexan zoites use an immobilized, the inner membrane complex 
(IMC) -localized myosin motor to move actin filaments which is linked to the 
cytoplasmic tails of secreted adhesins during the invasion process (Morrissette & 
Gubbels 2014).  
 
There are five genes in microtubule-based movement GO term which have been 
identified as dynein heavy chain 1, axonemal, related and dynein heavy chain family. 
The functional GO terms of these genes are associated with microtubule-based 
movement (BP), microtubule motor activity (MF) and dynein complex (CC). The 
dynein is an extremely large motor protein that translocate along microtubules 
through the minus end. While the other motor protein, called kinesin, moves toward 
the plus end of the microtubule. Dynein can be divided into two classes as axonemal 
and cytoplasmics dyneins (Milisav, 1998). It comprises of heavy, intermediate and 
light polypeptides chain. Cytoplasmic dyneins involved in transport vesicles and 
organelles moves in the opposite direction with kinesin. While, axonemal dynein 
generates the motility of cilia and flagella by sliding of outer microtubule doublets 
(Cooper., 2000). The dyneins role in microtubule-based motility and their 
biochemistry were reviewed in many publications (Gibbons, 1995, 1996; Milisav, 
1998; Ogawa and Mohri, 1996). Dynein heavy chain (DHCs) encompass a motor 
domain. Axonemal dynein may contain one to three DHCs which connect two 
microtubules to generate the sliding of flagellar movement. Three accessory subunit 
types as the WD40 repeat intermediate chain, axonemal assembly factor and 
axonemal light chain are specific to flagellar dyneins in T. gondii (Morrissette and 
Gubbels, 2014).  
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3.4.7 Limitations of the study 
 
3.4.7.1 Parasite strains 
 
In this study differentially expressed transcripts were compared between a single 
low- and a single high-virulent strain of N. caninum. This means that each virulent 
phenotype was represented by only one strain of N. caninum which is not enough to 
to identify the similarity and/or difference in term of transcript expression related to 
virulence. Increasing sample size can increase confidentiality of the result. However, 
the virulence of each strain needs to be determined by showing its ability to cause 
pathogenicity in the animal. Therefore, this study provided a preliminary result for 
further investigation of N. caninum virulence. 
 
3.4.7.2 Most genes do not have GO terms 
 
Most of identified transcripts were conserved hypothetical proteins and unspecified 
products. The hypothetical proteins have not been annotated for and have no 
experimental evidence to support their function. While unspecified proteins are 
predicted and have experimentally proven but there is no biochemical evidence for 
their function. So hypothetical proteins and unspecified products cannot be assigned 
a functional role. Many of these proteins were identified as the differentially 
expressed genes between the two strains of N. caninum and could not be included in 
the GO analysis. However, many hypothetical genes will be gradually annotated 
which might be explained more for their role in nearly future.   
 
3.4.7.3 Transcript expression is not protein expression 
 
RNA-Seq provides a transcript expression profile that is not equivalent to protein 
expression as a transcript can have multiple translational variants. So the transcript 
expression from this study is the expression of specific transcript.  
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3.5 Conclusions 
 
In conclusion, PP2C is expected to be involed in virulence of N. caninum, while the 
SRS proteins may reduce the virulence of the parasite. These two proteins might 
work together to modulate the virulence of N. caninum. All significant GO 
enrichment term found in biological process, cellular component and molecular 
function of Nc Spain 1 H are associated with the parasite movement and parasite 
growth.  
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Chapter 4: Comparative proteomics of  
low- and high-virulence strains of N. caninum 
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4.1 Introduction 
 
Chapter 3 was a study of the comparative transcriptomics of low- and high-virulent 
strains of N. caninum. This detected two sets of genes that were differentially 
expressed between the conditions. Those might be related to N. caninum virulence, 
such as protein phosphatase 2C (PP2C), which was significantly more abundant in 
the high-virulent strain, and SRS genes, which were significantly preferentially 
expressed in the low-virulent strain.  This chapter will further analyse the proteins 
expressed by N. caninum with distinct virulence-related phenotypes and compare the 
differential expression of transcripts and the proteins, which could be associated with 
N. caninum virulence. Since transcript abundance can be an inaccurate indicator of 
gene expression for several reasons, this will produce a more robust picture of the 
relationship between virulence and gene expression.     
 
It is often assumed that transcript and protein expression are well correlated, based 
on the Central Dogma (Haider and Pal, 2013). However, many studies have revealed 
that the association between mRNA and protein expression can be low due to many 
factors (Maier et al., 2009). The reasons for a poor correlation include post-
translational modification of proteins, altered half-life of specific proteins, and the 
method used for protein detection (Perco et al., 2010). However, protein abundance 
cannot be predicted by transcript expression alone so post-translational modification 
of proteins and post-transcriptional regulation of mRNA should be considered 
together (Juschke et al., 2013; Yang et al., 2015).  
 
This study has performed comparative and quantitative proteomic analysis of low- 
and high-virulence of N. caninum at three different time points, i.e. 12, 36 and 56 
hours post infection (hour p.i.). These data will enable proteins that are preferentially 
expressed in the virulent strain and tachyzoites stage to be identified.  The three time 
points chosen to measure protein abundance relate to the development tachyzoites in 
vivo; 12 hours pi. is approximately the time when tachyzoites invade and proliferate 
in the host cells, 36 hours p.i. is the time when tachyzoites begin to egress, and by 56 
hours p.i. all tachzoites have egressed. The proteomic data in this chapter were also 
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compared with the transcriptomic data from Chapter 3 to visualise the similarities 
and differences between them in gene expression values. 
 
4.1.1 Label-free proteomics  
 
Label-free proteomics is a method for generating mass spectrometry data from 
protein samples without requiring a stable isotope-containing compound to label the 
protein. The raw data can be directly compared to the protein abundances in each 
protein run (Cutillas and Vanhaesebroeck, 2007; Wastling et al., 2012). The 
advantages of this technique are that it is simple, requires a relatively low 
concentration of sample, and does not require extra experimental steps compared to 
label-based quantitative technique such as gel electrophoresis and gel imaging. 
However, a label-free proteomics method may provide a variable result, as every 
sample has to be prepared separately and individually run on LC-MS/MS. There are 
two different quantification approaches of label-free proteomics, known as spectral 
counting (Liu et al., 2004) and peak intensity measurement (Bondarenko et al., 
2002). Spectral counting quantifies the number of fragment ion spectra (MS/MS) for 
peptides of a specific protein. However, this method depends on a simple counting of 
spectra rather than determining any direct physical property of peptides. It assumes 
that the linearity of response are the same for every protein. Actually, they are 
different for every peptide in terms of the chromatographic profiles such as retention 
time and peak width, which vary for every peptide (Bantscheff et al., 2007).While, 
the measurement of peak intensity has been performed by calculating 
chromatographic peak area to measure peptide abundance. The chromatographic 
peak area of identified peptides depends on the concentration of peptides. If the 
peptide concentration of increases, the peak area will be increased. 
 
In this study, peak intensity was employed for label-free quantification. 
Subsequently, mass spectrometry data were analysed using commercial software 
such as Progenesis QI (http://www.nonlinear.com/progenesis) and Mascot program 
(Version 2.3.02, Matrix Science) to identify proteins.  
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4.1.2 Proteomic analysis of N. caninum virulence  
 
Several proteomic studies have addressed parasite virulence in N. caninum. 
Proteomic comparison  N. caninum tachyzoites (Nc KBA-2 and Nc JPA-1) with 
T.gondii was performed by Lee et al. (2005) using 2-DE, immunoblotting and mass 
spectrometry. They found considerable differences between the N. caninum and T. 
gondii proteomes as the 2-DE spots were different pattern of both parasites.  
Conversely, proteomics comparisons among N. caninum strains, for example of Nc 
KBA-2 (high-virulence strain) from South Korea (Kim et al., 2000) and Nc JPA-1 
(low-virulence strain) from Japan (Yamane et al., 1996) revealed great similarity, 
with 78% of proteins spots by 2-DE and 80% of antigen spots on immunoblotting of 
2-DE being consistent (Lee et al., 2005). Another proteomic study visualised the 
similarity and differences between two geographically distinct N. caninum strains, 
KBA-2 from South Korea and VMDL-1 from USA (Shin et al. (2005). Both strains 
are considered to be virulent as they both caused abortion in cattle (Hyun et al., 2003; 
Kim et al., 2000). Shin et al. (2005) found that most spots on 2-DE and antigenic 
spots on 2-DE immunoblots had the same locations by isoelectric point and 
molecular weight. They concluded that these virulent strains displayed consistent 
proteomic and antigenic profiles, despite coming from very different locations.  
 
The proteomic analysis of virulence specifically began with Nischik et al. (2001), 
who used 2D-PAGE and mass spectrometry to identify host proteins that displayed a 
modified expression profile after attenuation of a virulent strain in mice (T. gondii 
type I). The parasites were attenuated by continuous passage in fibroblast cell 
culture, and these were then compared to the parental strain inoculated in mice. 
Attenuated parasites induced a reduced interleukin-12 and interferon-γ response in 
the mouse relative to virulent T. gondii.  Moreover, the abundance of diverse parasite 
proteins common secreted by tachyzoites was reduced in the attenuated T. gondii, 
such as actin, catalase, microneme protein 5, nucleoside triphosphate hydrolase 1 and 
dense granule proteins 1, 2, 3, 4, 5, 6, 7 and 8 (Nischik et al. (2001).  
 
Regidor-Cerrillo et al., (2012) compared protein expression patterns in the virulent 
N. caninum strains Nc-Liv and Nc Spain 7 with the attenuated strain Nc Spain 1H 
using Difference Gel Electrophoresis (DIGE) coupled to mass spectrometry (MS)  
105 
 
(Regidor-Cerrillo et al., 2012b). The comparison of Nc Spain 7 and Nc Spain 1H 
showed that 39 protein spots were more abundant in Nc Spain 7, while  21  protein 
spots were more abundant in Nc Spain 1H. In addition, 3 Nc-Liv protein spots were 
significantly more abundant when compared to Nc Spain 1H (Regidor-Cerrillo et al., 
2012). Protein spots were also compared between the two high virulence strains Nc 
Liv and Nc Spain 7. 24 spots were more abundant in Nc Spain 7 and 12 spots in Nc-
Liv. Of the three strains, Nc Spain 7 was found to have the highest number of 
differentially expressed protein spots (Regidor-Cerrillo et al., 2012).  
 
The functions associated with these differentially-expressed proteins were associated 
with known aspects of virulence, and given some indications of its mechanism. 
Eleven differentially expressed proteins were involved in gliding motility and lytic 
cycles, as well as in oxidative stress. The key proteins that they found increased in 
expression in Nc Spain 7 included NcNTPase, microneme protein NcMIC1 and 
NcROP40, which are thought to be associated with virulence.  
 
These previous studies have shown various similarities and differences among 
Neospora strains, as well as with the related parasite as T. gondii. The purpose of this 
study is to provide the first quantitative proteomic analysis of expression profile by 
using label free proteomics techniques in two strains of N. caninum known to differ 
in virulence phenotype, which were shown different in term of phenotype and 
pathogenicity.  This analysis will identify the proteins that are differentially 
expressed in the two conditions, and therefore, consistent with a role in regulating 
virulence. These new insights can advance our understanding of the molecular 
mechanisms of pathogenesis. 
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4.1.3 Aims and Objectives 
 
The main aim of this chapter is to identify proteins preferentially expressed in either 
low- and high-virulence strains of N. caninum at different time points post-infection 
using label-free quantitative proteomics, and then to examine the possible role of 
these proteins in virulence by inferring their likely functions.  
 
Objectives of this study: 
1. To compare, identify and quantify the protein expression profile between low- 
and high- virulence of N. caninum using a label-free quantitative proteomics 
approach  
2. To identify enriched functional terms among proteins consistent with a role in 
virulence. 
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4.2 Materials and Methods 
 
4.2.1 Parasite preparation 
 
The MARC-145 monkey kidney cell culture infected with the N. caninum isolated 
Nc Spain 1H (low-virulence) and Nc Spain 7 (high-virulence) was prepared by Prof. 
Luis Ortega-Mora’s group, Complutense University of Madrid, Spain at 12, 36 and 
56 hours post infection. Each of the three biological replicates of both N. caninum 
tachyzoites were purified using PD10 columns. The pellets of N. caninum 
tachyzoites were then sent to Department of Infection Biology, University of 
Liverpool for subsequent analysis. 
 
4.2.2 N. caninum tachyzoites preparation 
 
A total of eighteen pellets of Nc tachyzoites (three replicates in three different time 
points for both strains) in the range of 1.6-7×107 tachyzoites were prepared in the 
same methods described in section 2.2.6.  
 
4.2.3 Protein identification and quantification 
 
4.2.3.1 Liquid chromatography mass spectrometry LC-MS/MS 
 
LC-MS/MS was performed by Dr. Dong Xia, Department of Infection Biology, 
University of Liverpool following the procedure described in section 2.2.7. 
 
4.2.3.2 Peptides quantification and protein identification  
 
The raw data acquired from LC-MS/MS were imported to ProgenesisTM QI software 
(Version 3.0, Nonlinear Dynamics) for the label-free quantitative data analysis as 
previously explained in section 2.2.8. The protein identification was performed 
following the procedure mentined in section 2.2.9. The protein expressions in three 
different time points were compared between two strains. 
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4.2.4 Gene Ontology (GO) enrichment analysis and Cluster analysis 
 
In this study, GO enrichment analysis has taken an individually set of protein list 
from low- or high- virulence of N. caninum in different time points as the input data 
in order to find high representation or low representation of ontologies in 
comparisons between both strains. The input proteins data used for the enrichment 
test was the differentially expressed proteins with statistical significance at q-value < 
0.05 and fold-change greater than 2.  The interpretation of GO enrichment result was 
described in chapter 3.2.8.  
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4.3 Results  
 
4.3.1 Preferential expression of proteins in low and high-virulence N. 
caninum 
 
A total of 1,390 proteins from Nc Spain 1H and Nc Spain 7 sampled at three 
different time points were quantified by LC MS/MS.  
 
At 12 hours p.i., 351 proteins showed significant (q < 0.05) differential expression 
between low (Nc Spain 1H) and high (Nc Spain 7) virulent conditions, while 77 
proteins showed differential expression with fold-change greater than two. Of these 
77 proteins, 56 proteins were significantly more abundant in Nc Spain 1H (Table 4.1, 
Appendix Table 1 and Figure 4.1), while 21 proteins were significantly more 
abundant in Nc Spain 7 (Table 4.2, Appendix Table1 and Figure 4.1).  
 
Most of the proteins preferentially expressed in Nc Spain 1H at 12 hours pi were 
associated with host cell adhesion and invasion. The SRS domain-containing protein 
(NCLIV_019580), an orthologue of the SRS35A protein of T. gondii (TgSRS35A), 
showed the highest fold-change (6.53). SAG3 (NCLIV_034740), which plays an 
important role in host cell attachment during the infection process, was also highly 
abundant. SRS proteins are a family of cell surface glycoproteins in cyst-forming 
coccidian parasites, thought to mediate attachment to host cells.  
 
Cathepsin C2 (CPC2) (NCLIV_007010), which are lysosomal peptidases with an 
important role in growth and survival of Apicomplexan protozoa, had a fold-change 
of 2.57. The hypothetical protein (NCLIV_069110) is an orthologue of the rhoptry 
protein ROP1 of T. gondii (TgROP1) and was highly abundant with a fold-change of 
2.47.  
 
A group of microneme proteins were all found to be highly abundant in Nc Spain 
1H: NCLIV_022970 and NCLIV_033690 are hypothetical proteins homologous to 
microneme protein MIC2 in T. gondii (TgMIC2), NCLIV_062770 is orthologous to 
MIC9 in T.gondii, NCLIV_010600 is orthologous to putative microneme protein 
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MIC3 and NCLIV_002940 is orthologous to microneme protein MIC4 in T.gondii 
(MIC4).  
 
Other proteins associated with cell surface and host invasion machinery that were 
highly abundant in Nc Spain 1H at 12 hours pi include subtilisin (SUB1; 
NCLIV_021050), which is involved in host cell surface processing of micronemal 
secreted proteins in T.gondii (Lagal et al., 2010); protein phosphatase 2C 
(NCLIV_067490) which is secreted from the rhoptry and enters  the host nucleus 
during invasion; and apical membrane antigen 1 (AMA1) (NCLIV_028680), which 
has a key role in host cell invasion in T. gondii. 
 
There are some metabolic enzymes that were highly abundant in Nc Spain 1H, for 
example NCLIV_022920, the ortholog of aspartyl protease ASP1 (ASP1) in T. 
gondii, putative histidine acid phosphatase domain containing protein 
(NCLIV_053400), putative orotate phosphoribosyltransferase (NCLIV_027130),  
putative 3',5'-cyclic phosphodiesterase (NCLIV_019740), HIT family protein, related 
(NCLIV_018300), Lysyl-tRNA synthetase, related (NCLIV_012460).  putative 
DEAH-box RNA/DNA helicase (NCLIV_011110), putative Hsp20/alpha crystallin 
domain-containing protein (NCLIV_041850) and ubiquitin carrier protein, related 
(NCLIV_010370). 
  
Besides these various characterized proteins, there were nine hypothetical proteins 
and 1 uncharacterized protein that were preferentially expressed in this strain at 12 
hours pi.  
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Figure 4.1 Volcano plot of quantified Neospora proteins of Nc Spain 1H (right) and 
Nc Spain 7 (left) at 12 hours pi to host cells.  
 
The volcano plot (Figure 4.1, 4.2 and 4.3) of three time points show fold-change in 
protein expression of low- (Nc Spain 1H) and high-virulent (Nc Spain 7) strain. The 
plot compared between both strains. The y-axis is log10 of adjust p-value and the x-
axis has shown the differential protein expression  (measured in log2 fold change) 
between Nc Spain 1H  and Nc spain 7. Vertical red dash lines between -1 and +1 
indicate the fold-change of protein expression equal to 2 (log2 fold-change -1 and 1). 
While horizontal dash line on y-axis is equivalent to p-value of 0.05. Significant 
proteins with fold-change greater than two of Nc Spain 7 were located at the top left 
corner, while significant proteins with fold-change greater than two of Nc Spain 1H 
were located at the top right corner. 
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Table 4.1 Summary of the most important proteins identified as significantly differentially regulated of Nc Spain 1H at 12 hours pi. 
Accession Description 
Toxoplasma 
Ortholog 
Nc 1H-12hr Nc 7-12hr 
Max fold 
change 
q Value 
NCLIV_019580 
SRS domain-containing 
protein 
SAG-related sequence 
SRS35A  
231858.78 35504.03 6.53 0.010746 
NCLIV_022920 Renin, related 
aspartyl protease ASP1 
(ASP1) 
34023.50 6502.10 5.23 0.030770 
NCLIV_012090 
putative ATP-dependent 
protease ATP-binding 
subunit 
N/A 23024.58 6765.14 3.40 0.008507 
NCLIV_018300 
HIT family protein, 
related 
Hit family protein 
involved in cell-cycle 
regulation, putative 
1402055.32 421821.52 3.32 0.015779 
NCLIV_012460 
Lysyl-tRNA synthetase, 
related 
hypothetical protein 2738.42 826.68 3.31 0.033022 
NCLIV_037460 hypothetical protein citrate synthase I 404581.56 152092.37 2.66 0.024397 
NCLIV_007010 putative cathepsin C2  cathepsin CPC2 (CPC2) 274324.17 106677.59 2.57 0.024397 
NCLIV_011110 
putative DEAH-box 
RNA/DNA helicase 
helicase associated 
domain (ha2) protein 
20806.13 8151.25 2.55 0.017953 
NCLIV_041850 
putative Hsp20/alpha 
crystallin domain-
containing protein 
heat shock protein HSP28 
(HSP28) 
2691566.63 1056490.91 2.55 0.010746 
NCLIV_069110 hypothetical protein 
rhoptry protein ROP1 
(ROP1) 
27187.72 11024.39 2.47 0.049761 
NCLIV_022970 unspecified product 
microneme protein MIC2 
(MIC2) 
1968924.78 807753.17 2.44 0.008713 
NCLIV_062770 unspecified product 
microneme protein MIC9 
(MIC9) 
1338525.62 552301.84 2.42 0.037391 
NCLIV_010600 
putative microneme 
protein MIC3 
microneme protein MIC3 
(MIC3) 
34648535.79 14310252.42 2.42 0.008507 
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On the other hand, from Table 4.2, Appendix Table1 and Figure 4.1, there were a 
smaller number of significant preferentially expressed proteins revealed in Nc Spain 
7 at 12 hours pi comparing to Nc Spain 1H. Twenty-one proteins show most 
abundant in Nc Spain 7. SRS domain-containing protein (NCLIV_023620) 
orthologue of the SRS39 protein in T. gondii (TgSRS39) showed highest fold-change 
of 7.48 which determines as a surface protein of the parasite.  The other 
preferentially expressed protein with fold-change 2.94 is Predicted rhoptry kinase, 
subfamily ROP20 (NCLIV_068850) orthologue of T. gondii predicted rhoptry 
kinase, subfamily ROP24 (TgROP24). This protein is suspected to play vital role in 
the early invasion process and later in invasion process. Putative serine/threonine 
protein phosphatase 5 (NCLIV_066900) show fold-change of 2.44, which is 
important for the invasion process of the parasite. There were some metabolic 
emzyme showing high abundant of protein expression in Nc Spain 7 at 12 hours pi 
which composed of transporter/ permease protein (NCLIV_039290) with fold-
change 3.33, putative vacuolar ATP synthase subunit d (NCLIV_023610), putative 
acetyltransferase domain-containing protein (NCLIV_030730), putative CW-type 
zinc finger domain-containing protein (NCLIV_032350), Peroxiredoxin-2E-1, 
related (NCLIV_014020),  putative regulator of chromosome condensation 
(NCLIV_013660) and high mobility group protein, related (NCLIV_043670). Eight 
hypothetical proteins have also found more abundant in Nc Spain 7 at 12 hours pi. 
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Table 4.2 Summary of the most important proteins identified as significantly differentially regulated of Nc Spain 7 at 12 hours pi. 
Accession Description 
Toxoplasma 
Ortholog 
Nc 1H-12hr Nc 7-12hr 
Max fold 
change 
q Value 
NCLIV_023620 
SRS domain-
containing protein 
SAG-related 
sequence SRS39 
(SRS39) 
11502.31 86069.13 -7.48 0.010746 
NCLIV_039290 hypothetical protein 
transporter/permease 
protein 
27564.48 91771.33 -3.33 0.013090 
NCLIV_023610 
putative vacuolar ATP 
synthase subunit d 
V-type ATPase, D 
subunit protein 
15790.05 46768.32 -2.96 0.017404 
NCLIV_068850 
Predicted rhoptry 
kinase, subfamily 
ROP20 
rhoptry kinase family 
protein ROP24 
(incomplete catalytic 
triad) (ROP24) 
307278.32 902109.59 -2.94 0.013006 
NCLIV_026210 hypothetical protein 
apicoplast 
triosephosphate 
translocator APT1 
(APT1) 
184546.29 520631.34 -2.82 0.012491 
NCLIV_066900 
putative 
serine/threonine 
protein phosphatase 5 
serine/threonine 
protein phosphatase 
9279.11 22678.42 -2.44 0.017355 
NCLIV_014020 
Peroxiredoxin-2E-1, 
related 
redoxin domain-
containing protein 
282524.95 673761.93 -2.38 0.013090 
NCLIV_013660 
putative regulator of 
chromosome 
condensation 
regulator of 
chromosome 
condensation RCC1 
6377.03 14349.80 -2.25 0.020239 
NCLIV_043670 
high mobility group 
protein, related 
HMG (high mobility 
group) box domain-
containing protein 
1151938.37 2390237.21 -2.07 0.017404 
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Figure 4.2 Volcano plot of quantified Neospora  proteins of Nc Spain 1H (right) and 
Nc Spain 7 (left) at 36 hours pi to host cells.  
 
At 36 hours pi, 136 proteins show differential expression between low (Nc Spain 1H) 
and high (Nc Spain 7) virulence strains of N. caninum with statistically significant 
difference (q value < 0.05). A much smaller number of significant proteins 
expression at 36 hours pi has found comparing to 12 hours pi that only 19 proteins 
showed differential expression with fold-change more than two. Among 19 
differentailly expressed proteins, 13 proteins were preferentially expressed in Nc 
Spain 1H (Table 4.3, Appendix Table2 and Figure 4.2) and 6 proteins were 
preferentially expressed in Nc Spain 7 as shown in Table 4.4, Appendix Table2 and 
Figure 4.2. 
 
Among 13 proteins which were preferentially expressed in Nc Spain 1H, there were 
9 same proteins have found both at 12 hours pi and 36 hours pi (Figure 4.4). There 
were comprised of  SRS domain-containing protein (NCLIV_019580) (TgSRS35A ), 
SAG3 protein, related (NCLIV_034740), Renin, related (NCLIV_022920), putative 
histidine acid phosphatase domain containing protein (NCLIV_053400), putative 
cathepsin C2 (CPC2) (NCLIV_007010) , Oligoribonuclease, related 
(NCLIV_054180), Glucosamine-fructose-6-phosphate aminotransferase 
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(Isomerizing), related (NCLIV_031610) and  two conserved hypothetical protein 
(NCLIV_036640,  NCLIV_049520), 
  
The rest of four proteins, which showed more abundant in Nc Spain 1H at 36 hours 
pi and were not found at 12 hours pi. included protein F23B2.12, partially confirmed 
by transcript evidence, related (NCLIV_008320), peptidase, S9A/B/C family, 
catalytic domain protein, related (NCLIV_063570), putative glycerol-3-phosphate 
acyltransferase (NCLIV_029980), and hypothetical protein (NCLIV_031190). 
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Table 4.3 Summary of the most important proteins identified as significantly differentially regulated of Nc Spain 1H at 36 hours pi. 
Accession Description 
Toxoplasma 
Ortholog 
Nc 1H-36hr Nc 7-36hr 
Max fold 
change 
q Value 
NCLIV_019580 
SRS domain-
containing protein  
SAG-related 
sequence 
(SRS35A) 
310976.44 24221.35 12.84 0.010883 
NCLIV_022920 Renin, related 
aspartyl protease 
ASP1 (ASP1) 
32867.31 7075.07 4.65 0.038356 
NCLIV_053400 
putative histidine acid 
phosphatase domain 
containing protein 
hypothetical 
protein 40155.73 9350.73 4.29 0.028609 
NCLIV_007010 
putative cathepsin C2 
(CPC2) 
cathepsin CPC2 
(CPC2) 
 
233283.80 85862.13 2.72 0.014564 
NCLIV_008320 
protein F23B2.12, 
partially confirmed by 
transcript evidence, 
related 
 
RNA binding 
protein, putative 
 
12493.30 4700.62 2.66 0.044566 
NCLIV_034740 SAG3 protein, related N/A 1041019.33 396426.25 2.63 0.031809 
NCLIV_054180 
Oligoribonuclease, 
related 
small nuclease 
41807.20 17333.89 2.41 0.028769 
NCLIV_063570 
Peptidase, S9A/B/C 
family, catalytic 
domain protein, 
related 
acylaminoacyl-
peptidase, 
putative 
 
21390.60 9018.98 2.37 0.011348 
NCLIV_029980 
putative glycerol-3-
phosphate 
acyltransferase 
glycerol-3-
phosphate-
acyltransferase 
3380.46 1537.80 2.20 0.031926 
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Six proteins were preferentially expressed in Nc Spain 7 at 36 hour pi with fold-
change > 2 as shown in Table 4.4, Appendix Table2 and Figure 4.2. There were 3 
proteins (from 6 proteins) found high abundant in both 12 hours pi and 36 hours pi 
(Figure 4.5) which composed of SRS domain-containing protein (NCLIV_023620) 
orthologue of the TgSRS39 with fold-change 3.57, Predicted rhoptry kinase, 
subfamily ROP20 (NCLIV_068850) orthologue of T. gondii rhoptry kinase family 
protein ROP24 (incomplete catalytic triad) (TgROP24) with fold-change 2.78, and 
Peroxiredoxin-2E-1, related (NCLIV_014020) with fold-change 2.34. 
 
The other three more abundant proteins in Nc Spain 7 at 36 hours pi which were not 
found at 12 hours pi. included putative RNA binding protein (NCLIV_021440) and 
two conserved hypothetical protein (NCLIV_050060 and NCLIV_041790) 
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Table 4.4 Summary of the most important proteins identified as significantly differentially regulated of Nc Spain 7 at 36 hours pi. 
Accession Description 
Toxoplasma 
Ortholog 
Nc 1H-36hr Nc 7-36hr 
Max fold 
change 
q Value 
NCLIV_023620 
SRS domain-
containing protein 
SAG-related sequence 
SRS39 (SRS39) 
25932.55 92463.37 -3.57 0.015602 
NCLIV_068850 
Predicted rhoptry 
kinase, subfamily 
ROP20 
rhoptry kinase family 
protein ROP24 
(incomplete catalytic 
triad) (ROP24) 
258639.81 718755.68 -2.78 0.019337 
NCLIV_021440 
putative RNA 
binding protein 
RNA binding protein, 
putative 
2927.82 6963.26 -2.38 0.028897 
NCLIV_014020 
Peroxiredoxin-2E-1, 
related 
redoxin domain-
containing protein 
 
374177.49 877317.10 -2.34 0.015602 
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Figure 4.3 Volcano plot of quantified Neospora proteins of Nc Spain 1H (right) and 
Nc Spain 7 (left) at 56 hours pi to host cells.  
 
At 56 hours pi, 214 proteins showed differential expression between Nc Spain 1H 
and Nc Spain 7. However, 62 proteins exhibited preferential expression between low 
(Nc Spain 1H) and high (Nc Spain 7) virulence strains with statistically significant 
difference (q value < 0.05) at fold-change more than two.  Among 62 proteins, 44 
proteins were more abundant in Nc Spain 1H (Table 4.5, Appendix Table3 and 
Figure 4.3) and 18 proteins were significantly preferential expressed in Nc Spain 7 as 
shown in Table 4.6 , Appendix Table3 and Figure 4.3. 
 
Forty-four proteins showed preferentially expressed in Nc Spain 1H with statistically 
significant difference (q value < 0.05) and fold-change > 2 (Table 4.5, Appendix 
Table 3 and Figure 4.3). There were 7 proteins (from 44 proteins) found 
preferentially expressed in all three time points at 12, 36 and 56 hours pi respectively 
(Figure 4.4). Three out of seven proteins were related to host cell invasion which 
composed of putative cathepsin C2 (CPC2) (NCLIV_007010) and two surface 
antigens as SAG3 protein, related (NCLIV_034740) and SRS domain-containing 
protein (NCLIV_019580) orthologue of the TgSRS35A protein.  The other four 
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proteins comprised of putative Renin, related (NCLIV_022920), histidine acid 
phosphatase domain containing protein (NCLIV_053400) and two conserved 
hypothetical proteins (NCLIV_049520 and NCLIV_036640). 
 
There were 12 proteins found more abundant in Nc Spain 1H at both 12 and 56 hours 
pi (q < 0.05 and FC >2). Surprisingly, a group of microneme proteins which is 
important for host cell attachment were found in these two time points but not in 36 
hours pi such as two microneme protein MIC2 (TgMIC2) (NCLIV_022970 and  
NCLIV_033690), putative microneme protein MIC3 (NCLIV_010600) and 
microneme protein MIC4 (MIC4) (NCLIV_002940).  The other proteins which 
associated to host cell invasion were presented in these time points as subtilisin 
SUB1 (SUB1) (NCLIV_021050) and putative apical membrane antigen 1 (AMA1) 
(NCLIV_028680). Some metabolic enzyme proteins such as putative 3',5'-cyclic 
phosphodiesterase (NCLIV_019740), putative DEAH-box RNA/DNA helicase 
(NCLIV_011110), perforin-like protein PLP1 (PLP1) (NCLIV_020990), putative 
signal recognition particle protein (NCLIV_019540), Lysyl-tRNA synthetase, related 
(NCLIV_012460) and conserved hypothetical protein (NCLIV_065500) were 
revealed preferentially expressed in these time points. 
 
Three high abundant proteins of Nc Spain 1H found in both 36 and 56 hours pi (q < 
0.05 and FC >2) composed of some metabolic enzymes as Peptidase, S9A/B/C 
family, catalytic domain protein, related (NCLIV_063570), putative glycerol-3-
phosphate acyltransferase (NCLIV_029980) and protein F23B2.12, partially 
confirmed by transcript evidence, related (NCLIV_008320). 
 
There were 22 proteins which exhibited preferentially expression in Nc Spain 1 H at 
only 56 hours pi (q < 0.05 and FC >2). More surface antigen proteins had been found 
as SRS domain-containing protein (NCLIV_010050) ortholog of SAG-related 
sequence SRS16E in T. gondii (TgSRS16E), and hypothetical protein 
(NCLIV_046140) ortholog of SAG-related sequence SRS67 (TgSRS67). Moreover 
the other microneme proteins were found more abundant at 56 hours pi as putative 
microneme protein MIC1 (NCLIV_043270), putative MIC2-associated protein 
M2AP (NCLIV_051970), microneme protein MIC10 (MIC10) (NCLIV_066250), 
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putative microneme protein MIC11 (NCLIV_020720). The cathepsin L, related 
(NCLIV_004380) which related to host cell invasion was also found in this time 
points. The ALVEOLIN1, related (NCLIV_026500) was found in Nc Spain 1 H at 
56 hours pi. This protein play key role in maintenance of the cell shape in T. gondii. 
The other high abundant proteins were found at 56 hours pi composed of some 
metabolics enzymes such as Protein-L-isoaspartate O- methyltransferase, related 
(NCLIV_057890), dolichol-phosphate-mannose synthase family protein 
(NCLIV_068040), class I chitinase, related (NCLIV_000740), putative peptidase 
M16 domain containing protein (NCLIV_044230), GD24343, related 
(NCLIV_025760), ABC transporter transmembrane region domain-containing 
protein (NCLIV_009810), Acyl-CoA synthetase, related (NCLIV_054250) and small 
GTPase Rab2, putative (NCLIV_055690), putative rRNA processing protein 
(NCLIV_047570) and some hypothetical proteins (NCLIV_038110, 
NCLIV_061620, NCLIV_060220, NCLIV_031300 and NCLIV_018530). 
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Table 4.5 Summary of the most important proteins identified as significantly differentially regulated of Nc Spain 1H at 56 hours pi. 
Accession Description 
Toxoplasma 
Ortholog 
Nc 1H-56hr Nc 7-56hr 
Max fold 
change 
q Value 
NCLIV_019580 
SRS domain-
containing protein 
SAG-related 
sequence SRS35A 
(SRS35A) 
405070.47 27750.65 14.60 0.029754 
NCLIV_053400 
putative histidine 
acid phosphatase 
domain containing 
protein 
histidine acid 
phosphatase 
superfamily protein 
50228.98 6897.47 7.28 0.027695 
NCLIV_022920 Renin, related 
aspartyl protease 
ASP1 (ASP1) 
48104.27 6882.95 6.99 0.030872 
NCLIV_038110 hypothetical protein 
microneme protein 
MIC17C (MIC17C) 
53036.03 9072.69 5.85 0.036448 
NCLIV_007010 
putative cathepsin C2 
(CPC2) 
cathepsin CPC2 
(CPC2) 
436309.74 114586.24 3.81 0.041009 
NCLIV_034740 
SAG3 protein, 
related 
N/A 1452783.02 400652.78 3.63 0.016437 
NCLIV_008320 
protein F23B2.12, 
partially confirmed 
by transcript 
evidence, related 
serine 
carboxypeptidase 
s28 protein 
18642.01 5178.58 3.60 0.026346 
NCLIV_057890 
Protein-L-
isoaspartate O-
methyltransferase, 
related 
L-isoaspartyl protein 
carboxyl 
methyltransferase 
family protein 
43970.20 13736.82 3.20 0.024390 
NCLIV_010050 
SRS domain-
containing protein 
SAG-related 
sequence SRS16E 
(SRS6) 
220825.35 70365.37 3.14 0.028942 
NCLIV_033690 Hypothetical protein 
microneme protein 
MIC2 (MIC2) 
5164280.08 1867479.75 2.77 0.033339 
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Accession Description 
Toxoplasma 
Ortholog 
Nc 1H-56hr Nc 7-56hr 
Max fold 
change 
q Value 
NCLIV_002940 
putative microneme 
protein MIC4 
microneme protein 
MIC4 (MIC4) 
24897767.32 9017437.25 2.76 0.016437 
NCLIV_019740 
putative 3',5'-cyclic 
phosphodiesterase 
3'5'-cyclic nucleotide 
phosphodiesterase 
domain-containing 
protein 
3620.19 1317.63 2.75 0.029575 
NCLIV_028680 
putative apical 
membrane antigen 1 
apical membrane 
antigen AMA1 
6386731.22 2354879.39 2.71 0.049602 
NCLIV_020990 
perforin-like protein 
PLP1 (PLP1) 
perforin-like protein 
PLP1 (PLP1) 
311947.73 115987.59 2.69 0.027695 
NCLIV_068040 
dolichol-phosphate-
mannose synthase 
family protein 
dolichol-phosphate-
mannose synthase 
family protein 
29312.09 11032.95 2.66 0.025724 
NCLIV_043270 
putative microneme 
protein MIC1 
microneme protein 
MIC1 (MIC1) 
35922016.21 14004447.55 2.57 0.025376 
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Eighteen proteins revealed significant preferentially expressed in Nc Spain 7 at 56 
hours pi as shown in Table 4.6, Appendix Table 3 and Figure 4.3. Among 18 
proteins, only 2 proteins were found preferentially expressed in all time points as  
Predicted rhoptry kinase, subfamily ROP20 (NCLIV_068850) orthologue of T. 
gondii predicted rhoptry kinase, subfamily ROP24 (TgROP24) and SRS domain-
containing protein (NCLIV_023620) orthologue of the TgSRS39 protein (TgSRS39). 
The other two proteins were shown preferentially expressed in 12 and 56 hours pi as 
putative acetyltransferase domain-containing protein (NCLIV_030730) and 
hypothetical protein (NCLIV_026210). Ferthermore, 2 proteins were exhibited high 
abundant in 36 and 56 hours pi as putative RNA binding protein (NCLIV_021440) 
and conserved hypothetical protein (NCLIV_050060) (Figure: 3.5).  
 
The other 12 high abundant proteins which were seen only at 56 hours pi were as 
following.  The putative ubiquitin conjugation factor (NCLIV_019660) was shown 
the highest fold-change of 26.90 and the putative ubiquitin family domain-containing 
protein (NCLIV_012950) was also found in this time point. The ubiquitin protein is  
involved in cell division and host cell invasion of the parasite. GH23102, related 
(NCLIV_063510) ortholog of dynactin related protein in T. gondii which involed in 
intracellular transport. Moreover, putative Rhoptry kinase family protein, truncated 
(incomplete catalytic triad) (NCLIV_007770) was shown in 56 hours pi. The Rhoptry 
kinase protein play an important role in host cell invasion in Apicomplexa parasite. 
Some metabolic emzymes were found in this time point such as, putative opine 
dehydrogenase (NCLIV_042450), putative TPR domain-containing protein 
(NCLIV_037480), YbaK / prolyl-tRNA synthetases associated domain containing 
protein (NCLIV_0292) and beta-1 tubulin, putative (NCLIV_005150). Four 
conserved hypothetical protein (NCLIV_014040, NCLIV_025990, NCLIV_011740 
and NCLIV_046320) were also found in 56 hours pi which their function were not 
assigned  
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Table 4.6 Summary of the most important proteins identified as significantly differentially regulated of Nc Spain 7 at 56 hours pi. 
Accession Description 
Toxoplasma 
Ortholog Nc 1H-56hr Nc 7-56hr 
Max 
fold 
change 
q Value 
NCLIV_019660 
putative ubiquitin 
conjugation factor 
U-box domain-
containing protein 
137.21 3690.97 -26.90 0.030673 
NCLIV_068850 
Predicted rhoptry 
kinase, subfamily 
ROP20 
rhoptry kinase family 
protein ROP24 
(incomplete catalytic 
triad) (ROP24) 
335590.44 
1111069.0
9 
-3.31 0.002306 
NCLIV_063510 GH23102, related Dynactin related protein 3411.84 10578.65 -3.10 0.000387 
NCLIV_023620 
SRS domain-
containing protein  
SAG-related sequence 
SRS39 (SRS39) 
27474.34 80197.10 -2.92 0.000768 
NCLIV_042450 
putative opine 
dehydrogenase 
NAD/NADP 
octopine/nopaline 
dehydrogenase, alpha-
helical domain-
containing protein 
261448.45 725179.73 -2.77 0.024390 
NCLIV_037480 
putative TPR domain-
containing protein 
tetratricopeptide repeat-
containing protein 
7415.09 20097.99 -2.71 0.027695 
NCLIV_026210 
apicoplast 
triosephosphate 
translocator APT1 
(APT1) 
apicoplast 
triosephosphate 
translocator APT1 
(APT1) 
150238.98 343906.78 -2.29 0.010723 
NCLIV_007770 
putative Rhoptry 
kinase family protein, 
truncated (incomplete 
catalytic triad) 
Rhoptry kinase family 
protein, truncated 
(incomplete catalytic 
triad) 
433281.75 981688.73 -2.27 0.007757 
NCLIV_012950 
putative ubiquitin 
family domain-
containing protein 
ubiquitin family protein 5902.62 12357.41 -2.09 0.021485 
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Figure 4.4 Venn diagram showing the number of significant (q < 0.05) preferentially 
expressed of proteins in Nc Spain 1H in three time points as 12, 36, 56 hours pi., 
respectively. Seven proteins were found more abundant in all three time points in Nc 
Spain 1H 
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Figure 4.5 Venn diagram showing the number of significantl (q < 0.05) preferentially 
expressed of proteins in Nc Spain 7 in three time points as 12, 36, 56 pi respectively. 
Two proteins were found more abundant in all three time points in Nc Spain 7 
 
The venn diagram showed the number of high abundant of proteins found in one 
time points or overlapping to the other time points. The most protein abundant in Nc 
Spain 1H which were found in all time course included SRS domain-containing 
protein (NCLIV_019580), conserved hypothetical protein (NCLIV_049520), 
conserved hypothetical protein (NCLIV_036640), Renin, related (NCLIV_022920), 
putative histidine acid phosphatase domain containing protein (NCLIV_053400), 
putative cathepsin C2 (CPC2) (NCLIV_007010) and SAG3 protein, related 
(NCLIV_034740) (Figure 4.4). Conversely, there were 2 most protein abundant in 
Nc Spain 7 which were found in all time course were SRS domain-containing protein 
(SRS39) (NCLIV_023620) and predicted rhoptry kinase, subfamily ROP24 
NCLIV_068850. 
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4.3.2 GO enrichment analysis 
 
The proteins that showed preferentially expressed in Nc Spain 1H and Nc Spain 7in 
three time points as 12, 36 and 56 hours pi, respectively were grouped together and 
individually searched for their GO term using ToxoDB database.   
 
The GO term enrichment analysis could be obtained from only preferentially 
expressed proteins in Nc Spain 1H for all time points (Table 4.7, 3.8 and 3.9). 
However,  the GO term enrichment analysis for more abundant proteins in Nc Spain 
7 returned no significant GO term as there are small number of protein to be an input.  
The number of preferentially expressed proteins input for GO term in Nc Spain7 
were  21 proteins of 12 hr pi, 6 proteins of 36 hr pi and 18 proteins of 56 hr pi, 
respectively. 
 
Among 56 preferentially expressed proteins of low-virulence Nc Spain 1H, there 
were 14 significantly enriched biological process terms (Benjamini < 0.05), as shown 
in appendix Table 4. However, only carbohydrate metabolic process (GO:0005975), 
metabolic process (GO:0008152) and primary metabolic process (GO:0044238) of 
biological process GO terms revealed a statistically significant. The other biological 
process and molecular function terms illustrated a single or few proteins and some 
terms are related to the same proteins as a result in extensive redundancy among the 
results. 
 
Seven proteins that found associated with carbohydrate metabolic process 
(GO:0005975) were Glucosamine--fructose-6-phosphate aminotransferase 
(Isomerizing), related (NCLIV_031610), putative phosphoglucomutase 
(NCLIV_010960), Fructose-1,6-bisphosphatase, related (NCLIV_050070), Fructose-
1,6-bisphosphatase class 1, related (NCLIV_050080), cbr-GPDH-1 protein, related 
(NCLIV_001180), and two hypothetical protein (NCLIV_037460 and 
NCLIV_004200)
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4.3.2.1 Gene Ontology (GO) enrichments of the low- and high- virulence of N. caninum in different time points 
 
Table 4.7 Protein Ontology enrichment: Biological Process and Molecular Function of 56 high abundant proteins in Nc Spain 1H at 12 
hours post infection obtained from ToxoDB website 
Term ID Description 
Bgd 
count 
Result 
count 
Pct of bgd 
Fold 
enrichment 
Odds 
ratio 
P-value Benjamini 
Biological Process: 
GO:0005975 
carbohydrate metabolic 
process 
86 8 9.3 7.48 9 0.000013 0.000186 
GO:0008152 metabolic process 1317 24 1.8 1.46 2.08 0.013670 0.049091 
GO:0044238 primary metabolic process 1075 20 1.9 1.5 1.95 0.024545 0.049091 
Molecular Function: 
GO:0003824 catalytic activity 1365 23 1.7 1.35 1.78 0.043708 0.048274 
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Table 4.8 Gene Ontology enrichment: Biological Process and Molecular Function of 13 high abundant proteins in Nc Spain 1H at 36 
hours post infection obtained from ToxoDB website 
Term ID Description 
Bgd 
count 
Result 
count 
Pct of bgd 
Fold 
enrichment 
Odds 
ratio 
P-value Benjamini 
Biological Process: 
GO:0006508 proteolysis 133 4 3 12.69 24.38 0.00016 0.00063 
GO:0019538 protein metabolic process 607 4 0.7 2.78 4.56 0.03996 0.04425 
GO:0008152 metabolic process 1317 6 0.5 1.92 4.69 0.04425 0.04425 
Molecular Function: 
GO:0016787 hydrolase activity 537 5 0.9 3.93 8.81 0.00380 0.00945 
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Table 4.9 Gene Ontology enrichment: Biological Process and Molecular Function of 44 high abundant proteins in Nc Spain 1H at 56 
hours post infection obtained from ToxoDB website 
Term ID Description 
Bgd 
count 
Result 
count 
Pct of bgd 
Fold 
enrichment 
Odds 
ratio 
P-value Benjamini 
Biological Process: 
GO:0006508 proteolysis 133 9 6.8 8.79 12.91 0.000001 0.000030 
GO:0019538 protein metabolic process 607 11 1.8 2.35 3.35 0.003563 0.028737 
GO:0008150 biological_process 1771 20 1.1 1.47 3.02 0.009605 0.028737 
GO:0043170 
macromolecule metabolic 
process 
823 12 1.5 1.89 2.66 0.013039 0.028737 
GO:0044238 primary metabolic process 1075 14 1.3 1.69 2.5 0.016877 0.028737 
GO:0008152 metabolic process 1317 16 1.2 1.58 2.5 0.017164 0.028737 
Molecular Function: 
GO:0070011 
peptidase activity, acting on 
L-amino acid peptides 
99 7 7.1 9.18 12.2 0.000009 0.000122 
GO:0008233 peptidase activity 106 7 6.6 8.57 11.37 0.000014 0.000122 
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Table 4.10 Identified genes involved in GO term: biological process and molecular function of preferentially expressed proteins of Nc 
Spain 1 H at 12 hous pi obtained fromToxoDB 
Gene ID Description Toxoplasma ortholog Biological process Molecular Function 
NCLIV_001180 
cbr-GPDH-1 protein, 
related 
NAD-dependent glycerol-3-
phosphate dehydrogenase 
carbohydrate metabolic 
process, glycerol-3-
phosphate catabolic 
process, oxidation-
reduction process 
NAD binding, glycerol-3-
phosphate dehydrogenase 
[NAD+] activity, protein 
homodimerization activity 
NCLIV_010960 
putative 
phosphoglucomutase 
glucosephosphate-mutase 
GPM2 (GPM2) 
carbohydrate metabolic 
process 
null 
NCLIV_031610 
Glucosamine--fructose-
6-phosphate 
aminotransferase 
(Isomerizing), related 
glucosamine-fructose-6-
phosphate aminotransferase 
carbohydrate biosynthetic 
process, carbohydrate 
metabolic process 
carbohydrate binding, 
glutamine-fructose-6-
phosphate transaminase 
(isomerizing) activity 
NCLIV_037460 hypothetical protein citrate synthase I 
cellular carbohydrate 
metabolic process 
null 
NCLIV_050070 
Fructose-1,6-
bisphosphatase,related 
sedoheptulose-1,7-
bisphosphatase 
carbohydrate metabolic 
process 
phosphoric ester hydrolase 
activity 
NCLIV_050080 
Fructose-1,6-
bisphosphatase class 1, 
related 
sedoheptulose-1,7-
bisphosphatase 
carbohydrate metabolic 
process 
phosphoric ester hydrolase 
activity 
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Gene ID Description Toxoplasma ortholog Biological process Molecular Function 
NCLIV_004200 hypothetical protein glycosyltransferase 
biosynthetic process, 
carbohydrate metabolic 
process 
catalytic activity, cation 
binding 
NCLIV_035300 
putative lipoate-protein 
ligase a 
lipoyltransferase and 
lipoate-protein ligase 
subfamily protein 
cellular protein 
modification process, 
protein lipoylation 
catalytic activity, 
transferase activity 
NCLIV_018300 
HIT family protein, 
related 
Hit family protein involved 
in cell-cycle regulation, 
putative 
null catalytic activity 
NCLIV_067490 
putative protein 
phosphatase 2C 
protein phosphatase 2C 
domain-containing protein 
null catalytic activity 
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Table 4.11 Identified proteins involved in GO term: biological process of 
preferentially express proteins of Nc Spain 1 H at 36 hous pi obtained ToxoDB 
Gene ID Description 
Toxoplasma 
ortholog 
Biological 
process 
NCLIV_007010 
putative cathepsin 
C2 (TgCPC2) 
cathepsin CPC2 
(CPC2) 
proteolysis 
NCLIV_008320 
protein F23B2.12, 
partially confirmed 
by transcript 
evidence, related 
serine 
carboxypeptidase 
s28 protein 
proteolysis 
NCLIV_022920 Renin, related 
aspartyl protease 
ASP1 (ASP1) 
proteolysis 
NCLIV_029980 
putative glycerol-
3-phosphate 
acyltransferase 
glycerol-3-
phosphate-
acyltransferase 
metabolic process 
NCLIV_031610 
Glucosamine--
fructose-6-
phosphate 
aminotransferase 
(Isomerizing), 
related 
glucosamine-
fructose-6-phosphate 
aminotransferase 
carbohydrate 
biosynthetic 
process, 
carbohydrate 
metabolic process 
NCLIV_063570 
Peptidase, 
S9A/B/C family, 
catalytic domain 
protein, related 
acylaminoacyl-
peptidase, 
proteolysis 
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Table 4.12 Identified genes involved in GO term: biological process and molecular function of preferentially expressed proteins of Nc 
Spain 1 H at 56 hous pi obtained from ToxoDB 
Gene ID Description Toxoplasma ortholog Biological process Molecular Function 
NCLIV_002940 
putative microneme 
protein MIC4 
microneme protein MIC4 
(MIC4) 
blood coagulation, 
proteolysis 
protein binding 
NCLIV_004380 cathepsin L, related cathepsin CPL (CPL) proteolysis 
cysteine-type peptidase 
activity 
NCLIV_007010 
putative cathepsin C2 
(TgCPC2) 
cathepsin CPC2 (CPC2) proteolysis 
cysteine-type peptidase 
activity 
NCLIV_008320 
protein F23B2.12, 
partially confirmed by 
transcript evidence, 
related 
serine carboxypeptidase s28 
protein 
proteolysis 
serine-type peptidase 
activity 
NCLIV_021050 unspecified product subtilisin SUB1 (SUB1) proteolysis 
serine-type endopeptidase 
activity 
NCLIV_022920 Renin, related 
aspartyl protease ASP1 
(ASP1) 
proteolysis 
aspartic-type endopeptidase 
activity 
NCLIV_038110 hypothetical protein 
microneme protein MIC17C 
(MIC17C) 
blood coagulation, 
proteolysis 
protein binding 
NCLIV_044230 putative peptidase M16 
domain containing 
toxolysin TLN4 (TLN4) proteolysis 
catalytic activity, metal ion 
binding, 
metalloendopeptidase 
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Gene ID Description Toxoplasma ortholog Biological process Molecular Function 
protein activity, zinc ion binding 
NCLIV_063570 
Peptidase, S9A/B/C 
family, catalytic 
domain protein, related 
acylaminoacyl-peptidase, proteolysis 
serine-type peptidase 
activity 
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Among 44 preferential expressed proteins of low-virulence Spain 1H, 59 biological 
process term were enriched (Benjamini < 0.05), as shown in appendix Table 7. 
However, only proteolysis (GO:0006508) of biological process GO terms showed 
statistically significant and was not redundancy of proteins with enrichment GO 
terms. 
 
Nine proteins that found related to proteolysis involved putative microneme protein 
MIC4 (NCLIV_002940), cathepsin L, related (NCLIV_004380), putative cathepsin 
C2 (TgCPC2) (NCLIV_007010), protein F23B2.12, partially confirmed by transcript 
evidence, related (NCLIV_008320),  unspecified product (NCLIV_021050), Renin, 
related (NCLIV_022920), hypothetical protein (NCLIV_038110),  putative peptidase 
M16 domain containing protein (NCLIV_044230) and eptidase, S9A/B/C family, 
catalytic domain protein, related (NCLIV_063570).  
 
There were four proteins involved in proteolysis in Nc Spain 1 H at 36 hours pi 
which comprised of protease or peptidase enzymes as putative cathepsin C2 
(TgCPC2) (NCLIV_007010) protein F23B2.12, partially confirmed by transcript 
evidence, related (NCLIV_008320) ortholog of serine carboxypeptidase s28 protein 
in T. gondii, Renin, related (NCLIV_022920) ortholog of aspartyl protease ASP1 
(TgASP1) and Peptidase, S9A/B/C family, catalytic domain protein, related 
(NCLIV_063570) (Table 3.11)  
 
There were nine proteins related to proteolysis in Nc Spain 1 H at 56 hour pi which 
comprised of two micronemes proteins as putative microneme protein MIC4 
(NCLIV_002940) and hypothetical protein (NCLIV_038110) ortholog of T. gondii 
microneme protein MIC17C (TgMIC17C), seven  peptidase or protease enzymes as 
cathepsin L related (NCLIV_004380) and  putative cathepsin C2 (TgCPC2) 
(NCLIV_007010), protein F23B2.12, partially confirmed by transcript evidence, 
related (NCLIV_008320) ortholog of serine carboxypeptidase s28 protein in T. 
gondii, Renin, related (NCLIV_022920) ortholog of aspartyl protease ASP1 
(TgASP1), Peptidase, S9A/B/C family, catalytic domain protein, related 
(NCLIV_063570), unspecified product (NCLIV_021050) ortholog of T. gondii 
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subtilisin SUB1 (TgSUB1), putative peptidase M16 domain containing protein 
ortholog of T. gondii  toxolysin TLN4 (TgTLN4) (Table 3.12) 
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4.4 Discussion 
 
The aim of this study is to identify key differences in the protein expression of low- 
(Nc Spain 1H) and high- (Nc Spain 7) virulence N. caninum at three different time 
points post-infection. In this study, all experiments have used three biological 
replicates of N. caninum rather than five because a minimum of three biological 
replicates was sufficient for detecting naturally biological variation of samples 
caused either by genetic variation or by the effect of environmental factors 
(Westermeier et al., 2008). Many label free quantitative proteomic studies were 
chosen three biological replicates in their study (Dudekula and Le Bihan, 2016; 
Zhang et al., 2015). The financial constraints to run samples, laborious and time 
consuming are major factors to keep in considering to select an appropriate amount 
of N. caninum replicates. However, more reliable proteomics profile will be 
increased if the experimental study includes more replicates. GO term enrichment 
was used to infer possible functional roles of differentially expressed proteins in each 
parasite strains and at each time point. GO enrichment analysis could only be 
performed in Nc Spain 1H at all three time points due to insufficient terms in other 
conditions. No GO terms were significantly enriched in Nc Spain 7 at any time point.  
   
4.4.1 GO enrichment analysis of preferentially expressed proteins in 
low-virulence Nc Spain 1H at three time points 
  
Carbohydrate metabolism (GO:0005975) was significantly enriched at 12 hours pi. 
This process is involved in the formation, breakdown and interconversion of 
carbohydrates. Seven preferentially expressed proteins in Nc Spain 1H are associated 
with carbohydrate metabolism, i.e. glucosamine-fructose-6-phosphate 
aminotransferase (isomerizing), phosphoglucomutase, fructose-1,6-bisphosphatase, 
fructose-1,6-bisphosphatase class 1, cbr-GPDH-1 protein and two hypothetical 
proteins. 
 
Fructose-1,6-bisphosphate aldolase is important for cell invasion by T. gondii. T. 
gondii tachyzoites invade host cells using an acomysin motor connected to 
extracellular adhesins, in which fructose-1,6-bisphosphate aldolase acts as a bridging 
protein. This enzyme also has a role in glycolysis (Boucher and Bosch, 2014). 
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Glucosamine-fructose-6-phosphate aminotransferase (GFAT) plays a key role in 
amino sugar biosynthesis and glycosylation (Durand et al., 2008).  
 
There were 13 preferentially expressed proteins in Nc Spain 1H at 36 hours pi that 
could be analyzed for GO enrichment.  Four biological process terms were 
significantly enriched, as shown in appendix Table 6. These were proteolysis, 
carbohydrate biosynthetic process, protein metabolic process and metabolic process.  
 
Four proteins associated with the proteolysis term were putative cathepsin C2 
(TgCPC2) (NCLIV_007010), protein F23B2.12, partially confirmed by transcript 
evidence, related (NCLIV_008320), Renin, related (NCLIV_022920) and Peptidase, 
S9A/B/C family, catalytic domain protein, related (NCLIV_063570). The proteolysis 
GO term is discussed below as this GO term was also found at 56 hr pi of Nc 
Spain1H  
 
Among GO terms applied to 44 preferentially expressed proteins in Spain 1H at 56 
hours pi, 59 biological process terms were enriched (Benjamini < 0.05), as shown in 
appendix Table 7. However, only proteolysis (GO:0006508) showed statistically 
significance and non-redundancy with other GO terms. Nine proteins were associated 
with proteolysis; these wereputative microneme protein MIC4 (NCLIV_002940), 
cathepsin L, related (NCLIV_004380), putative cathepsin C2 (TgCPC2) 
(NCLIV_007010), protein F23B2.12, partially confirmed by transcript evidence, 
related (NCLIV_008320), unspecified product (NCLIV_021050), Renin, related 
(NCLIV_022920), hypothetical protein (NCLIV_038110),  putative peptidase M16 
domain containing protein (NCLIV_044230) and eptidase, S9A/B/C family, catalytic 
domain protein, related (NCLIV_063570).  
 
The ‘proteolysis’ term is enriched in Nc Spain 1H at 36 and 56 hours pi. Proteolysis 
covers all process involved in breaking peptide bonds. This process plays a vital role 
in cell and tissue invasion as well as parasite egression from host cells (Miller et al., 
2001; Tampaki et al., 2015). Inhibition of proteases in T. gondii resulted in blocking 
parasite invasion and intracellular development (Conseil et al., 1999; Shaw et al., 
2002).  In this study, preferentially expressed proteins in Nc Spain 1H associated to 
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proteolysis were composed of a group of micronemes such as MIC4 and TgMIC17C 
which found in 56 hours pi. Moreover protease enzymes such as cathepsin L, 
cathepsin C2 (TgCPC2), serine carboxypeptidase s28 protein, renin, S9A/B/C family 
peptidase, subtilisin SUB1 (TgSUB1), a M16 domain-containing peptidase are also 
involved in the proteolytic process. The microneme secretes numerous soluble and 
transmembrane1-anchored proteins during the apical attachment of the parasite to 
host cells. Microneme proteins have variety of adhesive domains, which can bind to 
the receptors on mammalian cells (Soldati et al., 2001).  These groups of proteins 
help the parasite to penetrate the host cell.  Cathepsins are also proteases that are 
important for invading cells by apicomplexan parasite such as Toxoplasma and 
Plasmodium (Mayer et al., 1991; Que et al., 2002). Cell invasion is facilitated by 
extensive proteolysis of surface protein help for adhesion and penetration (Dou & 
Carruthers, 2011). Proteolysis is also associated with micronemes and rhoptry 
proteins, which are involved in three steps of invasion process. Firstly, proteolytic 
maturation en route to secretory organelles. Secondly, microneme proteins are 
trimmed to produce their functional forms after they are secreted on the parasite 
surface. Finally, microneme is shedding their products, which are released from the 
parasite surface during, and after they move toward the posterior end. For example, 
microneme protein 4 (MIC4) is secreted by T. gondii tachyzoites during microneme 
stimulation and exocytosis. Also, the rhoptry protein (ROP1) functions in post-
secretory proteolysis within the parasitophorous vacuole after parasite invasion 
(Bradley et al., 2002). The reason why proteolytic functions are enriched in low-
virulence Nc Spain 1H may be due to its essential role in cell invasion by N. caninum 
and all apicomplexan parasites. Greater efficiency in cell invasion by this strain may 
result in lower virulence since a more rapid invasion may cause less severe 
pathogenesis in the host.  
 
4.4.2 Preferential protein expression in the low-virulence strain Nc 
Spain 1H  
 
The high abundance proteins of Nc Spain 1H found in all three time points (12, 36 
and 56 pi) were cathepsin C2 protein and two surface antigens known as SRS  
domain-containing protein (TgSRS35A) and SAG3. Other high abandance proteins 
involved in host cell attachment and invasion found at 12 hours pi only included 
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rhoptry protein ROP1 (ROP1), microneme protein (MIC), MIC2, MIC3, MIC4 and 
MIC9, putative protein phosphatase 2C. The group of microneme proteins such as 
MIC1, MIC2, MIC3, MIC4, MIC 10, MIC11 were more abundant at 56 hours pi as 
were three further SRS domain-containing proteins. Cathepsin L also showed high 
abundance at 56 hours pi. These virulence-related proteins are discussed in the 
following paragraphs. 
 
4.4.2.1 Surface antigen proteins  
 
The surfaces of T. gondii and N. caninum tachyzoites are coated with 
glycosylphosphatidylinositol (GPI) -linked proteins that are homologous to the 
surface antigen SAG1 (Jung et al., 2004). The surface antigens are recognised as the 
SRS or SAG1-related superfamily of proteins which mediate attachment to host 
cells, and are thought to mediate the host immune response and so regulate virulence 
in T. gondii (Lekutis et al., 2001). The two surface antigens proteins shown to be 
preferentially expression at all three time points are SAG3 and SRS domain-
containing protein, the latter an orthologue of SRS35A in T. gondii (TgSRS35A). 
 
SAG3 is one out of five major surface antigens which play an important role in host 
cell attachment and invasion by T. gondii (Tomavo, 1996). It is assumed that SAG3 
is a T. gondii receptor that binds host cell ligands to mediate cell attachment 
(Dzierszinski et al., 2000). SAG3 can be found both in tachyzoites and bradyzoites 
stage; it binds sulphated proteoglycans (SPGs) with high affinity (Jacquet et al., 
2001). and can interact specifically with cellular heparin sulfate proteoglycan  that 
allows T. gondii to attach to host cells (Burg et al., 1988). A tachyzoites mutant that 
lack SAG3 display a decreased rate of host cell adhesion and reduced virulence in 
mice (Dzierszinski et al., 2000).  
 
SRS domain-containing protein (i.e. NcSRS35A) is highly abundant in Nc Spain 1H, 
with the highest fold-change at all three time points. Two other SRS proteins 
(NcSRS16E and NcSRS67) were most abundant at 56 hours pi.  The SRS proteins of 
N. caninum are also localised at the surface of the parasite (Reid et al., 2012). Most 
of them are members of the surface antigen 1 (SAG1) or SAG2 families (Boothroyd 
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et al., 1998; Lekutis et al., 2000; Manger et al., 1998).  These proteins seem to play 
important roles in host cell invasion, immune modulation and/or virulence 
attenuation (Lekutis et al., 2001).  As mentioned previously in chapter 2, 
overexpression of SRS proteins attenuates the virulence of T. gondii. (Wasmuth et al. 
(2012)) found that the transgenic overexpression of SRS29C protein can reduce the 
virulence of T. gondii RH type I.  Moreover, outbred mice experimentally infected 
with transgenic T. gondii overexpressing SRS29C survived, while all outbred mice 
infected with WT strain died. These surface antigen proteins may lower virulence of 
N. caninum also, explaining their particular abundance in Nc Spain 1H. However, 
studies of SRS proteins in N. caninum is very limited and further studies are need, for 
example, oblating SRS35A function in virulent strains of N. caninum and measuring 
their virulence in in vitro or in vivo.  
 
4.4.2.2 Putative cathepsin C2  
 
There are five cathepsins that are members of the cysteine proteases family, namely 
cathepsin L-like, cathepsin B-like and three cathepsin C –like (1,2 and 3) proteases 
(Dou and Carruthers, 2011). Cathepsins have a role in T. gondii microneme and 
rhoptry protein maturation, replication, host cell invasion and nutrient achievement. 
In apicomplexan protozoa, cysteine proteases play critical roles in host cell invasion, 
organellar biogenesis, and intracellular survival (Que et al., 2007).  Cathepsin C or 
dipeptidyl peptidase I (DPPI) has principally exopeptidase activity, which 
subsequently eliminates dipeptides from unblocked N-terminal substrates of proteins 
and peptides (Dahl et al., 2001). Cathepsin proteases play the part of lysosomal 
hydrolases, digesting endogenous and exogeneous polypeptides involved in 
endocytosis of eukaryotics organisms (Barrett and Kirschke, 1981). The cathepsin C 
in Toxoplasma is important for tachyzoite growth and differentiation (Que et al., 
2007).  
 
Moreover, putative cathepsin L was highly abundant in Nc Spain 1H at 56 hours pi. 
The role of cathepsin L-like protease has been described for Plasmodium. (Dahl and 
Rosenthal (2005)) stated that cathepsin L-like protease is critical for haemoglobin 
degradation within the parasite food vacuole through erythrocyte infection for 
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Plasmodium falciparum. The cathepsin C2 showed high abundance in the low 
virulence strain all three time points. Producing large quantities of cathepsin might 
be an adaptation of the low virulence parasite, allowing it to invade host cells faster, 
while the high-virulence strain remains outside the host cell for longer.  
  
4.4.2.3 Microneme proteins 
 
Microneme proteins are associated with adhesion and invasion of host cells and are 
released immediately after attachment to the host cells. TgMIC4, TgMIC1 and 
TgMIC6 are formed the complex which has been shown important for host cell 
penetration in T. gondii (Saouros et al., 2005b). Tg MIC1 and TgMIC4 function as 
adhesins while TgMIC 6 play role as escorter proteins (Reiss et al., 2001b). The 
deletion of TgMIC1 and TgMIC3 leads to a reduced in virulence of T. gondii 
(Cerede et al., 2005). NcMIC3 protein interact with surface proteoglycan of host 
cells and initiates attachment and invasion process to host cells (Naguleswaran et al., 
2002). MIC3  TgMIC2 and other transmembrane proteins make a link to the parasite 
actinomysin sytem through their cytoplasmics tail (Jewett and Sibley, 2003) which 
provide the force for host cell invasion (Soldati and Meissner, 2004). TgMIC10 and 
TgMIC11 do not relate to the parasite surface during invasion. They are soluble 
microneme proteins. TgMIC10 proteins are secreted at the time of penetration and 
are highly express in T.gondii tachyzoites which is responsible for active infection  
(Hoff et al., 2001). TgMIC11 consists of an alpha-chain and beta-chain tied by 
disulphide bond due to the internal propeptide is removed by two successive 
proteolytic events (Harper et al., 2004).  
 
High abundance of microneme proteins at 56 hours pi may be due to the parasite 
egressing and finding new host cells to invade. The putative MIC2-associated protein 
M2AP was found more abundant at 56 hours pi. M2AP plays important role in host 
cell entry by forming the complex with MIC2. The MIC2/M2AP complex is moved 
over the parasite to the posterior end where the MIC2 ectodomain is secreted through 
C-terminal proteolysis of MIC2. The evident of secreted the content and 
translocation of MIC2/M2AP complex are associated with the host cell invasion 
(Rabenau et al., 2001).   Huynh et al. (2003) found that the deletion of M2AP in T. 
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gondii were reduced more than 80% of host cell invasion. It seemed like deficient of 
the expression of MIC2 which is important for the parasite to attach the host cells. 
The finding of MICs protein from this study is contrast with the studied by (Regidor-
Cerrillo et al., 2012a). They studied proteomics expression change between 
attenuated (Nc Spain 1H) and virulent (Nc Spain 7 and Nc-Liv) of N. caninum using 
DIGE and MALDI-TOF MS technique. They found NcMIC1 showing higher 
abundant in Nc Spain 7 versus Nc Spain 1H at a ratio 1.57 of 3.5 days tachyzoites 
culture sample. The reason why many invasive microneme proteins were found more 
abundant in only Nc Spain 1H but not in Nc Spain 7, this may because the 
microneme proteins are a fundamental protein in all apicomplexan parasites. That 
means a group of microneme are essential for parasite survival and play important 
role for host cell attachment and invasion and this process does not indicate the 
virulence as mentioned before Nc low virulent might have higher ability to attach the 
host cell but the parasite itself may not cause severe harm to the host after invasion. 
 
4.4.2.4 Rhoptry protein ROP1 
 
Rhoptry proteins play a vital role in the initial and later stages of host cell invasion. 
Rhoptry kinase are known to be determinants of T. gondii virulence (Hunter and 
Sibley, 2012). ROP proteins are secreted after the invasion process following the 
microneme protein. ROP proteins are a large family proteins with conserved 
serine/threonine kinases domains, which are associated with the development and 
maintenance of the parasitophorous vacuole and regulation of host cell processes 
(Qiu et al., 2009). ROP5, ROP16 and ROP 18 have been determined as a genetically 
polymorphic virulence factors in T. gondii (El Hajj et al., 2007; Saeij et al., 2006; 
Taylor et al., 2006). ROP5 is essential for pathogenesis in T. gondii-infected mice 
(Behnke et al., 2011).  ROP1 is released into the parasitophorous vacuole (PV) by the 
time invasion was completed (Carruthers and Sibley, 1997b).    
4.4.2.5 Apical membrane antigen1 
  
Apical membrane antigen 1 (AMA1) localizes to the parasite surface (Mital et al., 
2005) and binds to microneme proteins and is highly conserved in apicomplexan 
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parasites.  It is one of the major components, along with rhoptry neck proteins RON 
2/4/5/8, of the moving junction (MJ) crucial to the invasion process (Besteiro et al., 
2009). Mital et al. (2005) showed that AMA1 depletion in T. gondii reduces the 
ability of parasite to invade host cells. The deficiency of TgAMA1 does not 
influence microneme secretion during the host cell attachment but it does inhibiting 
secretion from the rhoptries.  
 
4.4.2.6 Subtilisin SUB1 (SUB1) 
 
Subtilisin SUB1 is a microneme-secreted protein, released during the infection 
process.  A TgSUB1 protein is determined as a key marker for acute toxoplasmosis 
(Hruzik et al., 2011). This protein was highly abundant in Nc Spain 1H at 56 hr pi, 
during which N. caninum is likely to exit infected cells and attach the new host cells. 
The overall proteomic profiles of low-virulence Nc Spain 1H shows a high 
abundance of proteins involved in host cell invasion, host cell attachment, 
tyachyzoite growth and differentiation. This might mean that Nc Spain 1H has a 
better ability to attach and invade the host cells than the high-virulence strain Nc 
Spain 7. However, these findings contradict the previous study by Regidor-Cerrillo et 
al. (2011) who investigated the in vitro invasion and proliferation capabilities of the 
Nc-Liv and ten Spanish N. caninum isolates at 2, 4, and 6 hours post infection. Nc 
Spain 3H and Nc Spain 1H revealed the lowest invation rate by Dunn’s test. They 
found no significant difference in invasion rate between Nc Spain 1H and Nc Spain 7 
at any time points.  
 
4.4.3 Preferential proteins expression in high-virulence strains of N. 
caninum (Nc Spain 7) 
 
The proteins preferentially expressed in Nc Spain 7 that were found in all three time 
courses were a predicted rhoptry kinase, subfamily ROP24 (NCLIV_068850) and  
SRS39 domain-containing protein (NCLIV_023620).  
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4.4.3.1 Predicted rhoptry kinase, subfamily ROP24  
 
TgROP 24 is a member of the rhoptry kinase family. Talevich and Kannan (2013) 
found unusual motifs in non-canonical subfamilies ROP24 and ROP45 from T. 
gondii that could indicate novel kinase mechanisms of activation, ATP positioning 
and catalysis. A number of rhoptry kinases are implicated in the virulence of T. 
gondii, such as pesudokinase ROP5 (Talevich and Kannan, 2013), rhoptry kinase 
ROP18 (Reid et al., 2012)  and rhoptry kinase ROP16 (Denkers et al., 2012; Saeij et 
al., 2007b). However, these three rhoptry proteins in N. caninum are different from T. 
gondii as they differ in the specific location of loci. The rhoptry kinase ROP18 in N. 
caninum is pseudogenised, which means that N. caninum  is incapable of 
phosphorylating host immunity-related GTPases (Reid et al., 2012). This finding is 
contradicted with the study of (Regidor-Cerrillo et al., 2012b). They found that 
ROP40 and ROP9 were more abundant in Nc Spain 7 than Nc Spain 1H and Nc Liv. 
They suggested that these two proteins might play different roles in the two parasite 
strains. The role of ROP24 is still unknown in N. caninum; however, it may be 
associated with N. caninum virulence since it is significantly more abundant in Nc 
Spain 7 than Nc Spain 1H in all three time points.  
 
4.4.3.2 SRS domain containing protein (SRS39) 
 
As described above, the SRS proteins are thought to be responsible for host cells 
attachment and host immunity activation to regulate the parasite's virulence (Jung et 
al., 2004). ROP24 and SRS39 proteins may be involved in N. caninum virulence of 
as both proteins were significantly more abundant in Nc Spain 7 at all time points. 
These two proteins may work together in order to generate the Neospora virulence.  
 
4.4.4 Validation of identified protein 
Western blotting is a method to validate protein expression in a proteomics analysis 
(Nirmalan et al., 2009). It need to do validation for confirming protein expression 
over a larger sample size. Validation using antibodies and/or quantitative mass 
spectrometry are really crucial for being able to draw conclusions from identified protein. 
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4.4.5 Limitation of the study 
 
This study has no negative control to quantify the background level of population 
variation in protein expression.  The study should also contain comparisons of strains 
with the same virulence phenotypes, and comparisons of different phenotypes that 
are controlled for the population history of the strains. There is also no replication; 
ideally, we should compare multiple, independent instances of the low/high virulence 
differential.  
 
4.4.6 Establish functional role of the identified proteins  
 
The functional role could be established by using the ToxoDB as well as the protein 
databases. Known genes and proteins do not have any problem to know the 
functional role directly from the database. However, hypothetical proteins and 
unspecified products need to do further investigation. The databases of protein 
families, domains and functional sites such as PFAM (Finn et al., 2014), Interpro 
(Armean et al., 2018), UniProt (Gabella and Durinx, 2017) can be employed to 
investigate the unknown protein by comparing or matching the protein sequence in 
order to know or predict their function and characterise them.  
 
4.4.7 Conclusions and future purspectives  
 
In conclusion, the preferential expression of SRS domain-containing protein 
(NCLIV_019580) in Nc Spain 1H (low virulent strain) over the whole time course is 
thought to reflect a mechanistic role of SRS in limiting the virulence of the parasite. 
Conversely, TgROP24 and SRS39 proteins may be associated with increased 
virulence in Nc Spain 7.  
 
SRS domain-containing protein (NCLIV_019580) should be studied further to 
understand how it limits virulence. They might be performed by over expressing this 
protein in high virulent strains and measuring pathogenicity in vivo. Similarly, it 
would be beneficial to repress ROP24 in a virulent strain to better understand its 
stimulatory effect on virulence in N. caninum. 
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Chapter 5: General discussion 
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This thesis comprises a comparative study of gene expression in different N. caninum 
developmental stages and in parasite strains with distinct virulence phenotypes using 
advanced techniques to investigate global transcript and protein abundance.  
 
The interest to study the virulence of N. caninum was raised because N. caninum 
strains shows significant variation in this phenotype within the population, as defined 
by the pathogenesis associated with their infections (Al-Qassab et al., 2010). Similar 
to the tachyzoite and bradyzoite stages of N. caninum, strains varying in virulence 
are different in terms of morphology and their abilities to invade host cells. Together, 
understanding the genetic factors regulating virulence and development in N. 
caninum is necessary as this can promote the identification of vaccine and drug 
targets for disease prevention and treatment. Previous studies of N. caninum 
virulence mostly focused on the pathogenicity of the disease in clinically affected 
animals or neonatal infections (Arranz-Solis et al., 2015; Cavalcante et al., 2012; 
Regidor-Cerrillo et al., 2014; Rojo-Montejo et al., 2009a). The major finding of this 
thesis is the identification of transcripts and proteins that are preferentially expressed 
in either a low- and high- virulence condition in N. caninum, as well as the protein 
expression profiles during stage conversion of the parasites.   
 
In chapter two, the protein expression during tachyzoites-bradyzoites interconversion 
of N. caninum was investigated using label-free quantitative proteomics. Larger 
numbers of proteins were identified using label-free quantitative techniques than in 
previous studies that used gel-based methods. The result shows most of apical 
secretory proteins such as miconemes, dense granules and rhoptries proteins as well 
as the proteins associated to the parasite movement and invasion process have shown 
decreased expression in bradyzoites stage. The reduction of these groups of proteins 
suggests that they are not necessary in bradyzoites stage as these proteins role are 
involved in host cell attachment, invasion and PV formation.  However, the general 
GO enrichment terms were introduced the general board terms which could not 
provide a biological information of predicted function related to each N. caninum 
stage. 
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However, the development of bradyzoites from this study is from in vitro culture 
which is different from the bradyzoites from in vivo. Therefore bradyzoites from 
animal model has the influence from host immunity rather than receiving stress from 
chemical induction in vitro and the duration to be converted from tachyzoites to 
bradyzoites stage in vivo has shown longer time than in vitro (Skariah et al., 2010). 
These all affect the protein expression in stage conversion. As a consequence, the 
different pattern of proteins expressions might not be the same and not totally reflect 
the biological knowledge in in vivo. However, it is difficult to isolate the tissue cyst 
from animal model especially from natural infection (Hemphill et al., 2004). 
 
A proteomics analysis of gene expression during the reverse stage conversion of 
bradyzoites to tachyzoites might be studied in future using an alkaline medium to 
induce reversion (Soete et al., 1993). This might show whether the same patterns of 
gene expression changes occur with tachyzoites-bradyzoites interconversion or not. 
Moreover, other developmental changes during the N. caninum life cycle might be 
examined, such as differentiation from oocyst to tachyzoites. Since N. caninum 
oocyst also plays the important role in N. caninum transmission. Most of N. caninum 
abortion outbreak are most likely come from the cattle ingest the oocyst 
contaminated in food or water (McAllister et al., 2000; McAllister et al., 1996). 
However, it might be difficult to obtain sufficient N. caninum oocysts and induce 
stage conversion in vitro. The stage conversion might be studied in vivo to achieved 
the data that reflect the real situation in animal. 
 
Another type of cell culture might improve research on tachyzoites-bradyzoites stage 
conversion, for example astrocyte or neurons that are cell types related to the nervous 
system. The CNS is a favoured target of N. caninum and the parasites might show a 
different protein expression pattern against a different host cell background.  N. 
caninum can successfully infect astrocyte cell culture (Jesus et al., 2013; Pinheiro et 
al., 2006). This kind of information might give more understanding of the N. 
caninum stage biology. 
 
In chapter three, the transcriptomics expression change between low and high-
virulence N. caninum was investigated using RNA-Seq technology applications. The 
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main finding from these transcriptomic profiles was that several SRS domain-
containing transcripts were preferentially expressed in the low virulence strain. Reid 
et al. (2012) found a group family of surface antigens (SAGs) or SRS (SAG-1 related 
sequence) proteins which were vastly divergent in N. caninum than T. gondii. This 
might explain its narrower host range. These SRS proteins might associate with 
reduction of the virulence in N. caninum. On the other hand, protein phosphatase 2C 
might be involved in N. caninum virulence. This protein is localized to rhoptries and 
released during the host cell invasion. It transports the parasite protein into the host 
cell which might increase the possibility to effect the host cells (Gilbert et al., 2007).  
 
The major limitation of the transcriptomics study is the small number of significantly 
preferentially expressed transcripts, which means that the data cannot provide much 
insight into the functional consequences of differences in gene expression. This 
might be because of too few genes to be captured by GO term enrichment, which 
needs hundreds of genetic differences to be functionally characterised to produce 
anything compelling.  In addition, the most of the transcript found to be differentially 
expressed encoded hypothetical proteins, which by definition do not have functional 
ontological terms associated with them, and which cannot help a functional 
interpretation based on GO term enrichment. However, N. caninum strains used in 
this study came from the same country and population, such that there might not be 
vast differences in terms of genetic diversity. The genetic diversity seems to be 
restricted in N. caninum and the clonality is a prominent feature in this organism 
which transmission always occurs within intermediate host (Sibley and Ajioka, 
2008). Efficient vertical transmission of this parasite means that the parasite can live 
without definitive host and sexual reproduction is uncommon leading population 
diversity presumably low (Perez-Zaballos et al., 2005). There are no clear correlation 
between the pathogenicity and genetic diversity among the N. caninum isolates so far 
(Al-Qassab et al., 2010; Regidor-Cerrillo et al., 2006). One possibility reason is that 
most N. caninum used in many study were from the cell culture and the long term 
passage causes lower the pathogenicity and other features of the parasite in vivo 
(Bartley et al., 2006). The strict control and report number of the passage used in 
each experimental study as well as well maintenance the culture seed stock of N. 
caninum are suggested to be performed (Goodswen et al., 2013). 
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In future of the transcriptomics research, more N. caninum strains displaying both 
low and high-virulence phenotypes should be identified and examined because only 
one example of each condition cannot capture the full range of virulence phenotypes, 
or hope to identify characteristic variations in gene expression that are distinct from 
strain variations in the population at large. Moreover, the standard reference strains 
should be included in the experiment as the control to provide a measure of standard 
strain variation in transcript abundance. The data from this thesis showed that PP2C 
could be a virulent factor for N. caninum. This protein might be studied more in vivo  
such as knockout it from the parasite and infect to animal model to observe the 
pathogenicity occurring in infected animal. Additionally, a group of SRS proteins 
which were expected to lowering the virulence of the parasite have to investigate 
further for their functional role.   
 
In chapter four, differences in expression between low and high-virulence N. 
caninum were recorded during infections using a proteomic analysis at 12, 36 and 56 
hours pi. The predicted rhoptry kinase ROP24 is expected to be associated with 
virulence as this ROP protein was preferentially expressed in high-virulence strains 
of N. caninum at all three time points. This protein is involved in host cell invasion 
and might be one variable to cause impairment to the host.  However this finding 
contradicts with the study of Regidor-Cerrillo et al. (2012a), who found another ROP 
protein (TgRop40) was more abundance in Nc Spain 7. This could be that both 
rhoptry proteins might play role in virulence of N. caninum. Additional study related 
to virulence in these two strains need to be investigated in N. caninum such as 
disruption of these proteins and examine under either in vitro or in vivo.  Few known 
rhoptry proteins have been implicated in virulence in T. gondii such as ROP5 (Reese 
et al., 2011), ROP16 (Saeij et al., 2007b) and ROP18 (El Hajj et al., 2007). The 
rhoptries release effector proteins named ROPs which are brought into the host 
cytoplasm which hijack host cells function. Recently, Kim et al. (2016) had found 
the rhoptry peudokinase ROP54 in T. gondii can modulate its virulence. They 
demonstrated that the knockout of the ROP54 in type II strain of T. gondii did not 
affect in vitro growth but caused 100-fold reduction in virulence in vivo. They 
suggested that ROP54 is involved in invasion of innate immune effectors which 
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increased of guanylate binding protein 2 (GBP2) loading onto the PV of the ROP54-
disrupted T. gondii to promote the Toxoplasma infection.  
 
Surprisingly, most of host cell attachment-associated proteins are more abundant in 
low-virulence Nc Spain 1H. For example, MICs were most abundant at 12 and 56 hr 
pi. as well as putative cathepsin C2 and subtilisin SUB1proteins. It might indicate the 
better ability for host cell attachment than high virulence Nc Spain7. 
 
The limitation of this analysis is that no control was included to quantify the 
background level of protein expression variation between strains of the same 
virulence. Moreover, there is only one strain representing each virulence phenotype 
and therefore the observations are not replicated. 
 
Future proteomic research on N. caninum virulence should include more N. caninum 
strains that have defined virulence phenotypes. The functional consequences of 
modifying ROP24 expression should be explored, perhaps by observing the effects 
of enhancing or ablating its function on virulence in vivo.  
 
From the study, there are some identified protein involved in the stage conversion 
which decrease in expression during the differentiation process such as apical 
secretory proteins as microneme, rhoptries and dense granule. The transcript 
expression of PP2C might involve in virulence of N. caninum and ROP 24 and 
SRS39 proteins are expected to be associated in virulence of high virulent strains. 
Further investigation of these proteins and transcripts need to be performed such as 
gene/protein validation by realtime PCR and western blot which leads to know that 
they are definitely preferentially expressed. This outcome can be used to develop 
drug and vaccine against neosporosis. Up to date, no available commercial vaccine to 
N. caninum is on the market. Zhang et al. (2013) performed the cost of management 
practice to control neosporosis using the mathematical modelling to predict. They 
found that vaccine could be the efficient intervention strategy (Reichel and Ellis, 
2009). Most of the vaccine research using recombinant subunit vaccine candidates as 
antigents represent surface proteins, heat shock protein assessed to date. The proteins 
that are secreted from the secretory organelles; rhoptries, micronemes and dense 
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granule have been applied for producing vaccine. Recently, the chemotherapeutic 
drug for neosporosis treatment is not regarded as an economically variable factor 
because of long withdrawal duration period. The drug candidate should be prior 
tested in vitro. There is currently no effective drug on the market. Some genes and 
proteins from this study might be the candidate for drug and vaccine development in 
the future. 
 
In conclusion, this thesis has provided a view of N. caninum gene expression relating 
to developmental stage and virulence using transcriptomic and proteomic 
approaches. The comparative analysis between low- and high-virulence as well as 
tachyzoites and bradyzoites provide more biological information insight into the key 
genes and proteins related to these critical features of pathogenesis and parasite 
transmission. Thus, these findings contribute to an improved understanding of N. 
caninum cell function and move us closer to finding new ways of preventing and 
controlling neosporosis. 
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APPENDIX 
 
Appendix Table I: The list of proteins expression in cluster 1 showing downward expression trend throughout three time points 
ID N. caninum description T. gondii  orthologues D0 D3 D6 
Max fold 
change 
q Value 
NCLIV_025600 putative calmodulin calmodulin CAM2 (CAM2) 265739.36 263341.31 25032.09 10.61595 0.00139 
NCLIV_043870 conserved hypothetical protein hypothetical protein 632804.95 491318.85 83413.24 7.58639 0.00066 
NCLIV_036200 putative cyclophilin peptidyl-prolyl cis-trans isomerase family 1 440164.70 311944.18 61153.88 7.19766 0.00194 
NCLIV_053590 WD-40 repeat protein, related transducin beta-like protein TBL1 (TBL1) 1078432.05 1120640.79 167584.27 6.68703 0.00339 
NCLIV_043320 
rna recognition motif (RRM)-
containing protein,related 
U2 snRNP auxilliary factor, large subunit, 
splicing factor subfamily protein 
999741.20 910921.59 149615.12 6.68209 0.00293 
NCLIV_017040 Phosphofructokinase, related phosphofructokinase PFKII (PFKII) 846932.48 613245.67 156661.14 5.40614 0.00459 
NCLIV_047600 hypothetical protein hypothetical protein 245166.59 265982.91 50582.39 5.25841 0.00485 
NCLIV_064340 putative prefoldin subunit prefoldin subunit 6, putative 252216.14 225237.83 49038.51 5.14323 0.00198 
NCLIV_042770 hypothetical protein hydrolase, NUDIX family protein 191186.70 246180.35 48626.41 5.06269 0.02926 
NCLIV_048800 hypothetical protein ubiquitin family protein 1616946.72 1243199.11 319526.01 5.06045 0.00152 
NCLIV_019600 hypothetical protein 
clathrin adaptor complex small chain 
subfamily protein 
584126.80 516189.27 119401.46 4.89212 0.00175 
NCLIV_053360 conserved hypothetical protein transcription elongation factor SPT6 (SPT6) 133160.44 107140.26 30173.92 4.41310 0.00156 
NCLIV_001770 
putative DNAK family domain 
containing protein 
tetratricopeptide repeat-containing protein 1353555.83 938777.78 321447.71 4.21081 0.00267 
NCLIV_056590 
putative phosphatidylinositol-4-
phosphate 5-kinase 
MORN repeat-containing protein 1058324.45 896339.46 251841.30 4.20235 0.00751 
NCLIV_024440 hypothetical protein 
vacuolar protein sorting-associated protein 
26, putative 
265255.35 220355.64 66567.25 3.98477 0.00371 
NCLIV_056360 
Eukaryotic initiation factor, 
related 
DEAD (Asp-Glu-Ala-Asp) box polypeptide 
DDX6 (DDX6) 
512884.26 586998.49 151636.41 3.87109 0.02395 
NCLIV_054550 
Cytochrome c oxidase subunit 2, 
related 
cytochrome C oxidase subunit IIb, putative 3972133.77 2765119.30 1059769.0 3.74811 0.00058 
NCLIV_019450 hypothetical protein signal peptidase 551941.50 669909.50 192573.35 3.47872 0.00073 
NCLIV_025710 unspecified product microneme protein MIC7 (MIC7) 4010693.96 3108615.04 1165075.8 3.44243 0.00528 
NCLIV_005190 
putative transcription elongation 
factor FACT 140 kDa 
transcriptional elongation factor FACT140 
(FACT140) 
1102959.20 893566.69 329756.63 3.34477 0.00230 
NCLIV_045870 unspecified product dense granule protein GRA3 (GRA3) 29563772.10 20964950.60 8937345.3 3.30789 0.00146 
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ID N. caninum description T. gondii  orthologues D0 D3 D6 
Max fold 
change 
q Value 
NCLIV_062570 
Contig An13c0020, complete 
genome, related 
PCI domain-containing protein 3194546.53 4019722.08 1238916.0 3.24455 0.00382 
NCLIV_054110 YHL017Wp-like protein, related membrane protein, putative 1935637.03 1499365.93 599800.64 3.22713 0.00267 
NCLIV_036970 putative calmodulin calmodulin, putative 1495446.50 1301915.15 468635.32 3.19107 0.01038 
NCLIV_036720 CBR-CSN-5 protein, related proteasome regulatory subunit 887029.48 695815.78 287500.07 3.08532 0.00608 
NCLIV_002610 
putative isoleucine-
tRNAsynthetase 
isoleucyl-tRNA synthetase family protein 2307714.55 1989230.48 783400.08 2.94577 0.00293 
NCLIV_028240 
putative Ras family domain-
containing protein 
Rab1 protein 349939.55 375387.59 129222.97 2.90496 0.00156 
NCLIV_001600 
possible RNA-binding protein, 
related 
RNA recognition motif-containing protein 959189.50 840035.66 332709.65 2.88296 0.00369 
NCLIV_032620 Cs1 protein, related Hsp70 interacting protein HIP (HIP) 3553222.50 3090527.14 1286645.9 2.76162 0.00232 
NCLIV_017510 
putative 40S ribosomal protein 
S29 
N/A 1600757.06 1792729.13 654380.64 2.73958 0.00442 
NCLIV_030120 putative importin beta-3 subunit HEAT repeat-containing protein 2379127.75 1759619.30 887190.09 2.68164 0.00455 
NCLIV_059410 hypothetical protein 
cytokine induced apoptosis inhibitor 1 
family protein 
1556791.69 1422897.08 581884.56 2.67543 0.00480 
NCLIV_060560 conserved hypothetical protein hypothetical protein 1466291.69 1202805.36 552761.25 2.65267 0.01931 
NCLIV_049740 conserved hypothetical protein hypothetical protein 656117.74 582779.72 252292.50 2.60062 0.03507 
NCLIV_019480 
proteasome A-type and B-type 
domain-containing protein 
20S proteasome subunit beta 7, putative 3769139.21 3385413.13 1457230.5 2.58651 0.00264 
NCLIV_016370 Galactosyltransferase, related hypothetical protein 221053.48 215214.31 86240.68 2.56322 0.01653 
NCLIV_027100 
putative orotidine-
monophosphate-decarboxylase 
orotate phosphoribosyltransferase 108878.97 96123.69 43474.92 2.50441 0.01336 
NCLIV_027660 conserved hypothetical protein hypothetical protein 940014.22 820373.02 375591.06 2.50276 0.01836 
NCLIV_002680 agap001651-PA, related PCI domain-containing protein 1901213.38 2206691.82 906066.58 2.43546 0.00854 
NCLIV_062220 
Glutaminyl-tRNA 
synthetase,related 
glutaminyl-tRNA synthetase (GlnRS) 11921452.32 10815435.02 4897269.5 2.43431 0.00085 
NCLIV_027930 unspecified product rhoptry protein ROP17 (ROP17) 1141984.84 869393.11 475372.45 2.40229 0.01784 
NCLIV_028320 
putative actin-like family protein 
ARP4a 
actin-related protein ARP4A (ARP4A) 824039.22 627785.86 344666.43 2.39083 0.00755 
NCLIV_039960 hypothetical protein heat shock protein 40, putative 3269089.23 2546498.32 1371799.4 2.38307 0.00758 
NCLIV_019200 
Eukaryotic translation initiation 
factor 5,related 
eukaryotic initiation factor-5, putative 2509886.44 1971241.02 1060635.7 2.36640 0.00332 
NCLIV_024220 putative glycerol-3-phosphate FAD-dependent glycerol-3-phosphate 1067905.61 869111.34 458320.76 2.33004 0.02024 
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dehydrogenase dehydrogenase 
NCLIV_064880 conserved hypothetical protein hypothetical protein 5308282.98 4378444.63 2290038.3 2.31799 0.02948 
NCLIV_027290 
Ribosomal protein S21-maize 
(ISS), related 
ribosomal protein RPS21 (RPS21) 4131812.01 3303550.25 1785066.1 2.31465 0.04119 
NCLIV_005280 conserved hypothetical protein hypothetical protein 719881.37 693685.18 311969.84 2.30754 0.02944 
NCLIV_033830 hypothetical protein hypothetical protein 945120.67 807206.67 414628.18 2.27944 0.00367 
NCLIV_017020 hypothetical protein beta adaptin protein, putative 321899.29 287376.23 144604.48 2.22607 0.01204 
NCLIV_041210 
putative Ubiquinol-cytochrome c 
reductase complex 14 kDa protein 
ubiquinol-cytochrome c reductase 5696938.76 5387596.52 2562340.4 2.22333 0.00405 
NCLIV_007110 hypothetical protein ribosomal protein RPS10 (RPS10) 1611162.07 1383210.91 739344.96 2.17918 0.01788 
NCLIV_012830 
putative MORN repeat-containing 
protein 
phosphatidylinositol-4-phosphate 5-kinase 1841649.52 1794299.75 864260.51 2.13090 0.00655 
NCLIV_050300 GH18750, related 
eukaryotic initiation factor-2 gamma, 
putative 
8906939.60 8561857.33 4260432.2 2.09062 0.00589 
NCLIV_035220 hypothetical protein hypothetical protein 6119278.87 5235311.74 2949403.1 2.07475 0.00094 
NCLIV_065970 conserved hypothetical protein GAP40 protein (GAP40) 2492858.69 2120046.31 1208655.4 2.06251 0.03775 
NCLIV_044440 hypothetical protein 
eukaryotic peptide chain release factor, 
putative 
672906.17 690492.46 337929.55 2.04330 0.04579 
NCLIV_036400 unspecified product dense granule protein GRA1 (GRA1) 801663933.5 693263794.7 395255100 2.02822 0.00304 
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Appendix Table II: The list of proteins expression in cluster 2 showing downward expression trend and then not change in expression 
ID N. caninum description T. gondii  orthologues D0 D3 D6 
Max fold 
change 
q Value 
NCLIV_021510 conserved hypothetical protein DUF3228 domain-containing protein 396479.64 66940.64 20525.99 19.31598 0.01330 
NCLIV_021410 conserved hypothetical protein hypothetical protein 1934838.9 217867.71 638107.78 8.88080 0.00297 
NCLIV_056730 conserved hypothetical protein hypothetical protein 588892.91 92014.19 80675.27 7.29955 0.01047 
NCLIV_020430 
hypothetical protein 
cleft lip and palate transmembrane protein 1 
(clptm1) protein 
714046.52 151961.38 122149.83 
5.84566 0.04728 
NCLIV_018260 
putative U4/U6 small nuclear 
ribonucleoprotein WD domain, G-beta repeat-containing protein 
155932.92 44142.10 27703.00 
5.62874 0.03875 
NCLIV_040600 
hypothetical protein 
signal recognition particle receptor beta 
subunit protein 
5691004.5 1028281.60 1039360.9 
5.53448 0.03800 
NCLIV_008860 hypothetical protein UDP-galactose transporter family protein 671184.72 203690.15 142488.38 4.71045 0.00485 
NCLIV_065570 
putative translation initiation 
factor SUI1 translation initiation factor SUI1, putative 
1995635.1 558339.68 505226.56 
3.94998 0.00066 
NCLIV_046970 conserved hypothetical protein hypothetical protein 1103666.8 301124.81 411043.97 3.66515 0.00993 
NCLIV_048040 conserved hypothetical protein hypothetical protein 1109215.0 316639.53 401233.78 3.50308 0.01931 
NCLIV_051590 putative GTP binding protein GTP-binding protein, putative 8497994.9 3170482.10 2547632.1 3.33564 0.00293 
NCLIV_036630 putative 14-3-3 protein 14-3-3 superfamily protein 153305.83 46317.57 114537.63 3.30989 0.02400 
NCLIV_004510 
putative kelch motif domain-
containing protein kelch repeat-containing protein 
136045.70 41180.82 88555.08 
3.30362 0.04414 
NCLIV_005050 
putative coatomer delta subunit 
adaptor complexes medium subunit family 
protein 
3716585.0 1425511.92 1139790.5 
3.26076 0.00156 
NCLIV_005040 conserved hypothetical protein hypothetical protein 2968418.0 943944.08 1068584.0 3.14470 0.00273 
NCLIV_032240 Catalase (EC 1.11.1.6), related catalase 66004502. 21314140.59 23758910 3.09675 0.00282 
NCLIV_058300 hypothetical protein hypothetical protein 2576396.5 840942.93 1649767.2 3.06370 0.03922 
NCLIV_035190 
conserved hypothetical protein 
glideosome-associated protein with multiple-
membrane spans GAPM3 
3676957.3 1267464.45 2785751.4 
2.90103 0.00854 
NCLIV_045490 conserved hypothetical protein hypothetical protein 1081874.9 394781.00 617225.23 2.74044 0.00548 
NCLIV_058000 
putative alanine dehydrogenase 
NAD(P) transhydrogenase subunit beta, 
putative 
12759821 4755062.00 5570964.7 
2.68342 0.02397 
NCLIV_028500 
GJ17676, related 
homocysteine s-methyltransferase domain-
containing protein 
4317622.0 1628409.34 2028678.9 
2.65144 0.00822 
NCLIV_037760 Rhomboid-6, isoform A, related rhomboid protease ROM4 (ROM4) 1003097.6 384428.44 444785.57 2.60932 0.04511 
NCLIV_063810 conserved hypothetical protein hypothetical protein 3130555.7 1223202.26 1408204.15 2.55931 0.03104 
NCLIV_015290 hypothetical protein endomembrane protein 70 subfamily protein 1350738.4 574436.39 528568.87 2.55546 0.01453 
NCLIV_052900 conserved hypothetical protein hypothetical protein 5306909.2 2080671.92 3589507.33 2.55057 0.00262 
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NCLIV_042760 
dehydrogenases with different 
specificities,related carbonyl reductase 1, putative 
1560959.3 640367.74 1290273.37 
2.43760 0.01064 
NCLIV_006000 
hypothetical protein 
inositol(myo)-1(or 4)-monophosphatase 2, 
putative 
965612.84 401140.43 427750.64 
2.40717 0.02944 
NCLIV_028050 conserved hypothetical protein hypothetical protein 3300756.2 1515466.09 1384822.38 2.38352 0.01601 
NCLIV_069460 hypothetical protein N/A 487802.59 206080.78 378059.47 2.36705 0.00577 
NCLIV_022430 hypothetical protein GAPM1a 5163613.3 2196494.43 3621235.01 2.35084 0.04303 
NCLIV_010370 
ubiquitin carrier protein, related 
ubiquitin-conjugating enzyme subfamily 
protein 
10574042 4556562.03 4528909.29 
2.33479 0.01390 
NCLIV_043180 hypothetical protein Sec23/Sec24 trunk domain-containing protein 3937203.8 1719769.23 2680803.81 2.28938 0.00462 
NCLIV_018020 hypothetical protein myosin A 434415.96 211605.64 191959.78 2.26306 0.01179 
NCLIV_044350 
conserved hypothetical protein 
glideosome-associated protein with multiple-
membrane spans GAPM2B (GAPM2B) 
4400460.2 1959765.79 2343838.50 
2.24540 0.02756 
NCLIV_012610 conserved hypothetical protein hypothetical protein 412168.46 191188.75 201788.93 2.15582 0.04134 
NCLIV_018420 unspecified product rhoptry protein ROP9 (ROP9) 299806549 154910479.8 139926402.5 2.14260 0.00114 
NCLIV_013180 GM04207p, related hypothetical protein 7570779.8 3548726.29 4326689.82 2.13338 0.00842 
NCLIV_040650 conserved hypothetical protein hypothetical protein 1660775.0 794100.13 803617.55 2.09139 0.01485 
NCLIV_024740 
Myosin, heavy polypeptide 1, 
skeletal muscle,adult, related myosin A 
15700034. 7699189.39 7565961.09 
2.07509 0.00560 
NCLIV_025730 conserved hypothetical protein rhoptry neck protein RON10 (RON10) 1615724.7 779488.43 899737.63 2.07280 0.02139 
NCLIV_026340 hypothetical protein IMC sub-compartment protein ISP2 (ISP2) 34275112. 16686366.16 26602726.71 2.05408 0.00594 
NCLIV_006780 conserved hypothetical protein dense granule protein DG32 26762962. 13139404.22 15237274.41 2.03685 0.02584 
NCLIV_060810 conserved hypothetical protein hypothetical protein 6636406.5 3554296.22 3296969.09 2.01288 0.01640 
NCLIV_027850 unspecified product rhoptry protein ROP6 (ROP6) 21488945 10728440.37 19145440.15 2.00299 0.04332 
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Appendix Table III: The list of expressed proteins of cluster 3 showing upward expression trend throughout three time points 
ID N. caninum description T. gondii  orthologues D0 D3 D6 
Max fold 
change 
q Value 
NCLIV_012950 
putative ubiquitin family 
domain-containing protein 
ubiquitin family protein 32183.17 352394.63 1089634.23 33.85726 0.00250 
NCLIV_001290 conserved hypothetical protein HEAT repeat-containing protein 385271.78 820139.66 4696425.55 12.18990 0.00139 
NCLIV_035590 conserved hypothetical protein hypothetical protein 1513363.22 9352111.17 12779680.14 8.44456 0.01333 
NCLIV_033910 hypothetical protein 
WD domain, G-beta repeat-
containing protein 
665310.80 1515968.93 5159820.96 7.75550 0.00714 
NCLIV_012600 hypothetical protein UBX domain-containing protein 1216519.76 3110979.71 9384912.85 7.71456 0.01076 
NCLIV_031460 conserved hypothetical protein hypothetical protein 4253666.60 7494357.69 28251210.99 6.64161 0.00156 
NCLIV_066970 
putative enoyl-acyl carrier 
reductase 
enoyl-acyl carrier reductase 
ENR (ENR) 
7574215.54 22602986.54 41683983.44 5.50341 0.04438 
NCLIV_015620 
60S ribosomal protein L36, 
related 
ribosomal protein RPL36 
(RPL36) 
3902566.58 7980362.45 18483879.84 4.73634 0.00329 
NCLIV_044410 unspecified product 
rhoptry kinase family protein 
ROP35 (ROP35) 
20917373.66 28776282.42 95433729.32 4.56241 0.00762 
NCLIV_038590 conserved hypothetical protein hypothetical protein 150718.32 429752.79 655892.18 4.35177 0.00589 
NCLIV_065440 hypothetical protein calmodulin, putative 8454788.39 15033666.83 34716268.40 4.10611 0.00415 
NCLIV_065210 KLLA0F09449p, related 
heat shock protein HSP60 
(HSP60) 
36358177.28 54507306.08 140030918.30 3.85143 0.00569 
NCLIV_014050 conserved hypothetical protein 
microtubule associated protein 
SPM2 (SPM2) 
522829.03 827953.23 1913522.53 3.65994 0.01407 
NCLIV_030650 
putative 26S protease 
regulatory subunit 6b 
26S proteasome regulatory 
subunit 6b, putative 
1195117.95 1771237.37 4252425.39 3.55816 0.00085 
NCLIV_024860 
Proteasome/cyclosome repeat 
family protein,related 
Proteasome/cyclosome repeat-
containing protein 
2564313.44 3917997.98 9027531.44 3.52045 0.00419 
NCLIV_006060 conserved hypothetical protein hypothetical protein 728248.46 1356145.96 2366549.83 3.24965 0.00655 
NCLIV_034090 putative kinesin heavy chain kinesin heavy chain, putative 2048222.47 4914383.62 6617486.51 3.23084 0.01873 
NCLIV_022370 Ribophorin I, related hypothetical protein 125163.22 218550.97 383389.85 3.06312 0.02062 
NCLIV_002190 conserved hypothetical protein hypothetical protein 1368076.06 2540517.20 4097414.88 2.99502 0.01794 
NCLIV_037200 GJ21226, related 
MIF4G domain-containing 
protein 
836413.49 1010395.90 2482886.14 2.96849 0.00200 
NCLIV_054800 conserved hypothetical protein 
emp24/gp25L/p24 family 
protein 
8619496.12 13501701.49 25488973.60 2.95713 0.00678 
NCLIV_051960 conserved hypothetical protein hypothetical protein 3098086.23 5689450.17 8543120.04 2.75755 0.01073 
NCLIV_013380 hypothetical protein small nuclear ribonucleoprotein 332626.02 401441.27 907857.52 2.72936 0.00534 
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f (snrnp-f), putative 
NCLIV_015920 Histone H4, related histone H4 206581257.00 373831434.00 555071245.90 2.68694 0.01653 
NCLIV_056910 conserved hypothetical protein hypothetical protein 2935570.96 3948971.66 7735062.70 2.63494 0.02153 
NCLIV_067140 Myosin, related myosin I 1288308.68 2056757.40 3162016.98 2.45439 0.00197 
NCLIV_066760 
Translationally-controlled 
tumor protein,related 
histamine-releasing factor, 
putative 
1639514.27 2315527.11 3901201.33 2.37949 0.01216 
NCLIV_016800 
putative TCP-1/cpn60 
chaperonin family protein 
chaperonin cpn60, putative 19183439.88 22058701.47 45562092.73 2.37507 0.00415 
NCLIV_030890 
putative high molecular mass 
nuclear antigen 
hypothetical protein 3697571.32 4226171.79 8680097.38 2.34751 0.00326 
NCLIV_031440 
60S ribosomal protein L38, 
related 
ribosomal protein RPL38 
(RPL38) 
1905393.17 2677348.09 4466483.19 2.34413 0.00560 
NCLIV_004810 conserved hypothetical protein hypothetical protein 1178240.02 1686524.52 2741350.26 2.32665 0.01176 
NCLIV_038540 
rab22a, member RAS 
oncogene family, related 
Rab 5 4231851.02 6333408.81 9841077.71 2.32548 0.00536 
NCLIV_053190 hypothetical protein 
phenylalanine--tRNA ligase, 
beta subunit protein 
3436435.52 4447971.60 7816649.89 2.27464 0.01038 
NCLIV_009030 
metallophosphoesterase, 
related 
Ser/Thr phosphatase family 
protein 
652694.57 1444930.12 1464228.51 2.24336 0.01023 
NCLIV_022270 unspecified product polo kinase 1438094.89 3194609.96 3054610.10 2.22142 0.01900 
NCLIV_020840 hypothetical protein 
ATPase synthase subunit alpha, 
putative 
44966319.20 54487643.99 98864290.19 2.19863 0.01163 
NCLIV_040880 hsp90, related heat shock protein 90, putative 125472487.50 151042013.10 271525623.00 2.16403 0.00145 
NCLIV_007330 
similar to uniprot|P15705 
Saccharomyces cerevisiae 
YOR027w STI1, related 
tetratricopeptide repeat domain 
containing protein 
4896260.47 5635558.70 10442762.65 2.13280 0.00536 
NCLIV_025670 
ATP synthase subunit beta, 
related 
ATP synthase beta subunit ATP-
B (ATPB) 
128785733.80 151423081.60 272190341.80 2.11351 0.00854 
NCLIV_042810 hypothetical protein 
EMP/nonaspanin domain family 
protein 
2751840.09 3009979.57 5739587.73 2.08573 0.00720 
NCLIV_024610 conserved hypothetical protein hypothetical protein 3832033.97 4456824.89 7949808.85 2.07457 0.00066 
NCLIV_050070 
Fructose-1,6-
bisphosphatase,related 
sedoheptulose-1,7-
bisphosphatase 
2068309.82 2600648.55 4224774.74 2.04262 0.00420 
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Appendix Table IV: The list of proteins expression in cluster 4 showing not change or slightly down expression trend at the beginning 
and then upward expression trtend 
ID N. caninum Description T. gondii  orthologues D0 D3 D6 
Fold 
change 
q Value 
NCLIV_020970 conserved hypothetical protein GYF domain-containing protein 451657.79 625660.82 9665977.74 21.40111 0.00032 
NCLIV_019580 SRS domain-containing protein SAG-related sequence SRS35A 
(SRS35A) 
303766.07 373644.29 3658692.90 12.04444 0.00114 
NCLIV_004250 putative nuclear RNA binding 
protein 
hypothetical protein 2796716.17 4026163.48 23359224.10 8.35238 0.00066 
NCLIV_060500 conserved hypothetical protein hypothetical protein 37674990.75 53448716.98 297628121.50 7.89989 0.00417 
NCLIV_016250 putative cytidine deaminase cytidine and deoxycytidylate 
deaminase zinc-binding region 
domain-containing protein 
1710510.18 2416250.81 12384871.19 7.24045 0.00066 
NCLIV_007800 unspecified product hypothetical protein 57927434.60 69343600.66 343683829.60 5.93301 0.00133 
NCLIV_031700 DEHA2G03652p, related LsmAD domain-containing 
protein 
528306.96 101558.13 579518.71 5.70628 0.04211 
NCLIV_048330 hypothetical protein serine/threonine-protein 
phosphatase 2A catalytic subunit 
beta isoform, putative 
354085.24 232071.42 1157635.38 4.98827 0.00392 
NCLIV_007510 conserved hypothetical protein hypothetical protein 2835411.64 2798676.06 13455993.20 4.80799 0.00473 
NCLIV_039280 isocitrate dehydrogenase-like 
protein, related 
isocitrate dehydrogenase 3402418.68 4394418.36 16146865.25 4.74570 0.00196 
NCLIV_017840 conserved hypothetical protein membrane protein 3742394.05 3674093.12 15954504.80 4.34243 0.00170 
NCLIV_016330 putative phosphomannomutase 
2 
phosphomannomutase 78653.89 66253.03 273498.16 4.12809 0.02291 
NCLIV_031970 hypothetical protein pre-mRNA processing splicing 
factor PRP8 (PRP8) 
4616679.00 5443197.93 18867085.16 4.08672 0.00499 
NCLIV_041270 hypothetical protein RuvB family 2 protein 957256.25 658961.86 2433646.21 3.69315 0.00118 
NCLIV_055690 hypothetical protein small GTPase Rab2, putative 2685377.41 2725196.60 9531330.85 3.54934 0.00298 
NCLIV_063230 hypothetical protein CRAL/TRIO domain-containing 
protein 
989286.38 817158.05 2592223.66 3.17224 0.02502 
NCLIV_051820 hypothetical protein small GTP binding protein rab1a, 
putative 
7441716.63 7966699.96 23471753.59 3.15408 0.00367 
NCLIV_054750 hypothetical protein serine/threonine phosophatase 
PP1 
6688114.92 5946345.40 18412003.87 3.09636 0.00332 
NCLIV_009170 proteasome (Prosome, proteasome subunit beta type 2, 1264325.79 808412.90 2493083.11 3.08392 0.01410 
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Fold 
change 
q Value 
macropain) subunit, beta type, 
1, related 
putative 
NCLIV_052510 hypothetical protein hypothetical protein 5436994.54 5025834.72 14992101.37 2.98301 0.00937 
NCLIV_010850 mgc81714 protein, related 
ATP-binding cassette sub-family 
F member 1 564284.92 499364.18 1487229.03 2.97825 0.00793 
NCLIV_026430 
DnaJ domain containing 
protein, related DnaJ family Sec63 protein 3877682.42 4019747.38 10964191.90 2.82751 0.00066 
NCLIV_057550 unspecified product subtilisin SUB2 (SUB2) 1877603.77 2090967.91 5267163.96 2.80526 0.00697 
NCLIV_062940 
putative pyruvate 
dehydrogenase 
pyruvate dehydrogenase complex 
subunit PDH-E1Alpha 
(PDHE1A) 3896222.95 4070465.63 10646651.38 2.73256 0.00066 
NCLIV_056950 hypothetical protein 
adaptin n terminal region domain-
containing protein 364118.28 235458.95 630987.42 2.67982 0.02427 
NCLIV_005150 hypothetical protein beta-1 tubulin, putative 46973635.73 38482211.49 102357621.80 2.65987 0.00085 
NCLIV_042680 conserved hypothetical protein hypothetical protein 2804776.97 2017620.07 5262147.40 2.60810 0.00294 
NCLIV_003050 putative myosin heavy chain myosin heavy chain, putative 24804590.50 19699025.92 50219407.41 2.54933 0.00066 
NCLIV_007000 
adp-ribosylation factor 4, 
related 
ADP ribosylation factor ARF1 
(ARF1) 13384885.98 12113051.14 30380291.34 2.50806 0.00667 
NCLIV_062350 Ribosomal protein S27, related 
ribosomal protein RPS27 
(RPS27) 8523545.94 8054591.67 20069702.66 2.49171 0.00175 
NCLIV_026540 conserved hypothetical protein COPI associated protein, putative 1830119.98 1236842.70 2974515.40 2.40493 0.00198 
NCLIV_017500 hypothetical protein ribosomal protein RPS5 (RPS5) 21606091.19 22839638.84 51847984.72 2.39969 0.00496 
NCLIV_064810 hypothetical protein 
V-type H(+)-translocating 
pyrophosphatase VP1 1047602.74 745766.34 1768839.74 2.37184 0.00751 
NCLIV_022560 Thermosome subunit, related 
T-complex protein 1, epsilon 
subunit (TCP-1-epsilon), putative 6494927.85 5457768.29 12872209.09 2.35851 0.00156 
NCLIV_003440 actin, related actin ACT1 (ACT1) 773369556.50 636090488.10 1486659804.00 2.33718 0.00175 
NCLIV_034530 
putative TCP-1/cpn60 family 
chaperonin T-complex protein 1 delta subunit 6550443.57 6401245.06 14641121.07 2.28723 0.00226 
NCLIV_061460 
Family T1, proteasome beta 
subunit, threonine peptidase, 
related 
proteasome subunit beta type, 
putative 2463404.56 2073481.02 4683982.90 2.25899 0.00145 
NCLIV_065640 
putative Rhoptry kinase family 
protein, truncated (incomplete 
catalytic triad) 
Rhoptry kinase family protein, 
truncated (incomplete catalytic 
triad) 3193954.51 1641152.97 3673151.23 2.23815 0.00788 
NCLIV_018620 Os08g0464000 protein, related activator of hsp90 atpase 1 family 1452022.50 756348.86 1688512.59 2.23245 0.00842 
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ID N. caninum Description T. gondii  orthologues D0 D3 D6 
Fold 
change 
q Value 
protein 
NCLIV_027480 hypothetical protein 
vacuolar ATP synthase subunit d, 
putative 9420742.98 8570579.18 19038517.24 2.22138 0.03355 
NCLIV_056300 conserved hypothetical protein hypothetical protein 18091603.15 11119003.99 24595182.93 2.21200 0.00560 
NCLIV_057960 unspecified product rhoptry protein, putative 4988515.30 3781467.18 8363598.99 2.21173 0.00536 
NCLIV_005770 hypothetical protein 
importin-beta N-terminal domain-
containing protein 4185123.00 2841306.19 6130854.85 2.15776 0.00328 
NCLIV_039940 hypothetical protein 
cell-cycle-associated protein 
kinase GSK, putative 10954372.92 5460253.81 11639629.64 2.13170 0.01703 
NCLIV_058890 tubulin alpha chain alpha-tubulin I, putative 266952606.30 240376973.30 510267636.20 2.12278 0.00129 
NCLIV_035920 
Adenylate/guanylate cyclase 
with GAF sensor and FHA 
domain, related adenylate cyclase, putative 849211.24 569580.71 1162695.62 2.04132 0.01611 
NCLIV_063590 Glutathione reductase, related glutathione reductase 11763886.13 7666990.21 15431498.68 2.01272 0.00786 
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Appendix Table V: The list of proteins expression in cluster 5 showing upward expression and then downward expression trend 
ID N. caninum description T. gondii  orthologues D0 D3 D6 
Max fold 
change 
q Value 
NCLIV_042540 
putative PBS lyase HEAT-like repeat 
domain-containing protein 
HEAT repeat-containing protein 120685.78 233588.55 25276.21 9.24144 0.00337 
NCLIV_001550 
putative ribonucleoside-diphosphate 
reductase, large subunit 
ribonucleoside-diphosphate reductase 
large chain 
87340.33 583783.56 418757.21 6.68401 0.00638 
NCLIV_051450 
putative centromere/microtubule 
binding protein 
rRNA pseudouridine synthase 223142.17 1220448.03 675565.49 5.46937 0.00778 
NCLIV_033680 
Solute carrier family 25 
(Mitochondrial carrier,dicarboxylate 
transporter), member 10, related 
2-oxoglutarate/malate translocase 
OMT (OMT) 
329636.97 1525846.96 793626.42 4.62887 0.00066 
NCLIV_013700 
putative CHCH domain-containing 
protein 
CHCH domain-containing protein 856631.00 3695217.99 2024348.95 4.31366 0.01140 
NCLIV_032940 putative adenosine transporter nucleoside transporter protein 891615.53 2919848.11 767821.02 3.80277 0.00226 
NCLIV_037590 conserved hypothetical protein hypothetical protein 1270323.18 2177673.77 611453.73 3.56147 0.04333 
NCLIV_032950 
putative deoxyuridine 5'-triphosphate 
nucleotidohydrolase 
deoxyuridine 5'-triphosphate 
nucleotidohydrolase, putative 
564550.47 1609532.21 768416.03 2.85100 0.00751 
NCLIV_010050 srs domain-containing protein SAG-related sequence SRS16E (SRS6) 1285383.80 2211278.86 835739.05 2.64590 0.00175 
NCLIV_032910 hypothetical protein SPFH domain / Band 7 family protein 1312561.54 3427174.12 2072315.96 2.61106 0.00802 
NCLIV_061760 putative microneme protein MIC6 microneme protein MIC6 (MIC6) 99847150.72 145373153.80 57170746.58 2.54279 0.00214 
NCLIV_051890 unspecified product 
AP2 domain transcription factor 
AP2X-7 (AP2X7) 
512977.59 796420.85 316090.41 2.51960 0.01159 
NCLIV_022970 unspecified product microneme protein MIC2 (MIC2) 19596185.13 34068901.48 13797268.62 2.46925 0.00674 
NCLIV_001620 conserved hypothetical protein hypothetical protein 197451.04 472436.90 366920.74 2.39268 0.00720 
NCLIV_010600 putative microneme protein MIC3 microneme protein MIC3 (MIC3) 460862170.3 597623331.90 263553637.7 2.26756 0.00066 
NCLIV_012130 
eukaryotic translation initiation factor 
3 subunit 7-like protein, related 
eukaryotic translation initiation factor 3 
subunit 7, putative 
3058435.49 4282803.69 1901774.7 2.25200 0.00720 
NCLIV_060470 hypothetical protein cysteine-tRNA synthetase (CysRS) 1168807.61 2187167.46 993506.64 2.20146 0.04842 
NCLIV_046540 putative oligoendopeptidase F peptidase family M3 protein 559748.68 1227000.02 598720.08 2.19206 0.00556 
NCLIV_013360 putative plectin 
surface antigen repeat-containing 
protein 
161159.37 212122.31 97005.97 2.18669 0.00740 
NCLIV_016150 Serine--pyruvate transaminase,related alanine-glyoxylate aminotransferase 604348.13 1232329.87 570792.00 2.15898 0.01293 
NCLIV_046830 putative ATP synthase ATP synthase, putative 4028206.45 5389668.82 2508110.52 2.14890 0.00273 
NCLIV_066250 unspecified product microneme protein MIC10 (MIC10) 15263145.84 31405245.90 21647544.12 2.05759 0.00668 
NCLIV_020720 putative microneme protein MIC11 microneme protein MIC11 (MIC11) 37080653.29 69913253.09 34154350.16 2.04698 0.00197 
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Appendix Table VI: The list of proteins expression in cluster 6 showing similar expression trend throughout three time points 
ID N. caninum description T. gondii  orthologues D0 D3 D6 
Max fold 
change 
q Value 
NCLIV_004050 
formate/nitrite transporter 
family protein,related 
formate/nitrite transporter protein 526974.15 182506.23 8223.52 64.08132 0.00499 
NCLIV_0275 
peptidyl-prolyl cis-trans 
isomerase NIMA-interacting 1 
peptidylprolyl isomerase 1247517.81 221748.16 49890.12 25.00531 0.00332 
NCLIV_045400 hypothetical protein 
splicing factor 3A subunit 2, 
putative 
369688.77 177245.27 33584.01 11.00788 0.01333 
NCLIV_056130 conserved hypothetical protein hypothetical protein 1531949.74 740896.97 178443.55 8.58507 0.00078 
NCLIV_057250 conserved hypothetical protein hypothetical protein 3146278.19 1580093.20 376648.63 8.35335 0.00236 
NCLIV_046950 
UDP-glucose 4-epimerase, 
related 
UDP-glucose 4-epimerase 206692.55 85457.45 26501.99 7.79913 0.00739 
NCLIV_039080 
adaptin N terminal region 
family protein,related 
beta-COP 2967373.03 1361368.99 393575.40 7.53953 0.00259 
NCLIV_050780 conserved hypothetical protein hypothetical protein 1641546.33 736822.23 226831.19 7.23686 0.00282 
NCLIV_048930 hypothetical protein 
importin-beta N-terminal domain-
containing protein 
1152760.57 366793.78 161921.32 7.11926 0.00409 
NCLIV_060900 conserved hypothetical protein hypothetical protein 343669.12 126206.43 49841.19 6.89528 0.00655 
NCLIV_007120 hypothetical protein microneme protein, putative 1298651.02 635904.54 206501.33 6.28883 0.00467 
NCLIV_055980 conserved hypothetical protein hypothetical protein 5287578.25 2117710.36 880652.61 6.00416 0.00066 
NCLIV_063240 DnaJ homologue, related DnaJ domain-containing protein 379609.76 206332.62 66489.75 5.70930 0.00876 
NCLIV_044100 conserved hypothetical protein hypothetical protein 1075443.92 373675.67 193536.67 5.55680 0.01201 
NCLIV_057280 
Peptidylprolyl isomerase D 
(Cyclophilin D),related 
tetratricopeptide repeat-
containing protein 
389988.54 192061.67 70593.74 5.52441 0.01568 
NCLIV_011690 unspecified product rhoptry protein ROP15 (ROP15) 3193011.07 1200586.02 608179.47 5.25011 0.04398 
NCLIV_058260 hypothetical protein N/A 6073953.30 3533331.29 1282677.41 4.73537 0.00145 
NCLIV_010110 hypothetical protein 
ubiquinol-cytochrome c reductase 
hinge protein, putative 
1529043.10 938260.82 333063.12 4.59085 0.00372 
NCLIV_006620 
trehalose-6-phosphate synthase 
of likely plant origin, related 
trehalose-phosphatase 157243.48 69697.86 34737.52 4.52662 0.04629 
NCLIV_019240 conserved hypothetical protein hypothetical protein 2088544.07 1098747.25 465879.65 4.48301 0.00241 
NCLIV_053680 hypothetical protein 
oxidoreductase, short chain 
dehydrogenase/reductase family 
protein 
171812.59 113404.50 40062.08 4.28866 0.00930 
NCLIV_007580 hypothetical protein 
glycosyl hydrolase, family 31 
protein 
1118021.53 740504.92 260931.06 4.28474 0.01778 
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ID N. caninum description T. gondii  orthologues D0 D3 D6 
Max fold 
change 
q Value 
NCLIV_055370 conserved hypothetical protein hypothetical protein 4586380.78 2070334.04 1203494.55 3.81089 0.00502 
NCLIV_061030 hypothetical protein RuvB family 1 protein 1127153.72 564791.71 306764.83 3.67433 0.00304 
NCLIV_063980 conserved hypothetical protein hypothetical protein 1312187.43 578545.94 368569.44 3.56022 0.01488 
NCLIV_034900 
putative casein kinase II beta 
chain 
ck2 beta subunit 650239.43 382974.10 183041.91 3.55241 0.00379 
NCLIV_005860 
IMP-specific 5'-nucleotidase, 
related 
IMP-specific 5'-nucleotidase 1, 
putative 
580921.33 291978.48 166599.48 3.48693 0.00180 
NCLIV_023610 
putative vacuolar ATP synthase 
subunit d 
V-type ATPase, D subunit 
protein 
142938.57 94708.37 41048.32 3.48220 0.02397 
NCLIV_004570 hypothetical protein N/A 10511384.56 6728637.61 3137854.36 3.34986 0.00609 
NCLIV_066360 conserved hypothetical protein hypothetical protein 630736.47 282140.95 190170.78 3.31668 0.02648 
NCLIV_063150 
Serpin peptidase inhibitor, 
clade B (Ovalbumin),member 
1, like 3, related 
protease inhibitor PI1 (PI1) 16691405.78 7220226.92 5090209.34 3.27912 0.01204 
NCLIV_056660 conserved hypothetical protein hypothetical protein 181215.13 73395.65 56346.76 3.21607 0.01038 
NCLIV_044600 conserved hypothetical protein N/A 3233199.15 2043009.78 1006283.70 3.21301 0.00262 
NCLIV_023780 conserved hypothetical protein hypothetical protein 2031715.11 1084917.10 634411.40 3.20252 0.01101 
NCLIV_037540 
YOR039Wp-like protein, 
related 
ck2 beta subunit 511020.22 344545.21 162456.59 3.14558 0.00877 
NCLIV_024030 conserved hypothetical protein hypothetical protein 5689192.84 3941583.71 1824754.94 3.11778 0.00190 
NCLIV_021640 unspecified product 
dense granule protein GRA7 
(GRA7) 
618276610.00 326387253.80 199183314.30 3.10406 0.00337 
NCLIV_024320 conserved hypothetical protein hypothetical protein 3981815.13 2718709.96 1306110.09 3.04861 0.00057 
NCLIV_003120 unspecified product protease inhibitor PI2 (PI2) 8002697.31 5619635.96 2704237.69 2.95932 0.00066 
NCLIV_028820 hypothetical protein kelch repeat-containing protein 2916345.61 1858850.18 986041.21 2.95763 0.00377 
NCLIV_010390 
novel protein (Zgc:77804), 
related 
splicing factor U2AF family 
SnRNP auxilary factor large 
subunit, RRM domain-containing 
protein 
4239376.50 2740188.69 1453589.39 2.91649 0.00114 
NCLIV_003160 
nicotinate 
phosphoribosyltransferase, 
related 
nicotinate 
phosphoribosyltransferase 
942002.72 582945.66 325336.24 2.89547 0.00369 
NCLIV_020650 
putative splicing factor 3B 
subunit 1 
U2 small nuclear 
ribonucleoprotein family protein, 
putative 
447408.15 315823.69 156321.45 2.86210 0.00316 
NCLIV_025910 Histone H2A, related 26s proteasome subunit p55, 8532398.88 4526686.83 3144178.83 2.71371 0.00066 
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Max fold 
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putative 
NCLIV_052880 unspecified product 
dense granule protein GRA6 
(GRA6) 
108609131.00 60518770.01 40076337.39 2.71006 0.01293 
NCLIV_044690 conserved hypothetical protein hypothetical protein 581942.89 271475.56 215358.05 2.70221 0.01176 
NCLIV_062730 hypothetical protein 
mitotic checkpoint protein, BUB3 
family protein 
909942.70 543893.41 350182.10 2.59848 0.04129 
NCLIV_014360 hypothetical protein elongation factor 2 family protein 2310371.76 1446449.93 895882.47 2.57888 0.01931 
NCLIV_000520 conserved hypothetical protein prefoldin subunit protein 252553.53 181093.99 99943.97 2.52695 0.032541 
NCLIV_046530 
putative reticulon domain-
containing protein 
reticulon protein 334547.43 248164.11 136183.28 2.45660 0.02728 
NCLIV_050000 
putative deoxyhypusine 
synthase,related 
deoxyhypusine synthase 1934000.51 1189742.03 792001.16 2.44192 0.03219 
NCLIV_009790 putative Rab 11b Rab11b 1687805.37 939852.19 696915.30 2.42182 0.02143 
NCLIV_045260 hypothetical protein acid phosphatase 7027822.22 4247139.50 2908004.04 2.41672 0.00674 
NCLIV_020380 conserved hypothetical protein hypothetical protein 608311.00 306796.52 251817.89 2.41568 0.02674 
NCLIV_020340 unspecified product hypothetical protein 1336222.10 697723.19 557333.42 2.39753 0.01140 
NCLIV_036640 conserved hypothetical protein hypothetical protein 16650725.79 8620559.91 7061373.27 2.35800 0.00175 
NCLIV_036830 conserved hypothetical protein hypothetical protein 8699374.91 5567171.76 3707757.33 2.34626 0.00085 
NCLIV_068460 unspecified product NTPase I 57901902.25 35903346.15 24898096.57 2.32556 0.00110 
NCLIV_047110 conserved hypothetical protein N/A 731201.03 464361.89 315671.65 2.31633 0.00534 
NCLIV_070060 RNA binding protein, putative 
RNA recognition motif-
containing protein 
14347608.80 9019075.82 6227731.82 2.30383 0.01336 
NCLIV_061200 putative actin actin like protein ALP1 (ALP1) 1629642.80 1081094.38 708821.73 2.29909 0.02298 
NCLIV_001370 
putative DEAD/DEAH box 
helicase 
DEAD/DEAH box helicase 
domain-containing protein 
1500299.11 993070.44 654154.77 2.29349 0.01900 
NCLIV_067470 hypothetical protein 
multiprotein bridging factor type 
1 family transcriptional co-
activator, putative 
1176164.21 840727.53 514204.23 2.28735 0.00284 
NCLIV_069630 hypothetical protein, conserved hypothetical protein 5748488.26 3387961.65 2567834.16 2.23865 0.02048 
NCLIV_063760 hypothetical protein 
ubiquitin carboxyl-terminal 
hydrolase, family 1 protein 
1999938.21 1392250.99 895133.71 2.23423 0.00232 
NCLIV_031750 putative importin HEAT repeat-containing protein 2596120.33 1581932.50 1168221.72 2.22228 0.02113 
NCLIV_019780 
putative KH domain containing 
protein 
hypothetical protein 8771405.31 6430697.48 3950319.81 2.22043 0.00187 
NCLIV_031530 hypothetical protein hypothetical protein 13254567.02 7992470.97 5988436.38 2.21336 0.00770 
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NCLIV_008170 hypothetical protein hypothetical protein 16013829.89 9788103.29 7248816.55 2.20916 0.00503 
NCLIV_025000 hypothetical protein trypsin domain-containing protein 4138686.77 2628971.02 1874607.73 2.20776 0.00766 
NCLIV_045860 hypothetical protein 
histone deacetylase HDAC3 
(HDAC3) 
703371.86 540945.61 321244.59 2.18952 0.00775 
NCLIV_003100 unspecified product 
serine proteinase inhibitor PI-2, 
putative 
4546940.29 3356091.04 2093847.01 2.17157 0.02069 
NCLIV_068890 unspecified product hypothetical protein 11501016.82 6773863.20 5345851.67 2.15139 0.00505 
NCLIV_053370 
putative U2 small nuclear 
ribonucleoprotein auxiliary 
factor U2AF 
splicing factor U2AF protein 624439.79 386557.49 290806.17 2.14727 0.04941 
NCLIV_022000 
putative para-aminobenzoate 
synthase 
N/A 1744171.81 1309820.70 834935.81 2.08899 0.01692 
NCLIV_012090 
putative ATP-dependent 
protease ATP-binding subunit 
N/A 743237.21 411773.61 356410.79 2.08534 0.03659 
NCLIV_013150 conserved hypothetical protein hypothetical protein 10411671.65 7444974.26 4997737.59 2.08328 0.01653 
NCLIV_013460 hypothetical protein 
lanthionine synthetase C family 
protein 
3473036.78 2412415.31 1673632.76 2.07515 0.03516 
NCLIV_068850 unspecified product 
rhoptry kinase family protein 
ROP24 (incomplete catalytic 
triad) (ROP24) 
3384889.18 1981671.93 1644380.20 2.05846 0.00534 
NCLIV_041740 conserved hypothetical protein hypothetical protein 18042761.99 11078187.63 8788788.17 2.05293 0.00675 
NCLIV_062890 hypothetical protein 
ribosomal-ubiquitin protein 
RPS27A (RPS27A) 
1592854.49 967630.17 789082.18 2.01862 0.03616 
NCLIV_041790 conserved hypothetical protein hypothetical protein 4117481.52 2802880.94 2049093.08 2.00942 0.00298 
NCLIV_011960 conserved hypothetical protein hypothetical protein 2550948.21 1955209.25 1269521.48 2.00938 0.00993 
NCLIV_054810 hypothetical protein 
protein phosphatase 2C domain-
containing protein 
661665.95 463870.77 329676.27 2.00702 0.02949 
NCLIV_061750 conserved hypothetical protein 
proteasome-interacting 
thioredoxin domain-containing 
protein 
1222449.17 859812.02 609298.88 2.00632 0.03468 
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Appendix Table VII: The preferentially expressed genes in Nc Spain 1H by FPKM 
(Fragments per kilobase of exon per million fragments mapped) 
 
 
Gene ID 
 
Description 
FPKM 
Nc Spain 
1H 
FPKM 
Nc Spain 
7 
Fold 
change 
(1H/7) 
 
q value 
NCLIV_005760 putative SRS13 
10.88 1.95 5.5784 0.0054 
NCLIV_060015 unspecified product 
44.03 9.91 4.4425 0.0054 
NCLIV_027990 
putative WD domain, G-beta 
repeat-containing protein 
4.49 1.04 4.3317 0.0498 
NCLIV_046230 
putative cGMP-inhibited 3',5'-
cyclic phosphodiesterase 
2.84 0.66 4.2684 0.0054 
NCLIV_067430 conserved hypothetical protein 
5.39 1.28 4.2081 0.0054 
NCLIV_016130 conserved hypothetical protein 
10.84 2.60 4.1759 0.0262 
NCLIV_042840 hypothetical protein 
23.65 5.82 4.0629 0.0054 
NCLIV_069900 
zinc finger (CCCH type) 
protein, putative 
2.87 0.73 3.9323 0.0349 
NCLIV_042910 malate dehydrogenase, related 
118.62 30.31 3.9142 0.0054 
NCLIV_003260 putative NcMCP3 
95.71 24.78 3.8627 0.0054 
NCLIV_038930 srs domain-containing protein 
19.96 5.29 3.7700 0.0174 
NCLIV_000750 conserved hypothetical protein 
75.53 20.05 3.7666 0.0054 
NCLIV_017300 
putative 3', 5'-cyclic nucleotide 
phosphodiesterase 
49.95 13.48 3.7067 0.0054 
NCLIV_031960 conserved hypothetical protein 
13.80 3.79 3.6409 0.0054 
NCLIV_015120 hypothetical protein 
16.51 4.63 3.5659 0.0054 
NCLIV_013310 hypothetical protein 
6.41 1.81 3.5423 0.0114 
NCLIV_068830 
PAN domain-containing 
protein (EC 3.4.21.27),related 
13.91 4.04 3.4439 0.0141 
NCLIV_019580 
SRS domain-containing 
protein 
1086.73 319.31 3.4034 0.0054 
NCLIV_009520 conserved hypothetical protein 
11.34 3.35 3.3876 0.0162 
NCLIV_021430 hypothetical protein 
8.56 2.60 3.2903 0.0054 
NCLIV_010810 
putative deoxyribose-
phosphate aldolase 
36.31 11.36 3.1967 0.0141 
NCLIV_069520 hypothetical protein 
36.03 11.44 3.1497 0.0054 
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7 
Fold 
change 
(1H/7) 
 
q value 
NCLIV_022840 conserved hypothetical protein 
14.04 4.49 3.1253 0.0141 
NCLIV_025840 conserved hypothetical protein 
18.66 6.01 3.1035 0.0054 
NCLIV_003250 putative NcMCP4 
126.36 40.85 3.0930 0.0054 
NCLIV_037560 conserved hypothetical protein 
26.60 8.66 3.0704 0.0136 
NCLIV_043730 hypothetical protein 
10.34 3.37 3.0642 0.0054 
NCLIV_037490 unspecified product 
127.20 41.62 3.0565 0.0054 
NCLIV_006950 conserved hypothetical protein 
7.08 2.34 3.0279 0.0054 
NCLIV_067410 conserved hypothetical protein 
3.33 1.11 2.9940 0.0349 
NCLIV_058130 conserved hypothetical protein 
10.67 3.57 2.9884 0.0141 
NCLIV_066170 hypothetical protein 
88.39 29.80 2.9660 0.0054 
NCLIV_034870 
MAC/Perforin domain 
containing protein, related 
3.03 1.03 2.9407 0.0392 
NCLIV_069935 unspecified product 
9.57 3.31 2.8922 0.0114 
NCLIV_026990 conserved hypothetical protein 
18.43 6.40 2.8775 0.0054 
NCLIV_037830 
putative RNA recognition 
motif-containing protein 
6.17 2.17 2.8483 0.0054 
NCLIV_027630 conserved hypothetical protein 
38.62 13.62 2.8354 0.0054 
NCLIV_027470 putative bradyzoite antigen 
201.69 71.24 2.8310 0.0141 
NCLIV_020100 
SRS domain-containing 
protein 
13.86 4.95 2.7995 0.0141 
NCLIV_000760 conserved hypothetical protein 
196.74 70.63 2.7855 0.0092 
NCLIV_038440 conserved hypothetical protein 
559.18 201.23 2.7788 0.0054 
NCLIV_070090 
hypothetical protein, 
conserved 
36.99 13.33 2.7759 0.0054 
NCLIV_038100 hypothetical protein 
11.72 4.23 2.7727 0.0402 
NCLIV_002790 conserved hypothetical protein 
1.77 0.65 2.7404 0.0162 
NCLIV_043600 srs domain-containing protein 
27.05 10.16 2.6621 0.0114 
NCLIV_025520 conserved hypothetical protein 
7.71 2.96 2.6010 0.0272 
NCLIV_022240 ATPase, related 
45.58 17.55 2.5972 0.0136 
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NCLIV_054090 hypothetical protein 
4.73 1.85 2.5555 0.0054 
NCLIV_034731 
SRS domain-containing 
protein 
31.25 12.23 2.5545 0.0114 
NCLIV_005420 
phosphoglycerate kinase, 
related 
10.49 4.11 2.5497 0.0114 
NCLIV_064160 conserved hypothetical protein 
15.87 6.27 2.5302 0.0174 
NCLIV_022830 conserved hypothetical protein 
10.09 4.00 2.5253 0.0287 
NCLIV_025120 unspecified product 
6.63 2.65 2.4970 0.0315 
NCLIV_0269 
GDA1/CD39 (nucleoside 
phospha tase) family domain 
containing protein 
25.03 10.07 2.4858 0.0054 
NCLIV_048010 
putative regulator of 
chromosome condensation 
domain-containing protein 
12.04 4.86 2.4756 0.0141 
NCLIV_062510 hypothetical protein 
13.59 5.52 2.4638 0.0449 
NCLIV_007660 hypothetical protein 
16.50 6.73 2.4522 0.0114 
NCLIV_044990 
putative high-affinity cGMP-
specific 3',5'-cyclic 
phosphodies terase 9A 
48.16 19.68 2.4477 0.0054 
NCLIV_034170 hypothetical protein 
11.37 4.65 2.4441 0.0054 
NCLIV_062990 hypothetical protein 
11.39 4.69 2.4268 0.0209 
NCLIV_033540 conserved hypothetical protein 
18.40 7.60 2.4204 0.0054 
NCLIV_051000 
Ethylene-inducible protein 
hever, related 
16.81 6.95 2.4185 0.0299 
NCLIV_043550 
glycerol-3-phosphate 
dehydrogenase, related 
90.35 37.37 2.4178 0.0209 
NCLIV_056990 
Proteophosphoglycan 5, 
related 
46.85 19.40 2.4155 0.0092 
NCLIV_065960 
Dynein heavy chain 1, 
axonemal, related 
7.73 3.21 2.4046 0.0054 
NCLIV_0380 
transporter, major facilitator 
family domain containing 
protein 
3.10 1.29 2.4046 0.0349 
NCLIV_006120 hypothetical protein 
172.10 72.61 2.3703 0.0054 
NCLIV_031040 
Peptidyl-prolyl cis-trans 
isomerase,related 
187.32 79.14 2.3669 0.0054 
NCLIV_009880 conserved hypothetical protein 
23.08 9.81 2.3527 0.0054 
NCLIV_069530 hypothetical protein 
7.25 3.09 2.3450 0.0141 
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Gene ID 
 
Description 
FPKM 
Nc Spain 
1H 
FPKM 
Nc Spain 
7 
Fold 
change 
(1H/7) 
 
q value 
NCLIV_009830 conserved hypothetical protein 
4.44 1.90 2.3376 0.0162 
NCLIV_023990 Acyl carrier protein, related 
184.02 79.39 2.3178 0.0054 
NCLIV_050200 GF18580, related 
3.15 1.36 2.3136 0.0162 
NCLIV_061910 hypothetical protein 
56.44 24.54 2.2999 0.0299 
NCLIV_015830 hypothetical protein 
8.92 3.89 2.2910 0.0136 
NCLIV_062520 
3-ketoacyl-(Acyl-carrier-
protein) reductase, related 
28.86 12.62 2.2869 0.0193 
NCLIV_028835 
Glucose-6-phosphate 
isomerase,related 
7.95 3.49 2.2759 0.0456 
NCLIV_038280 conserved hypothetical protein 
92.32 40.75 2.2657 0.0272 
NCLIV_061740 
Hydrolase, alpha/beta fold 
family, related 
20.57 9.09 2.2630 0.0262 
NCLIV_024130 
putative ATP-dependent RNA 
helicase 
20.91 9.25 2.2602 0.0272 
NCLIV_049510 
SRS domain-containing 
protein 
78.76 35.16 2.2399 0.0136 
NCLIV_066970 
putative enoyl-acyl carrier 
reductase 
16.35 7.33 2.2314 0.0456 
NCLIV_041630 conserved hypothetical protein 
80.84 36.23 2.2314 0.0054 
NCLIV_032950 
putative deoxyuridine 5'-
triphosphate 
nucleotidohydrolase 
247.83 112.74 2.1982 0.0054 
NCLIV_067820 conserved hypothetical protein 
11.93 5.44 2.1930 0.0349 
NCLIV_060330 
putative molybdopterin 
cofactor sulfurase 
6.87 3.16 2.1712 0.0450 
NCLIV_034180 conserved hypothetical protein 
35.67 16.47 2.1655 0.0449 
NCLIV_048760 conserved hypothetical protein 
14.85 6.86 2.1641 0.0092 
NCLIV_048340 
putative pseudouridylate 
synthase 1 
6.57 3.05 2.1584 0.0174 
NCLIV_063000 Coiled-coil protein, related 
11.02 5.11 2.1567 0.0114 
NCLIV_055730 hypothetical protein 
28.10 13.07 2.1505 0.0114 
NCLIV_068890 unspecified product 
92.09 43.02 2.1406 0.0054 
NCLIV_014020 Peroxiredoxin-2E-1, related 
76.10 35.60 2.1377 0.0054 
NCLIV_008230 
delta-aminolevulinic acid 
dehydratase, related 
27.99 13.10 2.1364 0.0054 
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change 
(1H/7) 
 
q value 
NCLIV_044100 conserved hypothetical protein 
57.62 26.99 2.1348 0.0141 
NCLIV_056970 conserved hypothetical protein 
13.92 6.53 2.1303 0.0092 
NCLIV_030730 
putative acetyltransferase 
domain-containing protein 
30.30 14.23 2.1291 0.0262 
NCLIV_042760 
dehydrogenases with different 
specificities,related 
74.90 35.36 2.1184 0.0054 
NCLIV_008220 putative M16 family peptidase 
8.71 4.14 2.1053 0.0114 
NCLIV_014420 conserved hypothetical protein 
17.89 8.53 2.0975 0.0378 
NCLIV_026260 GA26239, related 
24.22 11.55 2.0969 0.0054 
NCLIV_0155 
alpha/beta hydrolase fold 
domain containing protein 
23.55 11.28 2.0885 0.0141 
NCLIV_001280 putative ribokinase 
59.24 28.90 2.0499 0.0092 
NCLIV_059130 hypothetical protein 
1576.34 770.60 2.0456 0.0054 
NCLIV_023380 
putative protein kinase, PfPK7 
homolog 
19.81 9.70 2.0421 0.0449 
NCLIV_062650 
putative DNA polymerase 
alpha catalytic subunit 
10.10 5.02 2.0094 0.0054 
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Appendix Table VIII: The preferentially expressed genes in Nc Spain 7 by FPKM 
(Fragments per kilobase of exon per million fragments mapped) 
Gene ID Description 
FPKM 
Nc Spain 
1H 
FPKM 
Nc Spain 
7 
Fold  
Change 
(7/1H) 
q 
value 
NCLIV_047150 conserved hypothetical protein 
64.28 513.26 7.9853 0.0054 
NCLIV_015810 
putative retinitis pigmentosa 
GTPase regulator 
0.38 1.69 4.4847 0.0092 
NCLIV_038025 unspecified product 
0.72 2.62 3.6505 0.0092 
NCLIV_047420 conserved hypothetical protein 
0.53 1.84 3.4888 0.0092 
NCLIV_019010 putative protein phosphatase 2C 
1.48 4.64 3.1355 0.0054 
NCLIV_006200 hypothetical protein 
5.49 16.87 3.0747 0.0054 
NCLIV_069070 hypothetical protein 
110.04 310.79 2.8243 0.0141 
NCLIV_011060 conserved hypothetical protein 
10.85 29.42 2.7107 0.0114 
NCLIV_058960 conserved hypothetical protein 
2.43 6.51 2.6747 0.0054 
NCLIV_038021 unspecified product 
3.41 8.73 2.5585 0.0054 
NCLIV_050550 hypothetical protein 
6.38 15.86 2.4874 0.0114 
NCLIV_006110 conserved hypothetical protein 
8.67 21.15 2.4407 0.0054 
NCLIV_004950 putative actin 
17.14 41.13 2.4001 0.0054 
NCLIV_046220 hypothetical protein 
2.65 6.27 2.3639 0.0114 
NCLIV_019000 putative adenosine transporter 
273.57 626.16 2.2889 0.0136 
NCLIV_027970 conserved hypothetical protein 
243.12 555.45 2.2847 0.0249 
NCLIV_053760 unspecified product 
19.39 44.28 2.2839 0.0054 
NCLIV_012010 hypothetical protein 
64.07 144.57 2.2564 0.0054 
NCLIV_064250 
putative zinc finger (CCCH type) 
protein 
9.51 21.20 2.2306 0.0054 
NCLIV_066300 
putative PPR repeat-containing 
protein 
5.47 11.68 2.1356 0.0092 
NCLIV_027980 hypothetical protein 
76.14 160.91 2.1133 0.0287 
NCLIV_030830 conserved hypothetical protein 
29.53 61.02 2.0662 0.0141 
NCLIV_022340 putative protein phosphatase 2C 
7.99 16.38 2.0498 0.0114 
NCLIV_007720 conserved hypothetical protein 
978.93 1991.08 2.0339 0.0341 
NCLIV_006870 conserved hypothetical protein 
119.30 241.70 2.0260 0.0114 
NCLIV_051850 conserved hypothetical protein 
7.32 14.64 2.0003 0.0174 
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Appendix Table IX: Gene Ontology enrichment: Biological Process, Cellular Component and Molecular Function of 106 preferentially 
expressed genes in Nc Spain 1H obtained from ToxoDB website 
Term ID Description Bgd count Result count Pct of bgd Fold enrichment 
Odds 
ratio 
P-value Benjamini 
Biological Process: 
GO:0007018 microtubule-based movement 29 5 17.2 10.04 10.89 0.000220797 0.005393107 
GO:0006928 cellular component movement 31 5 16.1 9.39 10.18 0.000291519 0.005393107 
GO:0007017 microtubule-based process 41 5 12.2 7.1 7.67 0.000931729 0.011491325 
GO:0008150 biological_process 1771 40 2.3 1.31 2.01 0.008398139 0.04983305 
GO:0005975 carbohydrate metabolic process 86 5 5.8 3.38 3.61 0.017750058 0.04983305 
GO:0006633 fatty acid biosynthetic process 12 2 16.7 9.7 10.01 0.022399471 0.04983305 
GO:0071704 organic substance metabolic process 65 4 6.2 3.58 3.77 0.028068384 0.04983305 
GO:1901135 
carbohydrate derivative metabolic 
process 
65 4 6.2 3.58 3.77 0.028068384 0.04983305 
GO:0006096 glycolysis 14 2 14.3 8.32 8.58 0.028908028 0.04983305 
GO:0006631 fatty acid metabolic process 14 2 14.3 8.32 8.58 0.028908028 0.04983305 
GO:0046080 dUTP metabolic process 1 1 100 58.21 59.21 0.033499416 0.04983305 
GO:0009211 
pyrimidine deoxyribonucleoside 
triphosphate metabolic process 
1 1 100 58.21 59.21 0.033499416 0.04983305 
GO:0009211 
pyrimidine deoxyribonucleoside 
triphosphate metabolic process 
1 1 100 58.21 59.21 0.033499416 0.04983305 
GO:0006200 ATP catabolic process 1 1 100 58.21 59.21 0.033499416 0.04983305 
GO:0009200 
deoxyribonucleoside triphosphate 
metabolic process 
1 1 100 58.21 59.21 0.033499416 0.04983305 
GO:0042816 vitamin B6 metabolic process 1 1 100 58.21 59.21 0.033499416 0.04983305 
GO:0042822 
pyridoxal phosphate metabolic 
process 
1 1 100 58.21 59.21 0.033499416 0.04983305 
GO:0046836 glycolipid transport 1 1 100 58.21 59.21 0.033499416 0.04983305 
GO:0042823 
pyridoxal phosphate biosynthetic 
process 
1 1 100 58.21 59.21 0.033499416 0.04983305 
GO:0042819 vitamin B6 biosynthetic process 1 1 100 58.21 59.21 0.033499416 0.04983305 
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Term ID Description Bgd count Result count Pct of bgd Fold enrichment 
Odds 
ratio 
P-value Benjamini 
GO:0032787 
monocarboxylic acid metabolic 
process 
16 2 12.5 7.28 7.5 0.036073864 0.04983305 
GO:0007596 blood coagulation 18 2 11.1 6.47 6.66 0.043847232 0.04983305 
GO:0050878 regulation of body fluid levels 18 2 11.1 6.47 6.66 0.043847232 0.04983305 
GO:0007599 hemostasis 18 2 11.1 6.47 6.66 0.043847232 0.04983305 
GO:0042060 wound healing 18 2 11.1 6.47 6.66 0.043847232 0.04983305 
GO:0050817 coagulation 18 2 11.1 6.47 6.66 0.043847232 0.04983305 
GO:0009611 response to wounding 18 2 11.1 6.47 6.66 0.043847232 0.04983305 
GO:0044283 small molecule biosynthetic process 44 3 6.8 3.97 4.13 0.043889576 0.04983305 
GO:0006007 glucose catabolic process 19 2 10.5 6.13 6.31 0.04794688 0.04983305 
GO:0032501 multicellular organismal process 19 2 10.5 6.13 6.31 0.04794688 0.04983305 
GO:0019320 hexose catabolic process 19 2 10.5 6.13 6.31 0.04794688 0.04983305 
GO:0046365 monosaccharide catabolic process 19 2 10.5 6.13 6.31 0.04794688 0.04983305 
GO:0006108 malate metabolic process 2 1 50 29.1 29.6 0.04983305 0.04983305 
GO:0009394 
2'-deoxyribonucleotide metabolic 
process 
2 1 50 29.1 29.6 0.04983305 0.04983305 
GO:0046168 
glycerol-3-phosphate catabolic 
process 
2 1 50 29.1 29.6 0.04983305 0.04983305 
GO:0046434 organophosphate catabolic process 2 1 50 29.1 29.6 0.04983305 0.04983305 
GO:0009219 
pyrimidine deoxyribonucleotide 
metabolic process 
2 1 50 29.1 29.6 0.04983305 0.04983305 
GO:0006072 
glycerol-3-phosphate metabolic 
process 
2 1 50 29.1 29.6 0.04983305 0.04983305 
Cellular Component: 
GO:0030286 dynein complex 10 5 50 29.1 31.75 3.05E-06 2.13E-05 
GO:0005875 microtubule associated complex 17 5 29.4 17.12 18.64 2.44E-05 8.54E-05 
GO:0015630 microtubule cytoskeleton 22 5 22.7 13.23 14.38 7.01E-05 0.000164 
GO:0044430 cytoskeletal part 35 5 14.3 8.32 9.01 0.000483 0.000846 
GO:0005856 cytoskeleton 40 5 12.5 7.28 7.87 0.000841 0.001178 
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Term ID Description Bgd count Result count Pct of bgd Fold enrichment 
Odds 
ratio 
P-value Benjamini 
GO:0005576 extracellular region 25 3 12 6.98 7.31 0.011103 0.012954 
GO:0000015 phosphopyruvate hydratase complex 2 1 50 29.1 29.6 0.049833 0.049833 
Molecular Function: 
GO:0003777 microtubule motor activity 29 5 17.2 10.04 10.89 0.000221 0.005299 
GO:0003774 motor activity 40 5 12.5 7.28 7.87 0.000841 0.010095 
GO:0016887 ATPase activity 111 7 6.3 3.67 4.04 0.003326 0.019487 
GO:0003824 catalytic activity 1365 34 2.5 1.45 2.09 0.004211 0.019487 
GO:0016616 
oxidoreductase activity, acting on 
the CH-OH group of donors, NAD 
or NADP as acceptor 
18 3 16.7 9.7 10.18 0.004901 0.019487 
GO:0016614 
oxidoreductase activity, acting on 
CH-OH group of donors 
18 3 16.7 9.7 10.18 0.004901 0.019487 
GO:0048037 cofactor binding 64 5 7.8 4.55 4.88 0.005684 0.019487 
GO:0050662 coenzyme binding 50 4 8 4.66 4.93 0.012371 0.037113 
GO:0051287 NAD binding 9 2 22.2 12.93 13.36 0.013984 0.037291 
GO:0016836 hydro-lyase activity 10 2 20 11.64 12.02 0.016601 0.039841 
GO:0016835 carbon-oxygen lyase activity 11 2 18.2 10.58 10.93 0.019408 0.042345 
GO:0016829 lyase activity 37 3 8.1 4.72 4.92 0.029042 0.049833 
GO:0004655 porphobilinogen synthase activity 1 1 100 58.21 59.21 0.033499 0.049833 
GO:0051861 glycolipid binding 1 1 100 58.21 59.21 0.033499 0.049833 
GO:0004316 
3-oxoacyl-[acyl-carrier-protein] 
reductase (NADPH) activity 
1 1 100 58.21 59.21 0.033499 0.049833 
GO:0017089 glycolipid transporter activity 1 1 100 58.21 59.21 0.033499 0.049833 
GO:0036094 small molecule binding 641 17 2.7 1.54 1.77 0.039846 0.049833 
GO:0019842 vitamin binding 18 2 11.1 6.47 6.66 0.043847 0.049833 
GO:0030060 L-malate dehydrogenase activity 2 1 50 29.1 29.6 0.049833 0.049833 
GO:0016615 malate dehydrogenase activity 2 1 50 29.1 29.6 0.049833 0.049833 
GO:0004312 fatty acid synthase activity 2 1 50 29.1 29.6 0.049833 0.049833 
GO:0004618 phosphoglycerate kinase activity 2 1 50 29.1 29.6 0.049833 0.049833 
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Term ID Description Bgd count Result count Pct of bgd Fold enrichment 
Odds 
ratio 
P-value Benjamini 
GO:0004634 phosphopyruvate hydratase activity 2 1 50 29.1 29.6 0.049833 0.049833 
GO:0004367 
glycerol-3-phosphate 
dehydrogenase [NAD+] activity 
2 1 50 29.1 29.6 0.049833 0.049833 
 
Appendix Table X: Gene Ontology enrichment: Molecular Function of 26 preferentially genes in Nc Spain 7 obtained from ToxoDB 
website 
 
Term ID Description Bgd count Result count Pct of bgd Fold enrichment 
Odds 
ratio 
P-value Benjamini 
Molecular Function: 
GO:0015932 
nucleobase-containing compound 
transmembrane transporter 
activity 
3 1 33.3 225.07 281.08 0.005905 0.008857 
GO:0005337 
nucleoside transmembrane 
transporter activity 
3 1 33.3 225.07 281.08 0.005905 0.008857 
GO:0008270 zinc ion binding 232 2 0.9 5.82 9.03 0.041488 0.041488 
 
182 
 
Appendix Table XI: List of the preferentially expressed proteins between Nc Spain 
1H and Nc Spain 7 at 12 hours post infection  
 
Accession Description Nc 1H-12hr Nc 7-12hr 
 fold 
change 
q Value 
NCLIV_019580 
SRS domain-containing 
protein  231858.78 35504.03 6.53 0.010746 
NCLIV_036640 
conserved hypothetical 
protein  108409.67 20405.09 5.31 0.008713 
NCLIV_022920 Renin, related  34023.50 6502.10 5.23 0.030770 
NCLIV_049520 
conserved hypothetical 
protein  4166595.93 819051.67 5.09 0.008507 
NCLIV_053400 
putative histidine acid 
phosphatase domain 
containing protein  42523.80 11744.66 3.62 0.022182 
NCLIV_027130 
putative orotate 
phosphoribosyltransferase  94128.62 26321.87 3.58 0.028098 
NCLIV_019740 
putative 3',5'-cyclic 
phosphodiesterase  1855.22 537.45 3.45 0.037773 
NCLIV_012090 
putative ATP-dependent 
protease ATP-binding 
subunit  23024.58 6765.14 3.40 0.008507 
NCLIV_018300 HIT family protein, related  1402055.32 421821.52 3.32 0.015779 
NCLIV_012460 
Lysyl-tRNA synthetase, 
related  2738.42 826.68 3.31 0.033022 
NCLIV_020990 
perforin-like protein PLP1 
(PLP1) 202166.73 65566.06 3.08 0.008713 
NCLIV_037460 citrate synthase I 404581.56 152092.37 2.66 0.024397 
NCLIV_065500 
conserved hypothetical 
protein  445504.88 169497.34 2.63 0.019484 
NCLIV_007010 
putative cathepsin C2 
(TgCPC2)  274324.17 106677.59 2.57 0.024397 
NCLIV_011110 
putative DEAH-box 
RNA/DNA helicase  20806.13 8151.25 2.55 0.017953 
NCLIV_041850 
putative Hsp20/alpha 
crystallin domain-
containing protein  2691566.63 1056490.91 2.55 0.010746 
NCLIV_069110 Hypothetical protein 27187.72 11024.39 2.47 0.049761 
NCLIV_022970 
microneme protein MIC2 
(TgMIC2) 1968924.78 807753.17 2.44 0.008713 
NCLIV_062770 
microneme protein MIC9 
(TgMIC9) 1338525.62 552301.84 2.42 0.037391 
NCLIV_010600 
putative microneme protein 
MIC3  34648535.79 14310252.42 2.42 0.008507 
NCLIV_021050 subtilisin SUB1 (SUB1) 31262506.44 13006985.74 2.40 0.008507 
NCLIV_065650 
putative TPR domain-
containing protein  13131.28 5468.16 2.40 0.048395 
NCLIV_034740 SAG3 protein, related  1113514.51 465065.22 2.39 0.012491 
NCLIV_040860 
tryptophanyl-
tRNAsynthetase,related  6121008.97 2562229.27 2.39 0.012212 
NCLIV_035300 
putative lipoate-protein 
ligase a  51071.75 21468.28 2.38 0.030770 
NCLIV_063810 
conserved hypothetical 
protein  87183.75 36819.63 2.37 0.012212 
NCLIV_040360 conserved hypothetical 7030.48 2991.37 2.35 0.040856 
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Accession Description Nc 1H-12hr Nc 7-12hr 
 fold 
change 
q Value 
protein  
NCLIV_054180 Oligoribonuclease, related  29805.83 13001.33 2.29 0.034743 
NCLIV_004200 glycosyltransferase 16610.25 7300.75 2.28 0.024441 
NCLIV_028680 
putative apical membrane 
antigen 1  4014612.86 1813866.83 2.21 0.008507 
NCLIV_050070 
Fructose-1,6-
bisphosphatase,related  322702.68 146592.73 2.20 0.013771 
NCLIV_041900 
phosphoenolpyruvate 
carboxykinase (ATP), 
related  2037292.77 928541.53 2.19 0.008713 
NCLIV_068230 
putative nucleoside-
triphosphatase  90478.38 41289.12 2.19 0.030846 
NCLIV_041100 
novel protein (Zgc:66430), 
related  1796958.14 835818.69 2.15 0.041156 
NCLIV_010960 
putative 
phosphoglucomutase  440019.73 205599.99 2.14 0.008507 
NCLIV_033690 
microneme protein MIC2 
(MIC2) 3492514.19 1641563.85 2.13 0.008507 
NCLIV_031610 
Glucosamine--fructose-6-
phosphate aminotransferase 
(Isomerizing), related  19838.00 9328.99 2.13 0.032766 
NCLIV_007105 unspecified product  1031577.09 487742.66 2.12 0.040856 
NCLIV_002940 
putative microneme protein 
MIC4  14034172.45 6669575.98 2.10 0.012491 
NCLIV_006000 
inositol(myo)-1(or 4)-
monophosphatase 2, 
putative 14991.28 7142.59 2.10 0.040900 
NCLIV_054840 
conserved hypothetical 
protein  336594.75 161187.10 2.09 0.033319 
NCLIV_067490 
putative protein 
phosphatase 2C  579671.36 278164.64 2.08 0.014900 
NCLIV_030630 
p25-alpha family protein, 
related  855722.54 411525.19 2.08 0.019427 
NCLIV_029160 
Pyridine nucleotide-
disulphide oxidoreductase 
family protein, related  13199.86 6348.73 2.08 0.046223 
NCLIV_060910 
putative DNA replication 
licensing factor  5165.89 2489.96 2.07 0.014900 
NCLIV_054140 
putative adenylyl cyclase 
associated protein  6297412.92 3047581.05 2.07 0.010728 
NCLIV_001180 
cbr-GPDH-1 protein, 
related  30393.72 14727.40 2.06 0.018399 
NCLIV_058830 
Superoxide dismutase, 
related  949048.26 466515.17 2.03 0.008507 
NCLIV_050080 
Fructose-1,6-bisphosphatase 
class 1, related  380865.11 187603.60 2.03 0.037924 
NCLIV_060860 Cytochrome c, related  1576594.78 779486.43 2.02 0.009868 
NCLIV_019540 
putative signal recognition 
particle protein  57677.51 28535.99 2.02 0.022182 
NCLIV_064760 
Contig An16c0190, 
complete genome. 
(Precursor), related  110329.28 54614.20 2.02 0.041113 
NCLIV_010370 
ubiquitin carrier protein, 
related  4119127.04 2043757.57 2.02 0.038979 
NCLIV_060920 conserved hypothetical 521150.48 258834.59 2.01 0.045450 
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Accession Description Nc 1H-12hr Nc 7-12hr 
 fold 
change 
q Value 
protein  
NCLIV_011830 
conserved hypothetical 
protein  1314349.61 653788.87 2.01 0.012491 
NCLIV_027230 
Dihydropteroate synthase, 
related  1431083.85 713607.59 2.01 0.013090 
NCLIV_001070 histone H2B, related  7791806.08 15605528.63 -2.00 0.017404 
NCLIV_043670 
high mobility group protein, 
related  1151938.37 2390237.21 -2.07 0.017404 
NCLIV_003700 
conserved hypothetical 
protein  14446.79 32043.80 -2.22 0.014900 
NCLIV_004680 
conserved hypothetical 
protein  20769.13 46693.30 -2.25 0.019397 
NCLIV_013660 
putative regulator of 
chromosome condensation  6377.03 14349.80 -2.25 0.020239 
NCLIV_005800 unspecified product  7195.45 16205.26 -2.25 0.022798 
NCLIV_014020 Peroxiredoxin-2E-1, related  282524.95 673761.93 -2.38 0.013090 
NCLIV_057260 
conserved hypothetical 
protein  82029.28 199503.64 -2.43 0.039167 
NCLIV_066900 
putative serine/threonine 
protein phosphatase 5  9279.11 22678.42 -2.44 0.017355 
NCLIV_004340 
beta-hydroxyacyl-acyl 
carrier protein dehydratase 
(FABZ) 56748.15 139170.82 -2.45 0.039981 
NCLIV_032350 
putative CW-type zinc 
finger domain-containing 
protein  2525.99 6259.59 -2.48 0.015322 
NCLIV_056130 
conserved hypothetical 
protein  13192.10 33564.92 -2.54 0.040900 
NCLIV_030730 
putative acetyltransferase 
domain-containing protein  14096.68 36815.12 -2.61 0.017404 
NCLIV_058260 hypothetical protein  1164911.44 3279434.40 -2.82 0.047104 
NCLIV_026210 
apicoplast triosephosphate 
translocator APT1 (APT1) 184546.29 520631.34 -2.82 0.012491 
NCLIV_068850 
Predicted rhoptry kinase, 
subfamily ROP24  307278.32 902109.59 -2.94 0.013006 
NCLIV_023610 
putative vacuolar ATP 
synthase subunit d  15790.05 46768.32 -2.96 0.017404 
NCLIV_054690 
conserved hypothetical 
protein  1986.18 6184.76 -3.11 0.036273 
NCLIV_039290 
transporter/permease 
protein 27564.48 91771.33 -3.33 0.013090 
NCLIV_010650 
conserved hypothetical 
protein  8883.40 41789.64 -4.70 0.034678 
NCLIV_023620 
SRS domain-containing 
protein  11502.31 86069.13 -7.48 0.010746 
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Appendix Table XII: List of the preferentially expressed proteins between Nc Spain 
1H and Nc Spain 7 at 36 hours post infection  
 
Accession Description Nc 1H-12hr Nc 7-12hr Fold change q Value 
NCLIV_019580 SRS domain-containing 
protein  
310976.44 24221.35 12.84 0.010883 
NCLIV_049520 conserved hypothetical 
protein  
2507869.20 373570.09 6.71 0.010883 
NCLIV_036640 conserved hypothetical 
protein  
127257.07 24347.76 5.23 0.010883 
NCLIV_022920 Renin, related  32867.31 7075.07 4.65 0.038356 
NCLIV_053400 putative histidine acid 
phosphatase domain 
containing protein  
40155.73 9350.73 4.29 0.028609 
NCLIV_007010 putative cathepsin C2 
(TgCPC2)  
233283.80 85862.13 2.72 0.014564 
NCLIV_008320 protein F23B2.12, partially 
confirmed by transcript 
evidence, related  
12493.30 4700.62 2.66 0.044566 
NCLIV_034740 SAG3 protein, related  1041019.33 396426.25 2.63 0.031809 
NCLIV_054180 Oligoribonuclease, related  41807.20 17333.89 2.41 0.028769 
NCLIV_063570 Peptidase, S9A/B/C family, 
catalytic domain protein, 
related  
21390.60 9018.98 2.37 0.011348 
NCLIV_031190 hypothetical protein  18011.58 7713.01 2.34 0.028609 
NCLIV_029980 putative glycerol-3-
phosphate acyltransferase  
3380.46 1537.80 2.20 0.031926 
NCLIV_031610 Glucosamine--fructose-6-
phosphate aminotransferase 
(Isomerizing), related  
19100.03 9354.26 2.04 0.045253 
NCLIV_014020 Peroxiredoxin-2E-1, related  374177.49 877317.10 -2.34 0.015602 
NCLIV_041790 conserved hypothetical 
protein  
25897.95 61260.14 -2.37 0.015602 
NCLIV_021440 putative RNA binding 
protein  
2927.82 6963.26 -2.38 0.028897 
NCLIV_050060 conserved hypothetical 
protein  
168618.80 416210.17 -2.47 0.010883 
NCLIV_068850 Predicted rhoptry kinase, 
subfamily ROP24  
258639.81 718755.68 -2.78 0.019337 
NCLIV_023620 SRS domain-containing 
protein  
25932.55 92463.37 -3.57 0.015602 
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Appendix Table XIII: List of the preferentially expressed proteins between Nc Spain 
1H and Nc Spain 7 at 56 hours post infection  
 
Accession Description Nc 1H-12hr Nc 7-12hr Fold change q Value 
NCLIV_019580 
SRS domain-containing 
protein  405070.47 27750.65 14.60 0.029754 
NCLIV_049520 
conserved hypothetical 
protein  4695254.48 398502.96 11.78 0.027763 
NCLIV_053400 
putative histidine acid 
phosphatase domain 
containing protein  50228.98 6897.47 7.28 0.027695 
NCLIV_022920 Renin, related  48104.27 6882.95 6.99 0.030872 
NCLIV_038110 
microneme protein 
MIC17C (MIC17C) 53036.03 9072.69 5.85 0.036448 
NCLIV_036640 
conserved hypothetical 
protein  136244.42 27137.77 5.02 0.038383 
NCLIV_007010 
putative cathepsin C2 
(TgCPC2)  436309.74 114586.24 3.81 0.041009 
NCLIV_034740 SAG3 protein, related  1452783.02 400652.78 3.63 0.016437 
NCLIV_008320 
protein F23B2.12, partially 
confirmed by transcript 
evidence, related  18642.01 5178.58 3.60 0.026346 
NCLIV_057890 
Protein-L-isoaspartate O-
methyltransferase, related  43970.20 13736.82 3.20 0.024390 
NCLIV_010050 
srs domain-containing 
protein  220825.35 70365.37 3.14 0.028942 
NCLIV_033690 
microneme protein MIC2 
(MIC2) 5164280.08 1867479.75 2.77 0.033339 
NCLIV_002940 
putative microneme 
protein MIC4  24897767.32 9017437.25 2.76 0.016437 
NCLIV_019740 
putative 3',5'-cyclic 
phosphodiesterase  3620.19 1317.63 2.75 0.029575 
NCLIV_028680 
putative apical membrane 
antigen 1  6386731.22 2354879.39 2.71 0.049602 
NCLIV_020990 
perforin-like protein PLP1 
(PLP1) 311947.73 115987.59 2.69 0.027695 
NCLIV_018530 
conserved hypothetical 
protein  301938.58 113617.22 2.66 0.018488 
NCLIV_068040 
dolichol-phosphate-
mannose synthase family 
protein 29312.09 11032.95 2.66 0.025724 
NCLIV_043270 
putative microneme 
protein MIC1  35922016.21 14004447.55 2.57 0.025376 
NCLIV_012460 
Lysyl-tRNA synthetase, 
related  2906.03 1148.66 2.53 0.039886 
NCLIV_063570 
Peptidase, S9A/B/C 
family, catalytic domain 
protein, related  18390.84 7307.77 2.52 0.014812 
NCLIV_019540 
putative signal recognition 
particle protein  57604.59 23196.15 2.48 0.024390 
NCLIV_000740 class I chitinase, related  44813.57 18104.39 2.48 0.007757 
NCLIV_065500 
conserved hypothetical 
protein  483184.45 203994.24 2.37 0.000810 
NCLIV_021050 subtilisin SUB1 (SUB1) 42177088.26 18189478.66 2.32 0.045328 
NCLIV_010600 putative microneme 47685525.48 20568374.02 2.32 0.007757 
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Accession Description Nc 1H-12hr Nc 7-12hr Fold change q Value 
protein MIC3  
NCLIV_061620 hypothetical protein  94758.35 41032.99 2.31 0.025253 
NCLIV_060220 
conserved hypothetical 
protein  235590.26 103967.58 2.27 0.001965 
NCLIV_044230 
putative peptidase M16 
domain containing protein  193502.92 86978.56 2.22 0.017098 
NCLIV_031300 
conserved hypothetical 
protein  19532.98 8858.65 2.20 0.033525 
NCLIV_025760 GD24343, related  11936.57 5472.93 2.18 0.030673 
NCLIV_004380 cathepsin L, related  209872.33 96866.38 2.17 0.016437 
NCLIV_051970 
putative MIC2-associated 
protein M2AP  13344397.82 6185665.56 2.16 0.016167 
NCLIV_026500 ALVEOLIN1, related  253787.20 118003.62 2.15 0.037862 
NCLIV_009810 
ABC transporter 
transmembrane region 
domain-containing protein 6179.38 2888.94 2.14 0.025253 
NCLIV_022970 
microneme protein MIC2 
(MIC2) 2926575.86 1385297.87 2.11 0.014471 
NCLIV_054250 
Acyl-CoA synthetase, 
related  237789.24 114258.22 2.08 0.036672 
NCLIV_046140 
SAG-related sequence 
SRS67 (SRS67) 450194.60 217267.62 2.07 0.033379 
NCLIV_066250 
microneme protein MIC10 
(MIC10) 7031677.34 3398518.59 2.07 0.017098 
NCLIV_055690 
small GTPase Rab2, 
putative 430632.31 209274.21 2.06 0.008960 
NCLIV_011110 
putative DEAH-box 
RNA/DNA helicase  19478.67 9483.93 2.05 0.049702 
NCLIV_029980 
putative glycerol-3-
phosphate acyltransferase  4775.41 2325.68 2.05 0.030888 
NCLIV_047570 
putative rRNA processing 
protein  395877.67 195957.40 2.02 0.024390 
NCLIV_020720 
putative microneme 
protein MIC11  4785446.63 2376646.56 2.01 0.025376 
NCLIV_011740 
conserved hypothetical 
protein  180637.34 361764.45 -2.00 0.007514 
NCLIV_025990 hydrolase 53559.04 109114.64 -2.04 0.044545 
NCLIV_014040 
conserved hypothetical 
protein  215092.43 443753.72 -2.06 0.035656 
NCLIV_012950 
putative ubiquitin family 
domain-containing protein  5902.62 12357.41 -2.09 0.021485 
NCLIV_005150 beta-1 tubulin, putative 1982208.85 4173581.92 -2.11 0.013384 
NCLIV_030730 
putative acetyltransferase 
domain-containing protein  14445.32 32315.82 -2.24 0.025376 
NCLIV_007770 
putative Rhoptry kinase 
family protein, truncated 
(incomplete catalytic triad)  433281.75 981688.73 -2.27 0.007757 
NCLIV_0292 
YbaK / prolyl-tRNA 
synthetases associated 
domain containing protein  11133.55 25340.18 -2.28 0.024390 
NCLIV_026210 
apicoplast triosephosphate 
translocator APT1 (APT1) 150238.98 343906.78 -2.29 0.010723 
NCLIV_021440 
putative RNA binding 
protein  3683.31 8433.30 -2.29 0.018227 
NCLIV_050060 conserved hypothetical 140363.12 360203.43 -2.57 0.014471 
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Accession Description Nc 1H-12hr Nc 7-12hr Fold change q Value 
protein  
NCLIV_037480 
putative TPR domain-
containing protein  7415.09 20097.99 -2.71 0.027695 
NCLIV_042450 
putative opine 
dehydrogenase  261448.45 725179.73 -2.77 0.024390 
NCLIV_023620 
SRS domain-containing 
protein  27474.34 80197.10 -2.92 0.000768 
NCLIV_063510 GH23102, related  3411.84 10578.65 -3.10 0.000387 
NCLIV_068850 
Predicted rhoptry kinase, 
subfamily ROP24  335590.44 1111069.09 -3.31 0.002306 
NCLIV_046320 
conserved hypothetical 
protein  361.17 1890.59 -5.23 0.000387 
NCLIV_019660 
putative ubiquitin 
conjugation factor  137.21 3690.97 -26.90 0.030673 
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Appendix Table XIV: Gene Ontology enrichment: Biological Process, Cellular Component and Molecular Function of 56 preferentially 
expressed proteins in Nc Spain 1H at 12 hours post infection obtained from ToxoDB website 
Term ID Description Bgd count Result count Pct of bgd Fold enrichment 
Odds 
ratio 
P-value Benjamini 
Biological Process: 
GO:0005975 carbohydrate metabolic process 86 8 9.3 7.48 9 1.33E-05 0.000185783 
GO:0016051 carbohydrate biosynthetic process 10 2 20 16.08 16.83 0.009000007 0.049090616 
GO:0008152 metabolic process 1317 24 1.8 1.46 2.08 0.01367035 0.049090616 
GO:0009249 protein lipoylation 1 1 100 80.38 82.32 0.024428335 0.049090616 
GO:0006436 tryptophanyl-tRNA aminoacylation 1 1 100 80.38 82.32 0.024428335 0.049090616 
GO:0018065 protein-cofactor linkage 1 1 100 80.38 82.32 0.024428335 0.049090616 
GO:0044238 primary metabolic process 1075 20 1.9 1.5 1.95 0.024545308 0.049090616 
GO:0046434 organophosphate catabolic process 2 1 50 40.19 41.15 0.036423069 0.049803173 
GO:0046168 
glycerol-3-phosphate catabolic 
process 2 1 50 40.19 41.15 0.036423069 0.049803173 
GO:0006072 
glycerol-3-phosphate metabolic 
process 2 1 50 40.19 41.15 0.036423069 0.049803173 
GO:0072593 
reactive oxygen species metabolic 
process 3 1 33.3 26.79 27.42 0.048273795 0.049803173 
GO:0006801 superoxide metabolic process 3 1 33.3 26.79 27.42 0.048273795 0.049803173 
GO:1901135 
carbohydrate derivative metabolic 
process 65 3 4.6 3.71 3.92 0.049803173 0.049803173 
GO:0071704 organic substance metabolic process 65 3 4.6 3.71 3.92 0.049803173 0.049803173 
Cellular component: 
GO:0005785 
signal recognition particle receptor 
complex 
1 1 100 80.38 82.32 0.02443 0.02443 
GO:0005791 rough endoplasmic reticulum 1 1 100 80.38 82.32 0.02443 0.02443 
GO:0030867 
rough endoplasmic reticulum 
membrane 
1 1 100 80.38 82.32 0.02443 0.02443 
Molecular function: 
GO:0004360 
glutamine-fructose-6-phosphate 
transaminase (isomerizing) activity 1 1 100 80.38 82.32 0.024428 0.048273795 
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Term ID Description Bgd count Result count Pct of bgd Fold enrichment 
Odds 
ratio 
P-value Benjamini 
GO:0005047 signal recognition particle binding 1 1 100 80.38 82.32 0.024428 0.048273795 
GO:0004156 dihydropteroate synthase activity 1 1 100 80.38 82.32 0.024428 0.048273795 
GO:0070548 
L-glutamine aminotransferase 
activity 1 1 100 80.38 82.32 0.024428 0.048273795 
GO:0004830 tryptophan-tRNA ligase activity 1 1 100 80.38 82.32 0.024428 0.048273795 
GO:0003848 
2-amino-4-hydroxy-6-
hydroxymethyldihydropteridine 
diphosphokinase activity 1 1 100 80.38 82.32 0.024428 0.048273795 
GO:0004612 
phosphoenolpyruvate carboxykinase 
(ATP) activity 2 1 50 40.19 41.15 0.036423 0.048273795 
GO:0008483 transaminase activity 2 1 50 40.19 41.15 0.036423 0.048273795 
GO:0004611 
phosphoenolpyruvate carboxykinase 
activity 2 1 50 40.19 41.15 0.036423 0.048273795 
GO:0004367 
glycerol-3-phosphate 
dehydrogenase [NAD+] activity 2 1 50 40.19 41.15 0.036423 0.048273795 
GO:0016769 
transferase activity, transferring 
nitrogenous groups 2 1 50 40.19 41.15 0.036423 0.048273795 
GO:0003824 catalytic activity 1365 23 1.7 1.35 1.78 0.043708 0.048273795 
GO:0048037 cofactor binding 64 3 4.7 3.77 3.98 0.048007 0.048273795 
GO:0004784 superoxide dismutase activity 3 1 33.3 26.79 27.42 0.048274 0.048273795 
GO:0042802 identical protein binding 3 1 33.3 26.79 27.42 0.048274 0.048273795 
GO:0016721 
oxidoreductase activity, acting on 
superoxide radicals as acceptor 3 1 33.3 26.79 27.42 0.048274 0.048273795 
GO:0042803 protein homodimerization activity 3 1 33.3 26.79 27.42 0.048274 0.048273795 
GO:0043021 ribonucleoprotein complex binding 3 1 33.3 26.79 27.42 0.048274 0.048273795 
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Appendix Table XV: Gene Ontology enrichment: Biological Process, Cellular Component and Molecular Function of 21 decreased 
abundance proteins in Nc Spain 1H at 12-hours post infection obtained from ToxoDB website 
Term ID Description Bgd count Result count Pct of bgd Fold enrichment 
Odds 
ratio 
P-value Benjamini 
Biological Process: 
GO:0008643 carbohydrate transport 5 1 20 56.27 61.29 0.02108 0.04855 
GO:0015693 magnesium ion transport 7 1 14.3 40.19 43.75 0.02802 0.04855 
GO:0070838 divalent metal ion transport 8 1 12.5 35.17 38.27 0.03147 0.04855 
GO:0072511 divalent inorganic cation transport 8 1 12.5 35.17 38.27 0.03147 0.04855 
GO:0071702 organic substance transport 10 1 10 28.13 30.6 0.03833 0.04855 
GO:0006633 fatty acid biosynthetic process 12 1 8.3 23.44 25.48 0.04516 0.04855 
GO:0071824 
protein-DNA complex subunit 
organization 13 1 7.7 21.64 23.52 0.04855 0.04855 
GO:0031497 chromatin assembly 13 1 7.7 21.64 23.52 0.04855 0.04855 
GO:0034728 nucleosome organization 13 1 7.7 21.64 23.52 0.04855 0.04855 
GO:0065004 protein-DNA complex assembly 13 1 7.7 21.64 23.52 0.04855 0.04855 
GO:0006334 nucleosome assembly 13 1 7.7 21.64 23.52 0.04855 0.04855 
GO:0006323 DNA packaging 13 1 7.7 21.64 23.52 0.04855 0.04855 
Cellular Component: 
GO:0000785 chromatin 10 1 10 28.13 30.6 0.03833 0.04516 
GO:0000786 nucleosome 10 1 10 28.13 30.6 0.03833 0.04516 
GO:0032993 protein-DNA complex 10 1 10 28.13 30.6 0.03833 0.04516 
GO:0000139 Golgi membrane 11 1 9.1 25.58 27.81 0.04175 0.04516 
GO:0044427 chromosomal part 12 1 8.3 23.44 25.48 0.04516 0.04516 
Molecular Function: 
GO:0008324 
cation transmembrane transporter 
activity 50 2 4 11.25 13.3 0.01382 0.041953676 
GO:0005351 sugar:hydrogen symporter activity 4 1 25 70.33 76.64 0.01759 0.041953676 
GO:0051119 
sugar transmembrane transporter 
activity 4 1 25 70.33 76.64 0.01759 0.041953676 
192 
 
Term ID Description Bgd count Result count Pct of bgd Fold enrichment 
Odds 
ratio 
P-value Benjamini 
GO:0015295 solute:hydrogen symporter activity 4 1 25 70.33 76.64 0.01759 0.041953676 
GO:0005402 cation:sugar symporter activity 4 1 25 70.33 76.64 0.01759 0.041953676 
GO:0015144 
carbohydrate transmembrane 
transporter activity 5 1 20 56.27 61.29 0.02108 0.041953676 
GO:0015075 
ion transmembrane transporter 
activity 64 2 3.1 8.79 10.35 0.02175 0.041953676 
GO:0022891 
substrate-specific transmembrane 
transporter activity 71 2 2.8 7.92 9.31 0.02629 0.041953676 
GO:0015095 
magnesium ion transmembrane 
transporter activity 7 1 14.3 40.19 43.75 0.02802 0.041953676 
GO:0022857 transmembrane transporter activity 76 2 2.6 7.4 8.68 0.02974 0.041953676 
GO:0072509 
divalent inorganic cation 
transmembrane transporter activity 8 1 12.5 35.17 38.27 0.03147 0.041953676 
GO:0015293 symporter activity 9 1 11.1 31.26 34.01 0.03491 0.041953676 
GO:0015294 solute:cation symporter activity 9 1 11.1 31.26 34.01 0.03491 0.041953676 
GO:0046982 protein heterodimerization activity 10 1 10 28.13 30.6 0.03833 0.041953676 
GO:0016836 hydro-lyase activity 10 1 10 28.13 30.6 0.03833 0.041953676 
GO:0016835 carbon-oxygen lyase activity 11 1 9.1 25.58 27.81 0.04175 0.041953676 
GO:0022892 
substrate-specific transporter 
activity 92 2 2.2 6.12 7.14 0.04195 0.041953676 
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Appendix Table XVI: Gene Ontology enrichment: Biological Process, Cellular Component and Molecular Function of 13 preferentially 
expressed proteins in Nc Spain 1H at 36 hours post infection obtained from ToxoDB website 
Term ID Description Bgd count Result count Pct of bgd Fold enrichment 
Odds 
ratio 
P-value Benjamini 
Biological Process: 
GO:0006508 proteolysis 133 4 3 12.69 24.38 0.00016 0.00063 
GO:0016051 carbohydrate biosynthetic process 10 1 10 42.2 48.09 0.02574 0.04425 
GO:0019538 protein metabolic process 607 4 0.7 2.78 4.56 0.03996 0.04425 
GO:0008152 metabolic process 1317 6 0.5 1.92 4.69 0.04425 0.04425 
Molecular Function: 
GO:0070011 
peptidase activity, acting on L-
amino acid peptides 99 4 4 17.05 33.1 5.16E-05 0.00047 
GO:0008233 peptidase activity 106 4 3.8 15.92 30.85 6.69E-05 0.00047 
GO:0017171 serine hydrolase activity 24 2 8.3 35.17 46.56 0.00154523 0.00541 
GO:0008236 serine-type peptidase activity 24 2 8.3 35.17 46.56 0.00154523 0.00541 
GO:0016787 hydrolase activity 537 5 0.9 3.93 8.81 0.00380201 0.00945 
GO:0004360 
glutamine-fructose-6-phosphate 
transaminase (isomerizing) activity 1 1 100 422 482.14 0.00472324 0.00945 
GO:0070548 
L-glutamine aminotransferase 
activity 1 1 100 422 482.14 0.00472324 0.00945 
GO:0016769 
transferase activity, transferring 
nitrogenous groups 2 1 50 211 241 0.00707753 0.01101 
GO:0008483 transaminase activity 2 1 50 211 241 0.00707753 0.01101 
GO:0004190 aspartic-type endopeptidase activity 9 1 11.1 46.89 53.44 0.02342158 0.02981 
GO:0008234 cysteine-type peptidase activity 15 1 6.7 28.13 32.01 0.0372429 0.03953 
GO:0004527 exonuclease activity 16 1 6.3 26.37 30 0.03952973 0.03953 
GO:0030246 carbohydrate binding 16 1 6.3 26.37 30 0.03952973 0.03953 
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Appendix Table XVII: Gene Ontology enrichment: Biological Process, Cellular Component and Molecular Function of 44 preferentially 
expressed proteins in Nc Spain 1H at 56 hours post infection obtained from ToxoDB website 
Term ID Description Bgd count Result count Pct of bgd Fold enrichment 
Odds 
ratio 
P-value Benjamini 
Biological Process: 
GO:0006508 proteolysis 133 9 6.8 8.79 12.91 5.09E-07 3.01E-05 
GO:1901136 
carbohydrate derivative catabolic 
process 
30 3 10 12.98 14.55 0.001857789 0.028737471 
GO:0019538 protein metabolic process 607 11 1.8 2.35 3.35 0.003562624 0.028737471 
GO:0008150 biological_process 1771 20 1.1 1.47 3.02 0.009604511 0.028737471 
GO:0007599 hemostasis 18 2 11.1 14.43 15.55 0.009807769 0.028737471 
GO:0007596 blood coagulation 18 2 11.1 14.43 15.55 0.009807769 0.028737471 
GO:0042060 wound healing 18 2 11.1 14.43 15.55 0.009807769 0.028737471 
GO:0050878 regulation of body fluid levels 18 2 11.1 14.43 15.55 0.009807769 0.028737471 
GO:0009611 response to wounding 18 2 11.1 14.43 15.55 0.009807769 0.028737471 
GO:0050817 coagulation 18 2 11.1 14.43 15.55 0.009807769 0.028737471 
GO:0032501 multicellular organismal process 19 2 10.5 13.67 14.72 0.010789502 0.028737471 
GO:0043170 macromolecule metabolic process 823 12 1.5 1.89 2.66 0.01303924 0.028737471 
GO:1901135 
carbohydrate derivative metabolic 
process 
65 3 4.6 5.99 6.64 0.014295634 0.028737471 
GO:0071704 organic substance metabolic process 65 3 4.6 5.99 6.64 0.014295634 0.028737471 
GO:0006032 chitin catabolic process 1 1 100 129.85 135 0.015228948 0.028737471 
GO:0006026 aminoglycan catabolic process 1 1 100 129.85 135 0.015228948 0.028737471 
GO:0046348 amino sugar catabolic process 1 1 100 129.85 135 0.015228948 0.028737471 
GO:0000272 polysaccharide catabolic process 1 1 100 129.85 135 0.015228948 0.028737471 
GO:1901072 
glucosamine-containing compound 
catabolic process 
1 1 100 129.85 135 0.015228948 0.028737471 
GO:0046130 
purine ribonucleoside catabolic 
process 
24 2 8.3 10.82 11.64 0.016311915 0.028737471 
GO:0006152 purine nucleoside catabolic process 24 2 8.3 10.82 11.64 0.016311915 0.028737471 
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Term ID Description Bgd count Result count Pct of bgd Fold enrichment 
Odds 
ratio 
P-value Benjamini 
GO:1901069 
guanosine-containing compound 
catabolic process 
24 2 8.3 10.82 11.64 0.016311915 0.028737471 
GO:0006184 GTP catabolic process 24 2 8.3 10.82 11.64 0.016311915 0.028737471 
GO:0044238 primary metabolic process 1075 14 1.3 1.69 2.5 0.016876802 0.028737471 
GO:0008152 metabolic process 1317 16 1.2 1.58 2.5 0.017163759 0.028737471 
GO:0050896 response to stimulus 130 4 3.1 4 4.54 0.017534593 0.028737471 
GO:0009154 
purine ribonucleotide catabolic 
process 
25 2 8 10.39 11.17 0.017534728 0.028737471 
GO:0006195 purine nucleotide catabolic process 25 2 8 10.39 11.17 0.017534728 0.028737471 
GO:0072523 
purine-containing compound 
catabolic process 
25 2 8 10.39 11.17 0.017534728 0.028737471 
GO:0009164 nucleoside catabolic process 25 2 8 10.39 11.17 0.017534728 0.028737471 
GO:0009143 
nucleoside triphosphate catabolic 
process 
25 2 8 10.39 11.17 0.017534728 0.028737471 
GO:0042454 ribonucleoside catabolic process 25 2 8 10.39 11.17 0.017534728 0.028737471 
GO:0009207 
purine ribonucleoside triphosphate 
catabolic process 
25 2 8 10.39 11.17 0.017534728 0.028737471 
GO:0009261 ribonucleotide catabolic process 25 2 8 10.39 11.17 0.017534728 0.028737471 
GO:0009203 
ribonucleoside triphosphate 
catabolic process 
25 2 8 10.39 11.17 0.017534728 0.028737471 
GO:0009146 
purine nucleoside triphosphate 
catabolic process 
25 2 8 10.39 11.17 0.017534728 0.028737471 
GO:0046700 heterocycle catabolic process 27 2 7.4 9.62 10.34 0.020093753 0.031198196 
GO:0046039 GTP metabolic process 27 2 7.4 9.62 10.34 0.020093753 0.031198196 
GO:0009166 nucleotide catabolic process 28 2 7.1 9.27 9.96 0.021428761 0.032417869 
GO:0044270 
cellular nitrogen compound 
catabolic process 
29 2 6.9 8.95 9.62 0.022799974 0.032809719 
GO:0034655 
nucleobase-containing compound 
catabolic process 
29 2 6.9 8.95 9.62 0.022799974 0.032809719 
GO:1901068 
guanosine-containing compound 
metabolic process 
31 2 6.5 8.38 8.99 0.025648679 0.036030287 
GO:0044036 cell wall macromolecule metabolic 3 1 33.3 43.28 44.97 0.030234764 0.037471116 
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Term ID Description Bgd count Result count Pct of bgd Fold enrichment 
Odds 
ratio 
P-value Benjamini 
process 
GO:0071554 cell wall organization or biogenesis 3 1 33.3 43.28 44.97 0.030234764 0.037471116 
GO:0016998 
cell wall macromolecule catabolic 
process 
3 1 33.3 43.28 44.97 0.030234764 0.037471116 
GO:0046128 
purine ribonucleoside metabolic 
process 
35 2 5.7 7.42 7.95 0.031755183 0.037471116 
GO:0009144 
purine nucleoside triphosphate 
metabolic process 
35 2 5.7 7.42 7.95 0.031755183 0.037471116 
GO:0009199 
ribonucleoside triphosphate 
metabolic process 
35 2 5.7 7.42 7.95 0.031755183 0.037471116 
GO:0042278 purine nucleoside metabolic process 35 2 5.7 7.42 7.95 0.031755183 0.037471116 
GO:0009205 
purine ribonucleoside triphosphate 
metabolic process 
35 2 5.7 7.42 7.95 0.031755183 0.037471116 
GO:0009141 
nucleoside triphosphate metabolic 
process 
36 2 5.6 7.21 7.73 0.033363771 0.038597303 
GO:0009119 ribonucleoside metabolic process 37 2 5.4 7.02 7.52 0.035004048 0.039716131 
GO:0065007 biological regulation 165 4 2.4 3.15 3.54 0.037344695 0.040393524 
GO:0051704 multi-organism process 4 1 25 32.46 33.72 0.03765498 0.040393524 
GO:0009405 pathogenesis 4 1 25 32.46 33.72 0.03765498 0.040393524 
GO:0009150 
purine ribonucleotide metabolic 
process 
40 2 5 6.49 6.95 0.040109664 0.042258396 
GO:0009259 ribonucleotide metabolic process 41 2 4.9 6.33 6.78 0.041871379 0.04334055 
GO:0009116 nucleoside metabolic process 42 2 4.8 6.18 6.62 0.043662151 0.044414947 
GO:0006163 purine nucleotide metabolic process 43 2 4.7 6.04 6.46 0.045481473 0.045481473 
Cellular Component: 
GO:0005785 
signal recognition particle receptor 
complex 
1 1 100 129.85 135 0.01523 0.01753 
GO:0005791 rough endoplasmic reticulum 1 1 100 129.85 135 0.01523 0.01753 
GO:0030867 
rough endoplasmic reticulum 
membrane 
1 1 100 129.85 135 0.01523 0.01753 
GO:0005576 extracellular region 25 2 8 10.39 11.17 0.01753 0.01753 
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Term ID Description Bgd count Result count Pct of bgd Fold enrichment 
Odds 
ratio 
P-value Benjamini 
Molecular Function: 
GO:0070011 
peptidase activity, acting on L-
amino acid peptides 99 7 7.1 9.18 12.2 9.44E-06 0.00012 
GO:0008233 peptidase activity 106 7 6.6 8.57 11.37 1.44E-05 0.00012 
GO:0016787 hydrolase activity 537 12 2.2 2.9 4.53 0.000301538 0.00171 
GO:0017171 serine hydrolase activity 24 3 12.5 16.23 18.22 0.001026753 0.00349 
GO:0008236 serine-type peptidase activity 24 3 12.5 16.23 18.22 0.001026753 0.00349 
GO:0008234 cysteine-type peptidase activity 15 2 13.3 17.31 18.67 0.007119735 0.02017 
GO:0004568 chitinase activity 1 1 100 129.85 135 0.015228948 0.02834 
GO:0004719 
protein-L-isoaspartate (D-aspartate) 
O-methyltransferase activity 1 1 100 129.85 135 0.015228948 0.02834 
GO:0005047 signal recognition particle binding 1 1 100 129.85 135 0.015228948 0.02834 
GO:0004175 endopeptidase activity 69 3 4.3 5.65 6.25 0.016672522 0.02834 
GO:0051998 
protein carboxyl O-
methyltransferase activity 2 1 50 64.92 67.48 0.02275955 0.03224 
GO:0010340 
carboxyl-O-methyltransferase 
activity 2 1 50 64.92 67.48 0.02275955 0.03224 
GO:0008171 O-methyltransferase activity 3 1 33.3 43.28 44.97 0.030234764 0.03671 
GO:0043021 ribonucleoprotein complex binding 3 1 33.3 43.28 44.97 0.030234764 0.03671 
GO:0008276 protein methyltransferase activity 5 1 20 25.97 26.97 0.045020588 0.04502 
GO:0016798 
hydrolase activity, acting on 
glycosyl bonds 5 1 20 25.97 26.97 0.045020588 0.04502 
GO:0004553 
hydrolase activity, hydrolyzing O-
glycosyl compounds 5 1 20 25.97 26.97 0.045020588 0.04502 
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Appendix Table XVIII: Gene Ontology enrichment: Biological Process, Cellular Component and Molecular Function of 18 decreased 
abundant proteins in Nc Spain 1H at 56 hours post infection obtained from ToxoDB website 
Term ID Description Bgd count Result count Pct of bgd Fold enrichment 
Odds 
ratio 
P-value Benjamini 
Biological Process: 
GO:0016567 protein ubiquitination 3 1 33.3 102.3 112.43 0.01293 0.0396 
GO:0032446 
protein modification by small 
protein conjugation 
4 1 25 76.73 84.3 0.01614 0.0396 
GO:0070647 
protein modification by small 
protein conjugation or removal 
4 1 25 76.73 84.3 0.01614 0.0396 
GO:0036211 protein modification process 220 3 1.4 4.19 5.38 0.03132 0.0396 
GO:0006464 cellular protein modification process 220 3 1.4 4.19 5.38 0.03132 0.0396 
GO:0051258 protein polymerization 9 1 11.1 34.1 37.41 0.03205 0.0396 
GO:0044248 cellular catabolic process 89 2 2.2 6.9 8.21 0.03354 0.0396 
GO:0043623 cellular protein complex assembly 10 1 10 30.69 33.66 0.0352 0.0396 
GO:0043412 macromolecule modification 256 3 1.2 3.6 4.57 0.04604 0.04604 
Cellular Components: 
GO:0005869 dynactin complex 1 1 100 306.91 337.5 0.00649 0.01902 
GO:0043234 protein complex 156 3 1.9 5.9 7.74 0.01268 0.01902 
GO:0000151 ubiquitin ligase complex 9 1 11.1 34.1 37.41 0.03205 0.03205 
Molecular Functions: 
GO:0034450 ubiquitin-ubiquitin ligase activity 1 1 100 306.91 337.5 0.00649 0.019457496 
GO:0004842 ubiquitin-protein ligase activity 6 1 16.7 51.15 56.17 0.02253 0.02253345 
GO:0019787 
small conjugating protein ligase 
activity 
6 1 16.7 51.15 56.17 0.02253 0.02253345 
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